id	sid	tid	token	lemma	pos
aiua-11830	1	1	stesura	stesura	PROPN
aiua-11830	1	2	seveso	seveso	PROPN
aiua-11830	1	3	archivio	archivio	PROPN
aiua-11830	1	4	italiano	italiano	X
aiua-11830	1	5	di	di	X
aiua-11830	1	6	urologia	urologia	PROPN
aiua-11830	1	7	e	e	PROPN
aiua-11830	1	8	andrologia	andrologia	NOUN
aiua-11830	1	9	2023	2023	NUM
aiua-11830	1	10	;	;	PUNCT
aiua-11830	1	11	95(4):11830	95(4):11830	NUM
aiua-11830	1	12	1	1	NUM
aiua-11830	1	13	original	original	ADJ
aiua-11830	1	14	paper	paper	NOUN
aiua-11830	1	15	introduction	introduction	NOUN
aiua-11830	1	16	the	the	DET
aiua-11830	1	17	implementation	implementation	NOUN
aiua-11830	1	18	of	of	ADP
aiua-11830	1	19	multiparametric	multiparametric	ADJ
aiua-11830	1	20	prostate	prostate	NOUN
aiua-11830	1	21	magnetic	magnetic	ADJ
aiua-11830	1	22	resonance	resonance	NOUN
aiua-11830	1	23	imaging	imaging	NOUN
aiua-11830	1	24	(	(	PUNCT
aiua-11830	1	25	mpmri	mpmri	PROPN
aiua-11830	1	26	)	)	PUNCT
aiua-11830	1	27	prior	prior	ADV
aiua-11830	1	28	to	to	ADP
aiua-11830	1	29	prostate	prostate	NOUN
aiua-11830	1	30	biopsy	biopsy	NOUN
aiua-11830	1	31	led	lead	VERB
aiua-11830	1	32	to	to	ADP
aiua-11830	1	33	an	an	DET
aiua-11830	1	34	improvement	improvement	NOUN
aiua-11830	1	35	of	of	ADP
aiua-11830	1	36	clinically	clinically	ADV
aiua-11830	1	37	significant	significant	ADJ
aiua-11830	1	38	prostate	prostate	NOUN
aiua-11830	1	39	cancer	cancer	NOUN
aiua-11830	1	40	(	(	PUNCT
aiua-11830	1	41	cspca	cspca	NOUN
aiua-11830	1	42	)	)	PUNCT
aiua-11830	1	43	diagnosis	diagnosis	NOUN
aiua-11830	1	44	,	,	PUNCT
aiua-11830	1	45	contributing	contribute	VERB
aiua-11830	1	46	to	to	ADP
aiua-11830	1	47	the	the	DET
aiua-11830	1	48	reduction	reduction	NOUN
aiua-11830	1	49	of	of	ADP
aiua-11830	1	50	unnecessary	unnecessary	ADJ
aiua-11830	1	51	biopsies	biopsy	NOUN
aiua-11830	1	52	and	and	CCONJ
aiua-11830	1	53	over	over	ADP
aiua-11830	1	54	-	-	PUNCT
aiua-11830	1	55	diagnosis	diagnosis	NOUN
aiua-11830	1	56	of	of	ADP
aiua-11830	1	57	clinically	clinically	ADV
aiua-11830	1	58	insignificant	insignificant	ADJ
aiua-11830	1	59	prostate	prostate	NOUN
aiua-11830	1	60	cancer	cancer	NOUN
aiua-11830	1	61	and	and	CCONJ
aiua-11830	1	62	resultant	resultant	VERB
aiua-11830	1	63	overtreatment	overtreatment	NOUN
aiua-11830	1	64	(	(	PUNCT
aiua-11830	1	65	1	1	NUM
aiua-11830	1	66	-	-	SYM
aiua-11830	1	67	4	4	NUM
aiua-11830	1	68	)	)	PUNCT
aiua-11830	1	69	.	.	PUNCT
aiua-11830	2	1	in	in	ADP
aiua-11830	2	2	the	the	DET
aiua-11830	2	3	setting	setting	NOUN
aiua-11830	2	4	of	of	ADP
aiua-11830	2	5	primary	primary	ADJ
aiua-11830	2	6	diagnosis	diagnosis	NOUN
aiua-11830	2	7	,	,	PUNCT
aiua-11830	2	8	mpmri	mpmri	PROPN
aiua-11830	2	9	was	be	AUX
aiua-11830	2	10	interpreted	interpret	VERB
aiua-11830	2	11	according	accord	VERB
aiua-11830	2	12	to	to	ADP
aiua-11830	2	13	the	the	DET
aiua-11830	2	14	prostate	prostate	NOUN
aiua-11830	2	15	imaging	imaging	NOUN
aiua-11830	2	16	reporting	reporting	NOUN
aiua-11830	2	17	and	and	CCONJ
aiua-11830	2	18	data	datum	NOUN
aiua-11830	2	19	system	system	NOUN
aiua-11830	2	20	(	(	PUNCT
aiua-11830	2	21	pirads	pirad	NOUN
aiua-11830	2	22	)	)	PUNCT
aiua-11830	2	23	,	,	PUNCT
aiua-11830	2	24	created	create	VERB
aiua-11830	2	25	by	by	ADP
aiua-11830	2	26	the	the	DET
aiua-11830	2	27	european	european	PROPN
aiua-11830	2	28	society	society	NOUN
aiua-11830	2	29	of	of	ADP
aiua-11830	2	30	urogenital	urogenital	ADJ
aiua-11830	2	31	radiology	radiology	NOUN
aiua-11830	2	32	(	(	PUNCT
aiua-11830	2	33	esur	esur	PROPN
aiua-11830	2	34	)	)	PUNCT
aiua-11830	2	35	to	to	PART
aiua-11830	2	36	standardize	standardize	VERB
aiua-11830	2	37	radiologic	radiologic	ADJ
aiua-11830	2	38	reports	report	NOUN
aiua-11830	2	39	and	and	CCONJ
aiua-11830	2	40	improve	improve	VERB
aiua-11830	2	41	the	the	DET
aiua-11830	2	42	diagnostic	diagnostic	ADJ
aiua-11830	2	43	quality	quality	NOUN
aiua-11830	2	44	of	of	ADP
aiua-11830	2	45	prostate	prostate	NOUN
aiua-11830	2	46	mpmri	mpmri	PROPN
aiua-11830	2	47	exams	exam	NOUN
aiua-11830	2	48	(	(	PUNCT
aiua-11830	2	49	5	5	NUM
aiua-11830	2	50	)	)	PUNCT
aiua-11830	2	51	.	.	PUNCT
aiua-11830	3	1	in	in	ADP
aiua-11830	3	2	2021	2021	NUM
aiua-11830	3	3	a	a	DET
aiua-11830	3	4	new	new	ADJ
aiua-11830	3	5	pirads	pirad	NOUN
aiua-11830	3	6	version	version	NOUN
aiua-11830	3	7	2.1	2.1	NUM
aiua-11830	3	8	replaced	replace	VERB
aiua-11830	3	9	the	the	DET
aiua-11830	3	10	previous	previous	ADJ
aiua-11830	3	11	2.0	2.0	NUM
aiua-11830	3	12	version	version	NOUN
aiua-11830	3	13	published	publish	VERB
aiua-11830	3	14	in	in	ADP
aiua-11830	3	15	2015	2015	NUM
aiua-11830	3	16	(	(	PUNCT
aiua-11830	3	17	6	6	NUM
aiua-11830	3	18	)	)	PUNCT
aiua-11830	3	19	.	.	PUNCT
aiua-11830	4	1	the	the	DET
aiua-11830	4	2	pi	pi	NOUN
aiua-11830	4	3	-	-	PUNCT
aiua-11830	4	4	rads	rad	NOUN
aiua-11830	4	5	score	score	NOUN
aiua-11830	4	6	report	report	VERB
aiua-11830	4	7	the	the	DET
aiua-11830	4	8	likelihood	likelihood	NOUN
aiua-11830	4	9	of	of	ADP
aiua-11830	4	10	a	a	DET
aiua-11830	4	11	cspca	cspca	NOUN
aiua-11830	4	12	based	base	VERB
aiua-11830	4	13	on	on	ADP
aiua-11830	4	14	various	various	ADJ
aiua-11830	4	15	mpmri	mpmri	PROPN
aiua-11830	4	16	characteristics	characteristic	NOUN
aiua-11830	4	17	.	.	PUNCT
aiua-11830	5	1	categories	category	NOUN
aiua-11830	5	2	pi	pi	NOUN
aiua-11830	5	3	-	-	PUNCT
aiua-11830	5	4	rads	rad	NOUN
aiua-11830	5	5	1	1	NUM
aiua-11830	5	6	or	or	CCONJ
aiua-11830	5	7	2	2	NUM
aiua-11830	5	8	indicate	indicate	VERB
aiua-11830	5	9	(	(	PUNCT
aiua-11830	5	10	very	very	ADV
aiua-11830	5	11	)	)	PUNCT
aiua-11830	5	12	low	low	ADJ
aiua-11830	5	13	likelihood	likelihood	NOUN
aiua-11830	5	14	of	of	ADP
aiua-11830	5	15	cspca	cspca	NOUN
aiua-11830	5	16	,	,	PUNCT
aiua-11830	5	17	whereas	whereas	SCONJ
aiua-11830	5	18	categories	category	NOUN
aiua-11830	5	19	4	4	NUM
aiua-11830	5	20	or	or	CCONJ
aiua-11830	5	21	5	5	NUM
aiua-11830	5	22	indicate	indicate	VERB
aiua-11830	5	23	(	(	PUNCT
aiua-11830	5	24	very	very	ADV
aiua-11830	5	25	)	)	PUNCT
aiua-11830	5	26	high	high	ADJ
aiua-11830	5	27	likelihood	likelihood	NOUN
aiua-11830	5	28	of	of	ADP
aiua-11830	5	29	cspca	cspca	NOUN
aiua-11830	5	30	.	.	PUNCT
aiua-11830	6	1	the	the	DET
aiua-11830	6	2	european	european	PROPN
aiua-11830	6	3	association	association	PROPN
aiua-11830	6	4	of	of	ADP
aiua-11830	6	5	urology	urology	NOUN
aiua-11830	6	6	recommends	recommend	VERB
aiua-11830	6	7	performing	perform	VERB
aiua-11830	6	8	a	a	DET
aiua-11830	6	9	prostate	prostate	NOUN
aiua-11830	6	10	biopsy	biopsy	NOUN
aiua-11830	6	11	when	when	SCONJ
aiua-11830	6	12	mpmri	mpmri	PROPN
aiua-11830	6	13	shows	show	VERB
aiua-11830	6	14	lesions	lesion	NOUN
aiua-11830	6	15	with	with	ADP
aiua-11830	6	16	pi	pi	NOUN
aiua-11830	6	17	-	-	PUNCT
aiua-11830	6	18	rads	rad	NOUN
aiua-11830	6	19	≥	≥	NOUN
aiua-11830	6	20	3	3	NUM
aiua-11830	6	21	(	(	PUNCT
aiua-11830	6	22	7	7	NUM
aiua-11830	6	23	)	)	PUNCT
aiua-11830	6	24	.	.	PUNCT
aiua-11830	7	1	however	however	ADV
aiua-11830	7	2	,	,	PUNCT
aiua-11830	7	3	the	the	DET
aiua-11830	7	4	pi	pi	NOUN
aiua-11830	7	5	-	-	PUNCT
aiua-11830	7	6	rads	rad	NOUN
aiua-11830	7	7	category	category	NOUN
aiua-11830	7	8	3	3	NUM
aiua-11830	7	9	is	be	AUX
aiua-11830	7	10	an	an	DET
aiua-11830	7	11	intermediate	intermediate	ADJ
aiua-11830	7	12	status	status	NOUN
aiua-11830	7	13	,	,	PUNCT
aiua-11830	7	14	with	with	ADP
aiua-11830	7	15	an	an	DET
aiua-11830	7	16	equivocal	equivocal	ADJ
aiua-11830	7	17	risk	risk	NOUN
aiua-11830	7	18	of	of	ADP
aiua-11830	7	19	malignancy	malignancy	NOUN
aiua-11830	7	20	(	(	PUNCT
aiua-11830	7	21	8)	8)	NUM
aiua-11830	7	22	.	.	PUNCT
aiua-11830	8	1	a	a	DET
aiua-11830	8	2	metanalysis	metanalysis	NOUN
aiua-11830	8	3	with	with	ADP
aiua-11830	8	4	17	17	NUM
aiua-11830	8	5	studies	study	NOUN
aiua-11830	8	6	reported	report	VERB
aiua-11830	8	7	a	a	DET
aiua-11830	8	8	cancer	cancer	NOUN
aiua-11830	8	9	detection	detection	NOUN
aiua-11830	8	10	rate	rate	NOUN
aiua-11830	8	11	of	of	ADP
aiua-11830	8	12	16	16	NUM
aiua-11830	8	13	%	%	NOUN
aiua-11830	8	14	(	(	PUNCT
aiua-11830	8	15	7	7	NUM
aiua-11830	8	16	-	-	SYM
aiua-11830	8	17	27	27	NUM
aiua-11830	8	18	%	%	NOUN
aiua-11830	8	19	)	)	PUNCT
aiua-11830	8	20	in	in	ADP
aiua-11830	8	21	patients	patient	NOUN
aiua-11830	8	22	with	with	ADP
aiua-11830	8	23	pi	pi	NOUN
aiua-11830	8	24	-	-	PUNCT
aiua-11830	8	25	rads	rad	NOUN
aiua-11830	8	26	category	category	NOUN
aiua-11830	8	27	3	3	NUM
aiua-11830	8	28	lesions	lesion	NOUN
aiua-11830	8	29	.	.	PUNCT
aiua-11830	9	1	(	(	PUNCT
aiua-11830	9	2	9	9	X
aiua-11830	9	3	)	)	PUNCT
aiua-11830	9	4	the	the	DET
aiua-11830	9	5	psa	psa	NOUN
aiua-11830	9	6	density	density	NOUN
aiua-11830	9	7	(	(	PUNCT
aiua-11830	9	8	psad	psad	PROPN
aiua-11830	9	9	)	)	PUNCT
aiua-11830	9	10	has	have	AUX
aiua-11830	9	11	been	be	AUX
aiua-11830	9	12	proposed	propose	VERB
aiua-11830	9	13	as	as	ADP
aiua-11830	9	14	a	a	DET
aiua-11830	9	15	tool	tool	NOUN
aiua-11830	9	16	to	to	PART
aiua-11830	9	17	facilitate	facilitate	VERB
aiua-11830	9	18	biopsy	biopsy	NOUN
aiua-11830	9	19	decisions	decision	NOUN
aiua-11830	9	20	on	on	ADP
aiua-11830	9	21	pi	pi	NOUN
aiua-11830	9	22	-	-	PUNCT
aiua-11830	9	23	rads	rad	NOUN
aiua-11830	9	24	categoric	categoric	ADJ
aiua-11830	9	25	3	3	NUM
aiua-11830	9	26	lesions	lesion	NOUN
aiua-11830	9	27	.	.	PUNCT
aiua-11830	10	1	a	a	DET
aiua-11830	10	2	recent	recent	ADJ
aiua-11830	10	3	study	study	NOUN
aiua-11830	10	4	on	on	ADP
aiua-11830	10	5	biopsy	biopsy	ADJ
aiua-11830	10	6	naive	naive	ADJ
aiua-11830	10	7	patients	patient	NOUN
aiua-11830	10	8	with	with	ADP
aiua-11830	10	9	pi	pi	NOUN
aiua-11830	10	10	-	-	PUNCT
aiua-11830	10	11	rads	rad	NOUN
aiua-11830	10	12	3	3	NUM
aiua-11830	10	13	lesions	lesion	NOUN
aiua-11830	10	14	and	and	CCONJ
aiua-11830	10	15	low	low	ADJ
aiua-11830	10	16	psad	psad	ADJ
aiua-11830	10	17	(	(	PUNCT
aiua-11830	10	18	<	<	X
aiua-11830	10	19	0.10	0.10	NUM
aiua-11830	10	20	ng	ng	NOUN
aiua-11830	10	21	/	/	SYM
aiua-11830	10	22	ml	ml	NOUN
aiua-11830	10	23	/	/	SYM
aiua-11830	10	24	ml	ml	VERB
aiua-11830	10	25	)	)	PUNCT
aiua-11830	10	26	reported	report	VERB
aiua-11830	10	27	a	a	DET
aiua-11830	10	28	low	low	ADJ
aiua-11830	10	29	risk	risk	NOUN
aiua-11830	10	30	of	of	ADP
aiua-11830	10	31	sigintroduction	sigintroduction	NOUN
aiua-11830	10	32	and	and	CCONJ
aiua-11830	10	33	objectives	objective	NOUN
aiua-11830	10	34	:	:	PUNCT
aiua-11830	10	35	the	the	DET
aiua-11830	10	36	prostate	prostate	NOUN
aiua-11830	10	37	imaging	imaging	NOUN
aiua-11830	10	38	reporting	reporting	NOUN
aiua-11830	10	39	and	and	CCONJ
aiua-11830	10	40	data	datum	NOUN
aiua-11830	10	41	system	system	NOUN
aiua-11830	10	42	(	(	PUNCT
aiua-11830	10	43	pi	pi	NOUN
aiua-11830	10	44	-	-	PUNCT
aiua-11830	10	45	rads	rad	NOUN
aiua-11830	10	46	)	)	PUNCT
aiua-11830	10	47	score	score	NOUN
aiua-11830	10	48	reports	report	VERB
aiua-11830	10	49	the	the	DET
aiua-11830	10	50	likelihood	likelihood	NOUN
aiua-11830	10	51	of	of	ADP
aiua-11830	10	52	a	a	DET
aiua-11830	10	53	clinically	clinically	ADV
aiua-11830	10	54	significant	significant	ADJ
aiua-11830	10	55	prostate	prostate	NOUN
aiua-11830	10	56	cancer	cancer	NOUN
aiua-11830	10	57	(	(	PUNCT
aiua-11830	10	58	cspca	cspca	PROPN
aiua-11830	10	59	)	)	PUNCT
aiua-11830	10	60	based	base	VERB
aiua-11830	10	61	on	on	ADP
aiua-11830	10	62	various	various	ADJ
aiua-11830	10	63	multiparametric	multiparametric	ADJ
aiua-11830	10	64	prostate	prostate	NOUN
aiua-11830	10	65	magnetic	magnetic	ADJ
aiua-11830	10	66	resonance	resonance	NOUN
aiua-11830	10	67	imaging	imaging	NOUN
aiua-11830	10	68	(	(	PUNCT
aiua-11830	10	69	mpmri	mpmri	PROPN
aiua-11830	10	70	)	)	PUNCT
aiua-11830	10	71	characteristics	characteristic	NOUN
aiua-11830	10	72	.	.	PUNCT
aiua-11830	11	1	the	the	DET
aiua-11830	11	2	pi	pi	NOUN
aiua-11830	11	3	-	-	PUNCT
aiua-11830	11	4	rads	rad	NOUN
aiua-11830	11	5	category	category	NOUN
aiua-11830	11	6	3	3	NUM
aiua-11830	11	7	is	be	AUX
aiua-11830	11	8	an	an	DET
aiua-11830	11	9	intermediate	intermediate	ADJ
aiua-11830	11	10	status	status	NOUN
aiua-11830	11	11	,	,	PUNCT
aiua-11830	11	12	with	with	ADP
aiua-11830	11	13	an	an	DET
aiua-11830	11	14	equivocal	equivocal	ADJ
aiua-11830	11	15	risk	risk	NOUN
aiua-11830	11	16	of	of	ADP
aiua-11830	11	17	malignancy	malignancy	NOUN
aiua-11830	11	18	.	.	PUNCT
aiua-11830	12	1	the	the	DET
aiua-11830	12	2	psa	psa	NOUN
aiua-11830	12	3	density	density	NOUN
aiua-11830	12	4	(	(	PUNCT
aiua-11830	12	5	psad	psad	PROPN
aiua-11830	12	6	)	)	PUNCT
aiua-11830	12	7	has	have	AUX
aiua-11830	12	8	been	be	AUX
aiua-11830	12	9	proposed	propose	VERB
aiua-11830	12	10	as	as	ADP
aiua-11830	12	11	a	a	DET
aiua-11830	12	12	tool	tool	NOUN
aiua-11830	12	13	to	to	PART
aiua-11830	12	14	facilitate	facilitate	VERB
aiua-11830	12	15	biopsy	biopsy	NOUN
aiua-11830	12	16	decisions	decision	NOUN
aiua-11830	12	17	on	on	ADP
aiua-11830	12	18	pi	pi	NOUN
aiua-11830	12	19	-	-	PUNCT
aiua-11830	12	20	rads	rad	NOUN
aiua-11830	12	21	category	category	NOUN
aiua-11830	12	22	3	3	NUM
aiua-11830	12	23	lesions	lesion	NOUN
aiua-11830	12	24	.	.	PUNCT
aiua-11830	13	1	the	the	DET
aiua-11830	13	2	objective	objective	NOUN
aiua-11830	13	3	of	of	ADP
aiua-11830	13	4	this	this	DET
aiua-11830	13	5	study	study	NOUN
aiua-11830	13	6	is	be	AUX
aiua-11830	13	7	to	to	PART
aiua-11830	13	8	determine	determine	VERB
aiua-11830	13	9	the	the	DET
aiua-11830	13	10	frequency	frequency	NOUN
aiua-11830	13	11	of	of	ADP
aiua-11830	13	12	cspca	cspca	NOUN
aiua-11830	13	13	,	,	PUNCT
aiua-11830	13	14	assess	assess	VERB
aiua-11830	13	15	the	the	DET
aiua-11830	13	16	diagnostic	diagnostic	ADJ
aiua-11830	13	17	value	value	NOUN
aiua-11830	13	18	of	of	ADP
aiua-11830	13	19	targeted	target	VERB
aiua-11830	13	20	biopsy	biopsy	NOUN
aiua-11830	13	21	and	and	CCONJ
aiua-11830	13	22	identify	identify	VERB
aiua-11830	13	23	clinical	clinical	ADJ
aiua-11830	13	24	predictors	predictor	NOUN
aiua-11830	13	25	to	to	PART
aiua-11830	13	26	improve	improve	VERB
aiua-11830	13	27	the	the	DET
aiua-11830	13	28	cspca	cspca	NOUN
aiua-11830	13	29	detection	detection	NOUN
aiua-11830	13	30	rate	rate	NOUN
aiua-11830	13	31	in	in	ADP
aiua-11830	13	32	pi	pi	NOUN
aiua-11830	13	33	-	-	PUNCT
aiua-11830	13	34	rads	rad	NOUN
aiua-11830	13	35	category	category	NOUN
aiua-11830	13	36	3	3	NUM
aiua-11830	13	37	lesions	lesion	NOUN
aiua-11830	13	38	.	.	PUNCT
aiua-11830	14	1	methods	method	NOUN
aiua-11830	14	2	:	:	PUNCT
aiua-11830	14	3	between	between	ADP
aiua-11830	14	4	1st	1st	ADJ
aiua-11830	14	5	january	january	PROPN
aiua-11830	14	6	2017	2017	NUM
aiua-11830	14	7	and	and	CCONJ
aiua-11830	14	8	31st	31st	ADJ
aiua-11830	14	9	december	december	PROPN
aiua-11830	14	10	2022	2022	NUM
aiua-11830	14	11	,	,	PUNCT
aiua-11830	14	12	a	a	DET
aiua-11830	14	13	total	total	NOUN
aiua-11830	14	14	of	of	ADP
aiua-11830	14	15	1661	1661	NUM
aiua-11830	14	16	men	man	NOUN
aiua-11830	14	17	underwent	undergo	VERB
aiua-11830	14	18	a	a	DET
aiua-11830	14	19	prostate	prostate	NOUN
aiua-11830	14	20	biopsy	biopsy	NOUN
aiua-11830	14	21	at	at	ADP
aiua-11830	14	22	our	our	PRON
aiua-11830	14	23	institution	institution	NOUN
aiua-11830	14	24	.	.	PUNCT
aiua-11830	15	1	clinical	clinical	ADJ
aiua-11830	15	2	and	and	CCONJ
aiua-11830	15	3	mpmri	mpmri	PROPN
aiua-11830	15	4	data	datum	NOUN
aiua-11830	15	5	of	of	ADP
aiua-11830	15	6	men	man	NOUN
aiua-11830	15	7	with	with	ADP
aiua-11830	15	8	pi	pi	NOUN
aiua-11830	15	9	-	-	PUNCT
aiua-11830	15	10	rads	rad	NOUN
aiua-11830	15	11	3	3	NUM
aiua-11830	15	12	lesions	lesion	NOUN
aiua-11830	15	13	was	be	AUX
aiua-11830	15	14	reviewed	review	VERB
aiua-11830	15	15	.	.	PUNCT
aiua-11830	16	1	the	the	DET
aiua-11830	16	2	study	study	NOUN
aiua-11830	16	3	population	population	NOUN
aiua-11830	16	4	was	be	AUX
aiua-11830	16	5	divided	divide	VERB
aiua-11830	16	6	into	into	ADP
aiua-11830	16	7	two	two	NUM
aiua-11830	16	8	groups	group	NOUN
aiua-11830	16	9	:	:	PUNCT
aiua-11830	16	10	target	target	NOUN
aiua-11830	16	11	group	group	NOUN
aiua-11830	16	12	,	,	PUNCT
aiua-11830	16	13	including	include	VERB
aiua-11830	16	14	those	those	PRON
aiua-11830	16	15	submitted	submit	VERB
aiua-11830	16	16	to	to	ADP
aiua-11830	16	17	systematic	systematic	ADJ
aiua-11830	16	18	plus	plus	CCONJ
aiua-11830	16	19	targeted	target	VERB
aiua-11830	16	20	biopsy	biopsy	NOUN
aiua-11830	16	21	versus	versus	ADP
aiua-11830	16	22	non	non	ADJ
aiua-11830	16	23	-	-	ADJ
aiua-11830	16	24	target	target	ADJ
aiua-11830	16	25	group	group	NOUN
aiua-11830	16	26	when	when	SCONJ
aiua-11830	16	27	only	only	ADV
aiua-11830	16	28	systematic	systematic	ADJ
aiua-11830	16	29	or	or	CCONJ
aiua-11830	16	30	saturation	saturation	NOUN
aiua-11830	16	31	biopsy	biopsy	NOUN
aiua-11830	16	32	were	be	AUX
aiua-11830	16	33	performed	perform	VERB
aiua-11830	16	34	.	.	PUNCT
aiua-11830	17	1	patients	patient	NOUN
aiua-11830	17	2	with	with	ADP
aiua-11830	17	3	pi	pi	NOUN
aiua-11830	17	4	-	-	PUNCT
aiua-11830	17	5	rads	rad	NOUN
aiua-11830	17	6	3	3	NUM
aiua-11830	17	7	lesions	lesion	NOUN
aiua-11830	17	8	were	be	AUX
aiua-11830	17	9	divided	divide	VERB
aiua-11830	17	10	into	into	ADP
aiua-11830	17	11	three	three	NUM
aiua-11830	17	12	categories	category	NOUN
aiua-11830	17	13	based	base	VERB
aiua-11830	17	14	on	on	ADP
aiua-11830	17	15	pathological	pathological	ADJ
aiua-11830	17	16	biopsy	biopsy	NOUN
aiua-11830	17	17	results	result	NOUN
aiua-11830	17	18	:	:	PUNCT
aiua-11830	17	19	benign	benign	ADJ
aiua-11830	17	20	,	,	PUNCT
aiua-11830	17	21	clinically	clinically	ADV
aiua-11830	17	22	insignificant	insignificant	ADJ
aiua-11830	17	23	disease	disease	NOUN
aiua-11830	17	24	(	(	PUNCT
aiua-11830	17	25	score	score	NOUN
aiua-11830	17	26	gleason	gleason	NOUN
aiua-11830	17	27	=	=	SYM
aiua-11830	17	28	6	6	NUM
aiua-11830	17	29	or	or	CCONJ
aiua-11830	17	30	international	international	ADJ
aiua-11830	17	31	society	society	NOUN
aiua-11830	17	32	of	of	ADP
aiua-11830	17	33	urologic	urologic	ADJ
aiua-11830	17	34	pathologic	pathologic	NOUN
aiua-11830	17	35	(	(	PUNCT
aiua-11830	17	36	isup	isup	NOUN
aiua-11830	17	37	)	)	PUNCT
aiua-11830	17	38	1	1	NUM
aiua-11830	17	39	)	)	PUNCT
aiua-11830	17	40	and	and	CCONJ
aiua-11830	17	41	clinically	clinically	ADV
aiua-11830	17	42	significant	significant	ADJ
aiua-11830	17	43	cancer	cancer	NOUN
aiua-11830	17	44	(	(	PUNCT
aiua-11830	17	45	score	score	NOUN
aiua-11830	17	46	gleason	gleason	PROPN
aiua-11830	17	47	≥	≥	NUM
aiua-11830	17	48	7	7	NUM
aiua-11830	17	49	(	(	PUNCT
aiua-11830	17	50	3	3	NUM
aiua-11830	17	51	+	+	NOUN
aiua-11830	17	52	4	4	NUM
aiua-11830	17	53	)	)	PUNCT
aiua-11830	17	54	or	or	CCONJ
aiua-11830	17	55	isup	isup	ADJ
aiua-11830	17	56	≥	≥	NOUN
aiua-11830	17	57	2	2	NUM
aiua-11830	17	58	)	)	PUNCT
aiua-11830	17	59	according	accord	VERB
aiua-11830	17	60	to	to	ADP
aiua-11830	17	61	target	target	NOUN
aiua-11830	17	62	and	and	CCONJ
aiua-11830	17	63	non	non	ADJ
aiua-11830	17	64	-	-	ADJ
aiua-11830	17	65	target	target	ADJ
aiua-11830	17	66	group	group	NOUN
aiua-11830	17	67	.	.	PUNCT
aiua-11830	18	1	univariate	univariate	ADJ
aiua-11830	18	2	and	and	CCONJ
aiua-11830	18	3	multivariate	multivariate	NOUN
aiua-11830	18	4	analyses	analysis	NOUN
aiua-11830	18	5	were	be	AUX
aiua-11830	18	6	performed	perform	VERB
aiua-11830	18	7	to	to	PART
aiua-11830	18	8	identify	identify	VERB
aiua-11830	18	9	clinical	clinical	ADJ
aiua-11830	18	10	predictors	predictor	NOUN
aiua-11830	18	11	to	to	PART
aiua-11830	18	12	improve	improve	VERB
aiua-11830	18	13	the	the	DET
aiua-11830	18	14	cspca	cspca	NOUN
aiua-11830	18	15	detection	detection	NOUN
aiua-11830	18	16	rate	rate	NOUN
aiua-11830	18	17	in	in	ADP
aiua-11830	18	18	pi	pi	NOUN
aiua-11830	18	19	-	-	PUNCT
aiua-11830	18	20	rads	rad	NOUN
aiua-11830	18	21	category	category	NOUN
aiua-11830	18	22	3	3	NUM
aiua-11830	18	23	lesions	lesion	NOUN
aiua-11830	18	24	.	.	PUNCT
aiua-11830	19	1	results	result	NOUN
aiua-11830	19	2	:	:	PUNCT
aiua-11830	19	3	a	a	DET
aiua-11830	19	4	total	total	NOUN
aiua-11830	19	5	of	of	ADP
aiua-11830	19	6	130	130	NUM
aiua-11830	19	7	men	man	NOUN
aiua-11830	19	8	with	with	ADP
aiua-11830	19	9	pirads	pirad	NOUN
aiua-11830	19	10	3	3	NUM
aiua-11830	19	11	index	index	NOUN
aiua-11830	19	12	lesions	lesion	NOUN
aiua-11830	19	13	were	be	AUX
aiua-11830	19	14	identified	identify	VERB
aiua-11830	19	15	.	.	PUNCT
aiua-11830	20	1	pathologic	pathologic	ADJ
aiua-11830	20	2	results	result	NOUN
aiua-11830	20	3	were	be	AUX
aiua-11830	20	4	benign	benign	ADJ
aiua-11830	20	5	in	in	ADP
aiua-11830	20	6	77	77	NUM
aiua-11830	20	7	lesions	lesion	NOUN
aiua-11830	20	8	(	(	PUNCT
aiua-11830	20	9	59.2	59.2	NUM
aiua-11830	20	10	%	%	NOUN
aiua-11830	20	11	)	)	PUNCT
aiua-11830	20	12	,	,	PUNCT
aiua-11830	20	13	19	19	NUM
aiua-11830	20	14	(	(	PUNCT
aiua-11830	20	15	14.6	14.6	NUM
aiua-11830	20	16	%	%	NOUN
aiua-11830	20	17	)	)	PUNCT
aiua-11830	20	18	were	be	AUX
aiua-11830	20	19	clinically	clinically	ADV
aiua-11830	20	20	insignificant	insignificant	ADJ
aiua-11830	20	21	(	(	PUNCT
aiua-11830	20	22	gleason	gleason	PROPN
aiua-11830	20	23	score	score	NOUN
aiua-11830	20	24	6	6	NUM
aiua-11830	20	25	)	)	PUNCT
aiua-11830	20	26	and	and	CCONJ
aiua-11830	20	27	34	34	NUM
aiua-11830	20	28	(	(	PUNCT
aiua-11830	20	29	26.2	26.2	NUM
aiua-11830	20	30	%	%	NOUN
aiua-11830	20	31	)	)	PUNCT
aiua-11830	20	32	were	be	AUX
aiua-11830	20	33	clinically	clinically	ADV
aiua-11830	20	34	significant	significant	ADJ
aiua-11830	20	35	(	(	PUNCT
aiua-11830	20	36	gleason	gleason	PROPN
aiua-11830	20	37	score	score	VERB
aiua-11830	20	38	7	7	NUM
aiua-11830	20	39	or	or	CCONJ
aiua-11830	20	40	higher	high	ADJ
aiua-11830	20	41	)	)	PUNCT
aiua-11830	20	42	.	.	PUNCT
aiua-11830	21	1	eighty	eighty	NUM
aiua-11830	21	2	-	-	PUNCT
aiua-11830	21	3	seven	seven	NUM
aiua-11830	21	4	of	of	ADP
aiua-11830	21	5	the	the	DET
aiua-11830	21	6	patients	patient	NOUN
aiua-11830	21	7	were	be	AUX
aiua-11830	21	8	included	include	VERB
aiua-11830	21	9	in	in	ADP
aiua-11830	21	10	the	the	DET
aiua-11830	21	11	target	target	NOUN
aiua-11830	21	12	group	group	NOUN
aiua-11830	21	13	(	(	PUNCT
aiua-11830	21	14	66.9	66.9	NUM
aiua-11830	21	15	%	%	NOUN
aiua-11830	21	16	)	)	PUNCT
aiua-11830	21	17	and	and	CCONJ
aiua-11830	21	18	43	43	NUM
aiua-11830	21	19	in	in	ADP
aiua-11830	21	20	the	the	DET
aiua-11830	21	21	non	non	ADJ
aiua-11830	21	22	-	-	ADJ
aiua-11830	21	23	target	target	ADJ
aiua-11830	21	24	group	group	NOUN
aiua-11830	21	25	(	(	PUNCT
aiua-11830	21	26	33.1	33.1	NUM
aiua-11830	21	27	%	%	NOUN
aiua-11830	21	28	)	)	PUNCT
aiua-11830	21	29	.	.	PUNCT
aiua-11830	22	1	the	the	DET
aiua-11830	22	2	cspca	cspca	PROPN
aiua-11830	22	3	detection	detection	NOUN
aiua-11830	22	4	was	be	AUX
aiua-11830	22	5	higher	high	ADJ
aiua-11830	22	6	in	in	ADP
aiua-11830	22	7	the	the	DET
aiua-11830	22	8	non	non	ADJ
aiua-11830	22	9	-	-	ADJ
aiua-11830	22	10	target	target	ADJ
aiua-11830	22	11	group	group	NOUN
aiua-11830	22	12	(	(	PUNCT
aiua-11830	22	13	32.6	32.6	NUM
aiua-11830	22	14	%	%	NOUN
aiua-11830	22	15	,	,	PUNCT
aiua-11830	22	16	n	n	NOUN
aiua-11830	22	17	=	=	NUM
aiua-11830	22	18	14	14	NUM
aiua-11830	22	19	vs	vs	ADP
aiua-11830	22	20	23.0	23.0	NUM
aiua-11830	22	21	%	%	NOUN
aiua-11830	22	22	,	,	PUNCT
aiua-11830	22	23	n	n	NOUN
aiua-11830	22	24	=	=	NUM
aiua-11830	22	25	20	20	NUM
aiua-11830	22	26	respectively	respectively	ADV
aiua-11830	22	27	)	)	PUNCT
aiua-11830	22	28	.	.	PUNCT
aiua-11830	23	1	when	when	SCONJ
aiua-11830	23	2	systematic	systematic	ADJ
aiua-11830	23	3	and	and	CCONJ
aiua-11830	23	4	target	target	NOUN
aiua-11830	23	5	biopsies	biopsy	NOUN
aiua-11830	23	6	were	be	AUX
aiua-11830	23	7	jointly	jointly	ADV
aiua-11830	23	8	performed	perform	VERB
aiua-11830	23	9	,	,	PUNCT
aiua-11830	23	10	if	if	SCONJ
aiua-11830	23	11	the	the	DET
aiua-11830	23	12	results	result	NOUN
aiua-11830	23	13	of	of	ADP
aiua-11830	23	14	systematic	systematic	ADJ
aiua-11830	23	15	biopsies	biopsy	NOUN
aiua-11830	23	16	are	be	AUX
aiua-11830	23	17	not	not	PART
aiua-11830	23	18	considered	consider	VERB
aiua-11830	23	19	and	and	CCONJ
aiua-11830	23	20	only	only	ADV
aiua-11830	23	21	the	the	DET
aiua-11830	23	22	results	result	NOUN
aiua-11830	23	23	of	of	ADP
aiua-11830	23	24	target	target	NOUN
aiua-11830	23	25	biopsies	biopsy	NOUN
aiua-11830	23	26	are	be	AUX
aiua-11830	23	27	taken	take	VERB
aiua-11830	23	28	into	into	ADP
aiua-11830	23	29	account	account	NOUN
aiua-11830	23	30	,	,	PUNCT
aiua-11830	23	31	a	a	DET
aiua-11830	23	32	cspca	cspca	NOUN
aiua-11830	23	33	diagnosis	diagnosis	NOUN
aiua-11830	23	34	would	would	AUX
aiua-11830	23	35	be	be	AUX
aiua-11830	23	36	missed	miss	VERB
aiua-11830	23	37	on	on	ADP
aiua-11830	23	38	9	9	NUM
aiua-11830	23	39	patients	patient	NOUN
aiua-11830	23	40	.	.	PUNCT
aiua-11830	24	1	the	the	DET
aiua-11830	24	2	differences	difference	NOUN
aiua-11830	24	3	of	of	ADP
aiua-11830	24	4	insignificant	insignificant	ADJ
aiua-11830	24	5	cancer	cancer	NOUN
aiua-11830	24	6	and	and	CCONJ
aiua-11830	24	7	cspca	cspca	NOUN
aiua-11830	24	8	rates	rate	NOUN
aiua-11830	24	9	among	among	ADP
aiua-11830	24	10	the	the	DET
aiua-11830	24	11	target	target	NOUN
aiua-11830	24	12	or	or	CCONJ
aiua-11830	24	13	non	non	ADJ
aiua-11830	24	14	-	-	ADJ
aiua-11830	24	15	target	target	ADJ
aiua-11830	24	16	group	group	NOUN
aiua-11830	24	17	were	be	AUX
aiua-11830	24	18	not	not	PART
aiua-11830	24	19	statistically	statistically	ADV
aiua-11830	24	20	significant	significant	ADJ
aiua-11830	24	21	(	(	PUNCT
aiua-11830	24	22	p	p	X
aiua-11830	24	23	=	=	NOUN
aiua-11830	24	24	0.50	0.50	NUM
aiua-11830	24	25	and	and	CCONJ
aiua-11830	24	26	p	p	NOUN
aiua-11830	24	27	=	=	NOUN
aiua-11830	24	28	0.24	0.24	NUM
aiua-11830	24	29	,	,	PUNCT
aiua-11830	24	30	respectively	respectively	ADV
aiua-11830	24	31	)	)	PUNCT
aiua-11830	24	32	.	.	PUNCT
aiua-11830	25	1	on	on	ADP
aiua-11830	25	2	multivariate	multivariate	NOUN
aiua-11830	25	3	analysis	analysis	NOUN
aiua-11830	25	4	,	,	PUNCT
aiua-11830	25	5	the	the	DET
aiua-11830	25	6	abnormal	abnormal	ADJ
aiua-11830	25	7	dre	dre	NOUN
aiua-11830	25	8	and	and	CCONJ
aiua-11830	25	9	lesions	lesion	NOUN
aiua-11830	25	10	localized	localize	VERB
aiua-11830	25	11	in	in	ADP
aiua-11830	25	12	peripheral	peripheral	ADJ
aiua-11830	25	13	zone	zone	NOUN
aiua-11830	25	14	(	(	PUNCT
aiua-11830	25	15	pz	pz	NOUN
aiua-11830	25	16	)	)	PUNCT
aiua-11830	25	17	were	be	AUX
aiua-11830	25	18	significantly	significantly	ADV
aiua-11830	25	19	associated	associate	VERB
aiua-11830	25	20	with	with	ADP
aiua-11830	25	21	a	a	DET
aiua-11830	25	22	presence	presence	NOUN
aiua-11830	25	23	of	of	ADP
aiua-11830	25	24	cspca	cspca	NOUN
aiua-11830	25	25	in	in	ADP
aiua-11830	25	26	pi	pi	NOUN
aiua-11830	25	27	-	-	PUNCT
aiua-11830	25	28	rads	rad	NOUN
aiua-11830	25	29	3	3	NUM
aiua-11830	25	30	lesions	lesion	NOUN
aiua-11830	25	31	(	(	PUNCT
aiua-11830	25	32	or	or	CCONJ
aiua-11830	25	33	=	=	NUM
aiua-11830	25	34	3.61	3.61	NUM
aiua-11830	25	35	,	,	PUNCT
aiua-11830	25	36	95	95	NUM
aiua-11830	25	37	%	%	NOUN
aiua-11830	25	38	ci	ci	NOUN
aiua-11830	26	1	[	[	X
aiua-11830	26	2	1.22,10.72	1.22,10.72	X
aiua-11830	26	3	]	]	X
aiua-11830	26	4	,	,	PUNCT
aiua-11830	26	5	p	p	X
aiua-11830	26	6	=	=	NOUN
aiua-11830	26	7	0.02	0.02	NUM
aiua-11830	26	8	and	and	CCONJ
aiua-11830	26	9	or	or	CCONJ
aiua-11830	26	10	=	=	SYM
aiua-11830	26	11	3.31	3.31	NUM
aiua-11830	26	12	,	,	PUNCT
aiua-11830	26	13	95	95	NUM
aiua-11830	26	14	%	%	NOUN
aiua-11830	26	15	ci	ci	NOUN
aiua-11830	27	1	[	[	X
aiua-11830	27	2	1.35	1.35	NUM
aiua-11830	27	3	,	,	PUNCT
aiua-11830	27	4	8.11	8.11	NUM
aiua-11830	27	5	]	]	PUNCT
aiua-11830	27	6	,	,	PUNCT
aiua-11830	27	7	p	p	X
aiua-11830	27	8	=	=	NOUN
aiua-11830	27	9	0.01	0.01	NUM
aiua-11830	27	10	,	,	PUNCT
aiua-11830	27	11	respectively	respectively	ADV
aiua-11830	27	12	)	)	PUNCT
aiua-11830	27	13	.	.	PUNCT
aiua-11830	28	1	a	a	DET
aiua-11830	28	2	higher	high	ADJ
aiua-11830	28	3	median	median	NOUN
aiua-11830	28	4	psad	psad	NOUN
aiua-11830	28	5	significantly	significantly	ADV
aiua-11830	28	6	predisposed	predispose	VERB
aiua-11830	28	7	for	for	ADP
aiua-11830	28	8	predictors	predictor	NOUN
aiua-11830	28	9	of	of	ADP
aiua-11830	28	10	prostate	prostate	NOUN
aiua-11830	28	11	cancer	cancer	NOUN
aiua-11830	28	12	cetection	cetection	NOUN
aiua-11830	28	13	in	in	ADP
aiua-11830	28	14	mri	mri	NOUN
aiua-11830	28	15	pi	pi	NOUN
aiua-11830	28	16	-	-	PUNCT
aiua-11830	28	17	rads	rad	NOUN
aiua-11830	28	18	3	3	NUM
aiua-11830	28	19	lesions	lesion	NOUN
aiua-11830	28	20	–	–	PUNCT
aiua-11830	28	21	reality	reality	NOUN
aiua-11830	28	22	of	of	ADP
aiua-11830	28	23	a	a	DET
aiua-11830	28	24	terciary	terciary	ADJ
aiua-11830	28	25	center	center	NOUN
aiua-11830	28	26	débora	débora	PROPN
aiua-11830	28	27	araújo	araújo	NOUN
aiua-11830	28	28	1	1	NUM
aiua-11830	28	29	,	,	PUNCT
aiua-11830	28	30	alexandre	alexandre	PROPN
aiua-11830	28	31	gromicho	gromicho	NOUN
aiua-11830	28	32	2	2	NUM
aiua-11830	28	33	,	,	PUNCT
aiua-11830	28	34	jorge	jorge	VERB
aiua-11830	28	35	dias	dias	PROPN
aiua-11830	28	36	1	1	NUM
aiua-11830	28	37	,	,	PUNCT
aiua-11830	28	38	samuel	samuel	PROPN
aiua-11830	28	39	bastos	bastos	PROPN
aiua-11830	28	40	1	1	NUM
aiua-11830	28	41	,	,	PUNCT
aiua-11830	28	42	rui	rui	PROPN
aiua-11830	28	43	miguel	miguel	PROPN
aiua-11830	28	44	maciel	maciel	PROPN
aiua-11830	28	45	1	1	PROPN
aiua-11830	28	46	,	,	PUNCT
aiua-11830	28	47	ana	ana	PROPN
aiua-11830	28	48	sabença	sabença	PROPN
aiua-11830	28	49	1	1	NUM
aiua-11830	28	50	,	,	PUNCT
aiua-11830	28	51	luís	luís	X
aiua-11830	28	52	xambre	xambre	NOUN
aiua-11830	28	53	1	1	NUM
aiua-11830	28	54	1	1	NUM
aiua-11830	28	55	urology	urology	NOUN
aiua-11830	28	56	department	department	NOUN
aiua-11830	28	57	,	,	PUNCT
aiua-11830	28	58	centro	centro	PROPN
aiua-11830	28	59	hospitalar	hospitalar	PROPN
aiua-11830	28	60	vila	vila	PROPN
aiua-11830	28	61	nova	nova	PROPN
aiua-11830	28	62	de	de	PROPN
aiua-11830	28	63	gaia	gaia	PROPN
aiua-11830	28	64	/	/	SYM
aiua-11830	28	65	espinho	espinho	PROPN
aiua-11830	28	66	epe	epe	PROPN
aiua-11830	28	67	,	,	PUNCT
aiua-11830	28	68	vila	vila	PROPN
aiua-11830	28	69	nova	nova	PROPN
aiua-11830	28	70	de	de	PROPN
aiua-11830	28	71	gaia	gaia	PROPN
aiua-11830	28	72	,	,	PUNCT
aiua-11830	28	73	portugal	portugal	PROPN
aiua-11830	28	74	;	;	PUNCT
aiua-11830	28	75	2	2	NUM
aiua-11830	28	76	urology	urology	NOUN
aiua-11830	28	77	department	department	NOUN
aiua-11830	28	78	,	,	PUNCT
aiua-11830	28	79	centro	centro	PROPN
aiua-11830	28	80	hospitalar	hospitalar	PROPN
aiua-11830	28	81	do	do	VERB
aiua-11830	28	82	funchal	funchal	NOUN
aiua-11830	28	83	,	,	PUNCT
aiua-11830	28	84	madeira	madeira	PROPN
aiua-11830	28	85	,	,	PUNCT
aiua-11830	28	86	portugal	portugal	PROPN
aiua-11830	28	87	.	.	PUNCT
aiua-11830	29	1	doi	doi	PROPN
aiua-11830	29	2	:	:	PUNCT
aiua-11830	29	3	10.4081	10.4081	NUM
aiua-11830	29	4	/	/	SYM
aiua-11830	29	5	aiua.2023.11830	aiua.2023.11830	PRON
aiua-11830	29	6	summary	summary	VERB
aiua-11830	29	7	cspca	cspca	NOUN
aiua-11830	29	8	on	on	ADP
aiua-11830	29	9	univariate	univariate	ADJ
aiua-11830	29	10	analyses	analysis	NOUN
aiua-11830	29	11	(	(	PUNCT
aiua-11830	29	12	p	p	X
aiua-11830	29	13	=	=	NOUN
aiua-11830	29	14	0.05	0.05	NUM
aiua-11830	29	15	)	)	PUNCT
aiua-11830	29	16	,	,	PUNCT
aiua-11830	29	17	however	however	ADV
aiua-11830	29	18	,	,	PUNCT
aiua-11830	29	19	was	be	AUX
aiua-11830	29	20	not	not	PART
aiua-11830	29	21	significant	significant	ADJ
aiua-11830	29	22	in	in	ADP
aiua-11830	29	23	the	the	DET
aiua-11830	29	24	multivariate	multivariate	NOUN
aiua-11830	29	25	analysis	analysis	NOUN
aiua-11830	29	26	(	(	PUNCT
aiua-11830	29	27	p	p	X
aiua-11830	29	28	=	=	NOUN
aiua-11830	29	29	0.76	0.76	NUM
aiua-11830	29	30	)	)	PUNCT
aiua-11830	29	31	.	.	PUNCT
aiua-11830	30	1	in	in	ADP
aiua-11830	30	2	our	our	PRON
aiua-11830	30	3	population	population	NOUN
aiua-11830	30	4	,	,	PUNCT
aiua-11830	30	5	using	use	VERB
aiua-11830	30	6	0.10	0.10	NUM
aiua-11830	30	7	ng	ng	NOUN
aiua-11830	30	8	/	/	SYM
aiua-11830	30	9	ml	ml	NOUN
aiua-11830	30	10	/	/	SYM
aiua-11830	30	11	ml	ml	NOUN
aiua-11830	30	12	as	as	ADP
aiua-11830	30	13	a	a	DET
aiua-11830	30	14	cut	cut	NOUN
aiua-11830	30	15	-	-	PUNCT
aiua-11830	30	16	off	off	NOUN
aiua-11830	30	17	to	to	PART
aiua-11830	30	18	perform	perform	VERB
aiua-11830	30	19	biopsy	biopsy	NOUN
aiua-11830	30	20	,	,	PUNCT
aiua-11830	30	21	41	41	NUM
aiua-11830	30	22	patients	patient	NOUN
aiua-11830	30	23	would	would	AUX
aiua-11830	30	24	have	have	AUX
aiua-11830	30	25	avoided	avoid	VERB
aiua-11830	30	26	biopsy	biopsy	NOUN
aiua-11830	30	27	(	(	PUNCT
aiua-11830	30	28	31.5	31.5	NUM
aiua-11830	30	29	%	%	NOUN
aiua-11830	30	30	)	)	PUNCT
aiua-11830	30	31	,	,	PUNCT
aiua-11830	30	32	but	but	CCONJ
aiua-11830	30	33	5	5	NUM
aiua-11830	30	34	cases	case	NOUN
aiua-11830	30	35	of	of	ADP
aiua-11830	30	36	cspca	cspca	NOUN
aiua-11830	30	37	would	would	AUX
aiua-11830	30	38	not	not	PART
aiua-11830	30	39	have	have	AUX
aiua-11830	30	40	been	be	AUX
aiua-11830	30	41	detected	detect	VERB
aiua-11830	30	42	(	(	PUNCT
aiua-11830	30	43	3.4	3.4	NUM
aiua-11830	30	44	%	%	NOUN
aiua-11830	30	45	)	)	PUNCT
aiua-11830	30	46	.	.	PUNCT
aiua-11830	31	1	we	we	PRON
aiua-11830	31	2	could	could	AUX
aiua-11830	31	3	not	not	PART
aiua-11830	31	4	identify	identify	VERB
aiua-11830	31	5	any	any	DET
aiua-11830	31	6	statistical	statistical	ADJ
aiua-11830	31	7	significance	significance	NOUN
aiua-11830	31	8	between	between	ADP
aiua-11830	31	9	other	other	ADJ
aiua-11830	31	10	clinical	clinical	ADJ
aiua-11830	31	11	and	and	CCONJ
aiua-11830	31	12	imagiological	imagiological	ADJ
aiua-11830	31	13	variables	variable	NOUN
aiua-11830	31	14	and	and	CCONJ
aiua-11830	31	15	cspca	cspca	PROPN
aiua-11830	31	16	detection	detection	NOUN
aiua-11830	31	17	.	.	PUNCT
aiua-11830	32	1	conclusions	conclusion	NOUN
aiua-11830	32	2	:	:	PUNCT
aiua-11830	32	3	pi	pi	NOUN
aiua-11830	32	4	-	-	PUNCT
aiua-11830	32	5	rads	rad	VERB
aiua-11830	32	6	3	3	NUM
aiua-11830	32	7	lesions	lesion	NOUN
aiua-11830	32	8	were	be	AUX
aiua-11830	32	9	associated	associate	VERB
aiua-11830	32	10	with	with	ADP
aiua-11830	32	11	a	a	DET
aiua-11830	32	12	low	low	ADJ
aiua-11830	32	13	likelihood	likelihood	NOUN
aiua-11830	32	14	of	of	ADP
aiua-11830	32	15	cspca	cspca	PROPN
aiua-11830	32	16	detection	detection	NOUN
aiua-11830	32	17	.	.	PUNCT
aiua-11830	33	1	a	a	DET
aiua-11830	33	2	systematic	systematic	ADJ
aiua-11830	33	3	biopsy	biopsy	NOUN
aiua-11830	33	4	associated	associate	VERB
aiua-11830	33	5	or	or	CCONJ
aiua-11830	33	6	not	not	PART
aiua-11830	33	7	with	with	ADP
aiua-11830	33	8	target	target	NOUN
aiua-11830	33	9	biopsy	biopsy	NOUN
aiua-11830	33	10	is	be	AUX
aiua-11830	33	11	essential	essential	ADJ
aiua-11830	33	12	in	in	ADP
aiua-11830	33	13	pi	pi	NOUN
aiua-11830	33	14	-	-	PUNCT
aiua-11830	33	15	rads	rad	NOUN
aiua-11830	33	16	3	3	NUM
aiua-11830	33	17	lesions	lesion	NOUN
aiua-11830	33	18	,	,	PUNCT
aiua-11830	33	19	and	and	CCONJ
aiua-11830	33	20	targeted	target	VERB
aiua-11830	33	21	biopsy	biopsy	NOUN
aiua-11830	33	22	did	do	AUX
aiua-11830	33	23	not	not	PART
aiua-11830	33	24	demonstrate	demonstrate	VERB
aiua-11830	33	25	to	to	PART
aiua-11830	33	26	be	be	AUX
aiua-11830	33	27	superior	superior	ADJ
aiua-11830	33	28	in	in	ADP
aiua-11830	33	29	the	the	DET
aiua-11830	33	30	detection	detection	NOUN
aiua-11830	33	31	of	of	ADP
aiua-11830	33	32	cspca	cspca	NOUN
aiua-11830	33	33	.	.	PUNCT
aiua-11830	34	1	the	the	DET
aiua-11830	34	2	presence	presence	NOUN
aiua-11830	34	3	of	of	ADP
aiua-11830	34	4	abnormal	abnormal	ADJ
aiua-11830	34	5	dre	dre	NOUN
aiua-11830	34	6	and	and	CCONJ
aiua-11830	34	7	lesions	lesion	NOUN
aiua-11830	34	8	localized	localize	VERB
aiua-11830	34	9	in	in	ADP
aiua-11830	34	10	pz	pz	NOUN
aiua-11830	34	11	potentially	potentially	ADV
aiua-11830	34	12	predict	predict	VERB
aiua-11830	34	13	the	the	DET
aiua-11830	34	14	presence	presence	NOUN
aiua-11830	34	15	of	of	ADP
aiua-11830	34	16	cspca	cspca	NOUN
aiua-11830	34	17	in	in	ADP
aiua-11830	34	18	biopsied	biopsied	ADJ
aiua-11830	34	19	pi	pi	NOUN
aiua-11830	34	20	-	-	PUNCT
aiua-11830	34	21	rads	rad	NOUN
aiua-11830	34	22	3	3	NUM
aiua-11830	34	23	lesions	lesion	NOUN
aiua-11830	34	24	.	.	PUNCT
aiua-11830	35	1	key	key	ADJ
aiua-11830	35	2	words	word	NOUN
aiua-11830	35	3	:	:	PUNCT
aiua-11830	35	4	prostate	prostate	NOUN
aiua-11830	35	5	cancer	cancer	NOUN
aiua-11830	35	6	;	;	PUNCT
aiua-11830	35	7	pi	pi	NOUN
aiua-11830	35	8	-	-	PUNCT
aiua-11830	35	9	rads	rad	NOUN
aiua-11830	35	10	category	category	NOUN
aiua-11830	35	11	3	3	NUM
aiua-11830	35	12	lesions	lesion	NOUN
aiua-11830	35	13	;	;	PUNCT
aiua-11830	35	14	prostate	prostate	NOUN
aiua-11830	35	15	multiparametric	multiparametric	ADJ
aiua-11830	35	16	mri	mri	NOUN
aiua-11830	35	17	.	.	PUNCT
aiua-11830	35	18	submitted	submit	VERB
aiua-11830	35	19	17	17	NUM
aiua-11830	35	20	september	september	PROPN
aiua-11830	35	21	2023	2023	NUM
aiua-11830	35	22	;	;	PUNCT
aiua-11830	35	23	accepted	accept	VERB
aiua-11830	35	24	2	2	NUM
aiua-11830	35	25	november	november	PROPN
aiua-11830	35	26	2023	2023	NUM
aiua-11830	35	27	archivio	archivio	NOUN
aiua-11830	35	28	italiano	italiano	NOUN
aiua-11830	35	29	di	di	X
aiua-11830	35	30	urologia	urologia	PROPN
aiua-11830	35	31	e	e	PROPN
aiua-11830	35	32	andrologia	andrologia	NOUN
aiua-11830	35	33	2023	2023	NUM
aiua-11830	35	34	;	;	PUNCT
aiua-11830	35	35	95(4):11830	95(4):11830	NUM
aiua-11830	35	36	d.	d.	PROPN
aiua-11830	35	37	araújo	araújo	PROPN
aiua-11830	35	38	,	,	PUNCT
aiua-11830	35	39	a.	a.	NOUN
aiua-11830	35	40	gromicho	gromicho	NOUN
aiua-11830	35	41	,	,	PUNCT
aiua-11830	35	42	j.	j.	PROPN
aiua-11830	35	43	dias	dias	PROPN
aiua-11830	35	44	,	,	PUNCT
aiua-11830	35	45	s.	s.	PROPN
aiua-11830	35	46	bastos	bastos	PROPN
aiua-11830	35	47	,	,	PUNCT
aiua-11830	35	48	r.	r.	PROPN
aiua-11830	35	49	miguel	miguel	PROPN
aiua-11830	35	50	maciel	maciel	PROPN
aiua-11830	35	51	,	,	PUNCT
aiua-11830	35	52	a.	a.	NOUN
aiua-11830	35	53	sabença	sabença	PROPN
aiua-11830	35	54	,	,	PUNCT
aiua-11830	35	55	l.	l.	PROPN
aiua-11830	35	56	xambre	xambre	PROPN
aiua-11830	35	57	2	2	NUM
aiua-11830	35	58	nificant	nificant	ADJ
aiua-11830	35	59	disease	disease	NOUN
aiua-11830	35	60	(	(	PUNCT
aiua-11830	35	61	4	4	NUM
aiua-11830	35	62	%	%	NOUN
aiua-11830	35	63	)	)	PUNCT
aiua-11830	35	64	suggesting	suggest	VERB
aiua-11830	35	65	that	that	SCONJ
aiua-11830	35	66	biopsies	biopsy	NOUN
aiua-11830	35	67	could	could	AUX
aiua-11830	35	68	be	be	AUX
aiua-11830	35	69	avoided	avoid	VERB
aiua-11830	35	70	.	.	PUNCT
aiua-11830	36	1	nevertheless	nevertheless	ADV
aiua-11830	36	2	,	,	PUNCT
aiua-11830	36	3	pi	pi	NOUN
aiua-11830	36	4	-	-	PUNCT
aiua-11830	36	5	rads	rad	VERB
aiua-11830	36	6	3	3	NUM
aiua-11830	36	7	scores	score	NOUN
aiua-11830	36	8	in	in	ADP
aiua-11830	36	9	patients	patient	NOUN
aiua-11830	36	10	with	with	ADP
aiua-11830	36	11	high	high	ADJ
aiua-11830	36	12	psad	psad	NOUN
aiua-11830	36	13	(	(	PUNCT
aiua-11830	36	14	>	>	X
aiua-11830	36	15	0.20	0.20	NUM
aiua-11830	36	16	ng	ng	PROPN
aiua-11830	36	17	/	/	SYM
aiua-11830	36	18	ml	ml	NOUN
aiua-11830	36	19	/	/	SYM
aiua-11830	36	20	ml	ml	NOUN
aiua-11830	36	21	)	)	PUNCT
aiua-11830	36	22	should	should	AUX
aiua-11830	36	23	be	be	AUX
aiua-11830	36	24	offered	offer	VERB
aiua-11830	36	25	targeted	target	VERB
aiua-11830	36	26	and	and	CCONJ
aiua-11830	36	27	systematic	systematic	ADJ
aiua-11830	36	28	biopsies	biopsy	NOUN
aiua-11830	36	29	due	due	ADJ
aiua-11830	36	30	to	to	ADP
aiua-11830	36	31	the	the	DET
aiua-11830	36	32	higher	high	ADJ
aiua-11830	36	33	risk	risk	NOUN
aiua-11830	36	34	of	of	ADP
aiua-11830	36	35	significant	significant	ADJ
aiua-11830	36	36	disease	disease	NOUN
aiua-11830	36	37	(	(	PUNCT
aiua-11830	36	38	29	29	NUM
aiua-11830	36	39	%	%	NOUN
aiua-11830	36	40	)	)	PUNCT
aiua-11830	36	41	(	(	PUNCT
aiua-11830	36	42	10	10	NUM
aiua-11830	36	43	)	)	PUNCT
aiua-11830	36	44	.	.	PUNCT
aiua-11830	37	1	the	the	DET
aiua-11830	37	2	objective	objective	NOUN
aiua-11830	37	3	of	of	ADP
aiua-11830	37	4	this	this	DET
aiua-11830	37	5	study	study	NOUN
aiua-11830	37	6	is	be	AUX
aiua-11830	37	7	to	to	PART
aiua-11830	37	8	determine	determine	VERB
aiua-11830	37	9	the	the	DET
aiua-11830	37	10	frequency	frequency	NOUN
aiua-11830	37	11	of	of	ADP
aiua-11830	37	12	cspca	cspca	NOUN
aiua-11830	37	13	,	,	PUNCT
aiua-11830	37	14	assess	assess	VERB
aiua-11830	37	15	the	the	DET
aiua-11830	37	16	diagnostic	diagnostic	ADJ
aiua-11830	37	17	value	value	NOUN
aiua-11830	37	18	of	of	ADP
aiua-11830	37	19	targeted	target	VERB
aiua-11830	37	20	biopsy	biopsy	NOUN
aiua-11830	37	21	and	and	CCONJ
aiua-11830	37	22	identify	identify	VERB
aiua-11830	37	23	clinical	clinical	ADJ
aiua-11830	37	24	predictors	predictor	NOUN
aiua-11830	37	25	to	to	PART
aiua-11830	37	26	improve	improve	VERB
aiua-11830	37	27	the	the	DET
aiua-11830	37	28	cspca	cspca	NOUN
aiua-11830	37	29	detection	detection	NOUN
aiua-11830	37	30	rate	rate	NOUN
aiua-11830	37	31	in	in	ADP
aiua-11830	37	32	pi	pi	NOUN
aiua-11830	37	33	-	-	PUNCT
aiua-11830	37	34	rads	rad	NOUN
aiua-11830	37	35	category	category	NOUN
aiua-11830	37	36	3	3	NUM
aiua-11830	37	37	lesions	lesion	NOUN
aiua-11830	37	38	.	.	PUNCT
aiua-11830	38	1	materials	material	NOUN
aiua-11830	38	2	and	and	CCONJ
aiua-11830	38	3	methods	method	NOUN
aiua-11830	38	4	between	between	ADP
aiua-11830	38	5	1st	1st	ADJ
aiua-11830	38	6	january	january	PROPN
aiua-11830	38	7	2017	2017	NUM
aiua-11830	38	8	and	and	CCONJ
aiua-11830	38	9	31st	31st	ADJ
aiua-11830	38	10	december	december	PROPN
aiua-11830	38	11	2022	2022	NUM
aiua-11830	38	12	,	,	PUNCT
aiua-11830	38	13	a	a	DET
aiua-11830	38	14	total	total	NOUN
aiua-11830	38	15	of	of	ADP
aiua-11830	38	16	1661	1661	NUM
aiua-11830	38	17	men	man	NOUN
aiua-11830	38	18	underwent	undergo	VERB
aiua-11830	38	19	a	a	DET
aiua-11830	38	20	prostate	prostate	NOUN
aiua-11830	38	21	biopsy	biopsy	NOUN
aiua-11830	38	22	at	at	ADP
aiua-11830	38	23	our	our	PRON
aiua-11830	38	24	center	center	NOUN
aiua-11830	38	25	due	due	ADP
aiua-11830	38	26	to	to	ADP
aiua-11830	38	27	altered	alter	VERB
aiua-11830	38	28	prostate	prostate	NOUN
aiua-11830	38	29	-	-	PUNCT
aiua-11830	38	30	specific	specific	ADJ
aiua-11830	38	31	antigen	antigen	NOUN
aiua-11830	38	32	(	(	PUNCT
aiua-11830	38	33	psa	psa	NOUN
aiua-11830	38	34	)	)	PUNCT
aiua-11830	38	35	and/or	and/or	CCONJ
aiua-11830	38	36	abnormal	abnormal	ADJ
aiua-11830	38	37	digital	digital	ADJ
aiua-11830	38	38	rectal	rectal	ADJ
aiua-11830	38	39	examination	examination	NOUN
aiua-11830	38	40	(	(	PUNCT
aiua-11830	38	41	dre	dre	PROPN
aiua-11830	38	42	)	)	PUNCT
aiua-11830	38	43	.	.	PUNCT
aiua-11830	39	1	the	the	DET
aiua-11830	39	2	inclusion	inclusion	NOUN
aiua-11830	39	3	criteria	criterion	NOUN
aiua-11830	39	4	were	be	AUX
aiua-11830	39	5	:	:	PUNCT
aiua-11830	39	6	mpmri	mpmri	VERB
aiua-11830	39	7	with	with	ADP
aiua-11830	39	8	a	a	DET
aiua-11830	39	9	pi	pi	NOUN
aiua-11830	39	10	-	-	PUNCT
aiua-11830	39	11	rads	rad	NOUN
aiua-11830	39	12	3	3	NUM
aiua-11830	39	13	lesion	lesion	NOUN
aiua-11830	39	14	followed	follow	VERB
aiua-11830	39	15	by	by	ADP
aiua-11830	39	16	prostate	prostate	NOUN
aiua-11830	39	17	biopsy	biopsy	NOUN
aiua-11830	39	18	.	.	PUNCT
aiua-11830	40	1	these	these	DET
aiua-11830	40	2	patients	patient	NOUN
aiua-11830	40	3	could	could	AUX
aiua-11830	40	4	be	be	AUX
aiua-11830	40	5	biopsy	biopsy	VERB
aiua-11830	40	6	naive	naive	ADJ
aiua-11830	40	7	,	,	PUNCT
aiua-11830	40	8	with	with	ADP
aiua-11830	40	9	previous	previous	ADJ
aiua-11830	40	10	negative	negative	ADJ
aiua-11830	40	11	biopsies	biopsy	NOUN
aiua-11830	40	12	or	or	CCONJ
aiua-11830	40	13	in	in	ADP
aiua-11830	40	14	active	active	ADJ
aiua-11830	40	15	surveillance	surveillance	NOUN
aiua-11830	40	16	protocol	protocol	NOUN
aiua-11830	40	17	.	.	PUNCT
aiua-11830	41	1	the	the	DET
aiua-11830	41	2	exclusion	exclusion	NOUN
aiua-11830	41	3	criteria	criterion	NOUN
aiua-11830	41	4	were	be	AUX
aiua-11830	41	5	absence	absence	NOUN
aiua-11830	41	6	of	of	ADP
aiua-11830	41	7	mpmri	mpmri	PROPN
aiua-11830	41	8	before	before	ADP
aiua-11830	41	9	prostate	prostate	NOUN
aiua-11830	41	10	biopsy	biopsy	NOUN
aiua-11830	41	11	,	,	PUNCT
aiua-11830	41	12	mpmri	mpmri	PROPN
aiua-11830	41	13	without	without	ADP
aiua-11830	41	14	pi	pi	NOUN
aiua-11830	41	15	-	-	PUNCT
aiua-11830	41	16	rads	rad	NOUN
aiua-11830	41	17	classification	classification	NOUN
aiua-11830	41	18	,	,	PUNCT
aiua-11830	41	19	having	have	VERB
aiua-11830	41	20	a	a	DET
aiua-11830	41	21	scored	score	VERB
aiua-11830	41	22	lesion	lesion	NOUN
aiua-11830	41	23	other	other	ADJ
aiua-11830	41	24	than	than	ADP
aiua-11830	41	25	pi	pi	NOUN
aiua-11830	41	26	-	-	PUNCT
aiua-11830	41	27	rads	rad	NOUN
aiua-11830	41	28	3	3	NUM
aiua-11830	41	29	or	or	CCONJ
aiua-11830	41	30	only	only	ADV
aiua-11830	41	31	having	having	AUX
aiua-11830	41	32	performed	perform	VERB
aiua-11830	41	33	target	target	NOUN
aiua-11830	41	34	biopsy	biopsy	NOUN
aiua-11830	41	35	.	.	PUNCT
aiua-11830	42	1	a	a	DET
aiua-11830	42	2	flowchart	flowchart	NOUN
aiua-11830	42	3	with	with	ADP
aiua-11830	42	4	study	study	NOUN
aiua-11830	42	5	inclusion	inclusion	NOUN
aiua-11830	42	6	criteria	criterion	NOUN
aiua-11830	42	7	is	be	AUX
aiua-11830	42	8	presented	present	VERB
aiua-11830	42	9	in	in	ADP
aiua-11830	42	10	figure	figure	NOUN
aiua-11830	42	11	1	1	NUM
aiua-11830	42	12	.	.	PUNCT
aiua-11830	43	1	a	a	DET
aiua-11830	43	2	total	total	NOUN
aiua-11830	43	3	of	of	ADP
aiua-11830	43	4	130	130	NUM
aiua-11830	43	5	patients	patient	NOUN
aiua-11830	43	6	with	with	ADP
aiua-11830	43	7	pi	pi	NOUN
aiua-11830	43	8	-	-	PUNCT
aiua-11830	43	9	rads	rad	NOUN
aiua-11830	43	10	3	3	NUM
aiua-11830	43	11	index	index	NOUN
aiua-11830	43	12	lesions	lesion	NOUN
aiua-11830	43	13	were	be	AUX
aiua-11830	43	14	retrospectively	retrospectively	ADV
aiua-11830	43	15	reviewed	review	VERB
aiua-11830	43	16	.	.	PUNCT
aiua-11830	44	1	all	all	DET
aiua-11830	44	2	patients	patient	NOUN
aiua-11830	44	3	were	be	AUX
aiua-11830	44	4	treatment	treatment	NOUN
aiua-11830	44	5	naive	naive	ADJ
aiua-11830	44	6	and	and	CCONJ
aiua-11830	44	7	clinical	clinical	ADJ
aiua-11830	44	8	,	,	PUNCT
aiua-11830	44	9	mpmri	mpmri	PROPN
aiua-11830	44	10	and	and	CCONJ
aiua-11830	44	11	pathologic	pathologic	ADJ
aiua-11830	44	12	data	datum	NOUN
aiua-11830	44	13	were	be	AUX
aiua-11830	44	14	collected	collect	VERB
aiua-11830	44	15	for	for	ADP
aiua-11830	44	16	each	each	DET
aiua-11830	44	17	patient	patient	NOUN
aiua-11830	44	18	.	.	PUNCT
aiua-11830	45	1	clinical	clinical	ADJ
aiua-11830	45	2	data	datum	NOUN
aiua-11830	45	3	included	include	VERB
aiua-11830	45	4	age	age	NOUN
aiua-11830	45	5	,	,	PUNCT
aiua-11830	45	6	total	total	ADJ
aiua-11830	45	7	psa	psa	NOUN
aiua-11830	45	8	,	,	PUNCT
aiua-11830	45	9	ratio	ratio	NOUN
aiua-11830	45	10	free	free	ADJ
aiua-11830	45	11	to	to	PART
aiua-11830	45	12	total	total	VERB
aiua-11830	45	13	psa	psa	NOUN
aiua-11830	45	14	and	and	CCONJ
aiua-11830	45	15	dre	dre	PROPN
aiua-11830	45	16	results	result	NOUN
aiua-11830	45	17	(	(	PUNCT
aiua-11830	45	18	normal	normal	ADJ
aiua-11830	45	19	and	and	CCONJ
aiua-11830	45	20	abnormal	abnormal	ADJ
aiua-11830	45	21	findings	finding	NOUN
aiua-11830	45	22	)	)	PUNCT
aiua-11830	45	23	.	.	PUNCT
aiua-11830	46	1	abnormal	abnormal	ADJ
aiua-11830	46	2	findings	finding	NOUN
aiua-11830	46	3	were	be	AUX
aiua-11830	46	4	areas	area	NOUN
aiua-11830	46	5	of	of	ADP
aiua-11830	46	6	localized	localize	VERB
aiua-11830	46	7	or	or	CCONJ
aiua-11830	46	8	diffuse	diffuse	VERB
aiua-11830	46	9	firmness	firmness	NOUN
aiua-11830	46	10	,	,	PUNCT
aiua-11830	46	11	induration	induration	NOUN
aiua-11830	46	12	,	,	PUNCT
aiua-11830	46	13	irregularity	irregularity	NOUN
aiua-11830	46	14	or	or	CCONJ
aiua-11830	46	15	nodularity	nodularity	NOUN
aiua-11830	46	16	suggestive	suggestive	ADJ
aiua-11830	46	17	of	of	ADP
aiua-11830	46	18	a	a	DET
aiua-11830	46	19	ct2	ct2	PROPN
aiua-11830	46	20	lesion	lesion	NOUN
aiua-11830	46	21	.	.	PUNCT
aiua-11830	47	1	prostate	prostate	NOUN
aiua-11830	47	2	volume	volume	NOUN
aiua-11830	47	3	,	,	PUNCT
aiua-11830	47	4	number	number	NOUN
aiua-11830	47	5	of	of	ADP
aiua-11830	47	6	target	target	NOUN
aiua-11830	47	7	lesions	lesion	NOUN
aiua-11830	47	8	,	,	PUNCT
aiua-11830	47	9	maximum	maximum	ADJ
aiua-11830	47	10	lesion	lesion	NOUN
aiua-11830	47	11	diameter	diameter	NOUN
aiua-11830	47	12	and	and	CCONJ
aiua-11830	47	13	location	location	NOUN
aiua-11830	47	14	(	(	PUNCT
aiua-11830	47	15	peripheral	peripheral	ADJ
aiua-11830	47	16	,	,	PUNCT
aiua-11830	47	17	transitional	transitional	ADJ
aiua-11830	47	18	,	,	PUNCT
aiua-11830	47	19	or	or	CCONJ
aiua-11830	47	20	anterior	anterior	ADJ
aiua-11830	47	21	zone	zone	NOUN
aiua-11830	47	22	and	and	CCONJ
aiua-11830	47	23	the	the	DET
aiua-11830	47	24	base	base	NOUN
aiua-11830	47	25	,	,	PUNCT
aiua-11830	47	26	middle	middle	ADJ
aiua-11830	47	27	or	or	CCONJ
aiua-11830	47	28	apex	apex	NOUN
aiua-11830	47	29	)	)	PUNCT
aiua-11830	47	30	were	be	AUX
aiua-11830	47	31	examined	examine	VERB
aiua-11830	47	32	on	on	ADP
aiua-11830	47	33	mpmri	mpmri	PROPN
aiua-11830	47	34	.	.	PUNCT
aiua-11830	48	1	psad	psad	PROPN
aiua-11830	48	2	was	be	AUX
aiua-11830	48	3	calculated	calculate	VERB
aiua-11830	48	4	using	use	VERB
aiua-11830	48	5	pre	pre	ADJ
aiua-11830	48	6	-	-	ADJ
aiua-11830	48	7	biopsy	biopsy	ADJ
aiua-11830	48	8	psa	psa	NOUN
aiua-11830	48	9	and	and	CCONJ
aiua-11830	48	10	mpmri	mpmri	NOUN
aiua-11830	48	11	-	-	PUNCT
aiua-11830	48	12	derived	derive	VERB
aiua-11830	48	13	volume	volume	NOUN
aiua-11830	48	14	.	.	PUNCT
aiua-11830	49	1	all	all	DET
aiua-11830	49	2	patients	patient	NOUN
aiua-11830	49	3	were	be	AUX
aiua-11830	49	4	submitted	submit	VERB
aiua-11830	49	5	to	to	ADP
aiua-11830	49	6	a	a	DET
aiua-11830	49	7	transrectal	transrectal	ADJ
aiua-11830	49	8	ultrasound	ultrasound	NOUN
aiua-11830	49	9	(	(	PUNCT
aiua-11830	49	10	trus)-guided	trus)-guide	VERB
aiua-11830	49	11	biopsy	biopsy	NOUN
aiua-11830	49	12	performed	perform	VERB
aiua-11830	49	13	by	by	ADP
aiua-11830	49	14	an	an	DET
aiua-11830	49	15	urologist	urologist	NOUN
aiua-11830	49	16	(	(	PUNCT
aiua-11830	49	17	6	6	NUM
aiua-11830	49	18	urologists	urologist	NOUN
aiua-11830	49	19	,	,	PUNCT
aiua-11830	49	20	with	with	ADP
aiua-11830	49	21	a	a	DET
aiua-11830	49	22	median	median	ADJ
aiua-11830	49	23	6.5	6.5	NUM
aiua-11830	49	24	years	year	NOUN
aiua-11830	49	25	of	of	ADP
aiua-11830	49	26	experience	experience	NOUN
aiua-11830	49	27	(	(	PUNCT
aiua-11830	49	28	range	range	NOUN
aiua-11830	49	29	,	,	PUNCT
aiua-11830	49	30	3	3	NUM
aiua-11830	49	31	-	-	SYM
aiua-11830	49	32	10	10	NUM
aiua-11830	49	33	years	year	NOUN
aiua-11830	49	34	)	)	PUNCT
aiua-11830	49	35	)	)	PUNCT
aiua-11830	49	36	.	.	PUNCT
aiua-11830	50	1	before	before	ADP
aiua-11830	50	2	the	the	DET
aiua-11830	50	3	prostate	prostate	NOUN
aiua-11830	50	4	biopsy	biopsy	NOUN
aiua-11830	50	5	,	,	PUNCT
aiua-11830	50	6	mpmri	mpmri	PROPN
aiua-11830	50	7	was	be	AUX
aiua-11830	50	8	reviewed	review	VERB
aiua-11830	50	9	and	and	CCONJ
aiua-11830	50	10	analysed	analyse	VERB
aiua-11830	50	11	,	,	PUNCT
aiua-11830	50	12	identifying	identify	VERB
aiua-11830	50	13	the	the	DET
aiua-11830	50	14	presence	presence	NOUN
aiua-11830	50	15	of	of	ADP
aiua-11830	50	16	any	any	DET
aiua-11830	50	17	pi	pi	NOUN
aiua-11830	50	18	-	-	PUNCT
aiua-11830	50	19	rads	rad	NOUN
aiua-11830	50	20	lesion	lesion	NOUN
aiua-11830	50	21	.	.	PUNCT
aiua-11830	51	1	the	the	DET
aiua-11830	51	2	mpmri	mpmri	PROPN
aiua-11830	51	3	was	be	AUX
aiua-11830	51	4	performed	perform	VERB
aiua-11830	51	5	and	and	CCONJ
aiua-11830	51	6	reported	report	VERB
aiua-11830	51	7	by	by	ADP
aiua-11830	51	8	different	different	ADJ
aiua-11830	51	9	radiologists	radiologist	NOUN
aiua-11830	51	10	but	but	CCONJ
aiua-11830	51	11	every	every	DET
aiua-11830	51	12	mpmri	mpmri	PROPN
aiua-11830	51	13	protocol	protocol	NOUN
aiua-11830	51	14	included	include	VERB
aiua-11830	51	15	multiplanar	multiplanar	ADJ
aiua-11830	51	16	t2	t2	NOUN
aiua-11830	51	17	-	-	PUNCT
aiua-11830	51	18	weighted	weight	VERB
aiua-11830	51	19	imaging	imaging	NOUN
aiua-11830	51	20	,	,	PUNCT
aiua-11830	51	21	diffusion	diffusion	NOUN
aiua-11830	51	22	weighted	weight	VERB
aiua-11830	51	23	imaging	imaging	NOUN
aiua-11830	51	24	(	(	PUNCT
aiua-11830	51	25	dwi	dwi	PROPN
aiua-11830	51	26	)	)	PUNCT
aiua-11830	51	27	,	,	PUNCT
aiua-11830	51	28	and	and	CCONJ
aiua-11830	51	29	dynamic	dynamic	ADJ
aiua-11830	51	30	contrast	contrast	NOUN
aiua-11830	51	31	-	-	PUNCT
aiua-11830	51	32	enhanced	enhance	VERB
aiua-11830	51	33	mri	mri	NOUN
aiua-11830	51	34	(	(	PUNCT
aiua-11830	51	35	dcemri	dcemri	PROPN
aiua-11830	51	36	)	)	PUNCT
aiua-11830	51	37	.	.	PUNCT
aiua-11830	52	1	the	the	DET
aiua-11830	52	2	study	study	NOUN
aiua-11830	52	3	population	population	NOUN
aiua-11830	52	4	was	be	AUX
aiua-11830	52	5	divided	divide	VERB
aiua-11830	52	6	into	into	ADP
aiua-11830	52	7	two	two	NUM
aiua-11830	52	8	groups	group	NOUN
aiua-11830	52	9	to	to	PART
aiua-11830	52	10	assess	assess	VERB
aiua-11830	52	11	the	the	DET
aiua-11830	52	12	diagnostic	diagnostic	ADJ
aiua-11830	52	13	value	value	NOUN
aiua-11830	52	14	of	of	ADP
aiua-11830	52	15	targeted	target	VERB
aiua-11830	52	16	biopsy	biopsy	NOUN
aiua-11830	52	17	:	:	PUNCT
aiua-11830	52	18	target	target	NOUN
aiua-11830	52	19	group	group	NOUN
aiua-11830	52	20	,	,	PUNCT
aiua-11830	52	21	including	include	VERB
aiua-11830	52	22	those	those	PRON
aiua-11830	52	23	submitted	submit	VERB
aiua-11830	52	24	to	to	ADP
aiua-11830	52	25	systematic	systematic	ADJ
aiua-11830	52	26	plus	plus	CCONJ
aiua-11830	52	27	targeted	target	VERB
aiua-11830	52	28	biopsy	biopsy	NOUN
aiua-11830	52	29	versus	versus	ADP
aiua-11830	52	30	non	non	ADJ
aiua-11830	52	31	-	-	ADJ
aiua-11830	52	32	target	target	ADJ
aiua-11830	52	33	group	group	NOUN
aiua-11830	52	34	when	when	SCONJ
aiua-11830	52	35	only	only	ADV
aiua-11830	52	36	systematic	systematic	ADJ
aiua-11830	52	37	or	or	CCONJ
aiua-11830	52	38	saturation	saturation	NOUN
aiua-11830	52	39	biopsy	biopsy	NOUN
aiua-11830	52	40	were	be	AUX
aiua-11830	52	41	performed	perform	VERB
aiua-11830	52	42	.	.	PUNCT
aiua-11830	53	1	the	the	DET
aiua-11830	53	2	patients	patient	NOUN
aiua-11830	53	3	were	be	AUX
aiua-11830	53	4	distributed	distribute	VERB
aiua-11830	53	5	according	accord	VERB
aiua-11830	53	6	to	to	ADP
aiua-11830	53	7	physician	physician	NOUN
aiua-11830	53	8	’s	’s	PART
aiua-11830	53	9	preference	preference	NOUN
aiua-11830	53	10	,	,	PUNCT
aiua-11830	53	11	and	and	CCONJ
aiua-11830	53	12	the	the	DET
aiua-11830	53	13	two	two	NUM
aiua-11830	53	14	groups	group	NOUN
aiua-11830	53	15	’	'	PUNCT
aiua-11830	53	16	pathological	pathological	ADJ
aiua-11830	53	17	results	result	NOUN
aiua-11830	53	18	were	be	AUX
aiua-11830	53	19	compared	compare	VERB
aiua-11830	53	20	.	.	PUNCT
aiua-11830	54	1	the	the	DET
aiua-11830	54	2	mpmri	mpmri	NOUN
aiua-11830	54	3	-	-	PUNCT
aiua-11830	54	4	targeted	target	VERB
aiua-11830	54	5	biopsy	biopsy	NOUN
aiua-11830	54	6	was	be	AUX
aiua-11830	54	7	performed	perform	VERB
aiua-11830	54	8	through	through	ADP
aiua-11830	54	9	cognitive	cognitive	ADJ
aiua-11830	54	10	guidance	guidance	NOUN
aiua-11830	54	11	.	.	PUNCT
aiua-11830	55	1	three	three	NUM
aiua-11830	55	2	to	to	PART
aiua-11830	55	3	5	5	NUM
aiua-11830	55	4	cores	core	NOUN
aiua-11830	55	5	were	be	AUX
aiua-11830	55	6	obtained	obtain	VERB
aiua-11830	55	7	from	from	ADP
aiua-11830	55	8	each	each	DET
aiua-11830	55	9	target	target	NOUN
aiua-11830	55	10	lesion	lesion	NOUN
aiua-11830	55	11	.	.	PUNCT
aiua-11830	56	1	the	the	DET
aiua-11830	56	2	histopathology	histopathology	NOUN
aiua-11830	56	3	of	of	ADP
aiua-11830	56	4	the	the	DET
aiua-11830	56	5	prostate	prostate	NOUN
aiua-11830	56	6	biopsies	biopsy	NOUN
aiua-11830	56	7	was	be	AUX
aiua-11830	56	8	reported	report	VERB
aiua-11830	56	9	as	as	ADP
aiua-11830	56	10	a	a	DET
aiua-11830	56	11	gleason	gleason	PROPN
aiua-11830	56	12	score	score	NOUN
aiua-11830	56	13	and	and	CCONJ
aiua-11830	56	14	according	accord	VERB
aiua-11830	56	15	to	to	ADP
aiua-11830	56	16	the	the	DET
aiua-11830	56	17	2014	2014	NUM
aiua-11830	56	18	international	international	ADJ
aiua-11830	56	19	society	society	NOUN
aiua-11830	56	20	of	of	ADP
aiua-11830	56	21	urologic	urologic	ADJ
aiua-11830	56	22	pathologic	pathologic	NOUN
aiua-11830	56	23	(	(	PUNCT
aiua-11830	56	24	isup	isup	NOUN
aiua-11830	56	25	)	)	PUNCT
aiua-11830	56	26	guidelines	guideline	NOUN
aiua-11830	56	27	.	.	PUNCT
aiua-11830	57	1	patients	patient	NOUN
aiua-11830	57	2	with	with	ADP
aiua-11830	57	3	pi	pi	NOUN
aiua-11830	57	4	-	-	PUNCT
aiua-11830	57	5	rads	rad	NOUN
aiua-11830	57	6	3	3	NUM
aiua-11830	57	7	lesions	lesion	NOUN
aiua-11830	57	8	were	be	AUX
aiua-11830	57	9	divided	divide	VERB
aiua-11830	57	10	into	into	ADP
aiua-11830	57	11	three	three	NUM
aiua-11830	57	12	categories	category	NOUN
aiua-11830	57	13	based	base	VERB
aiua-11830	57	14	on	on	ADP
aiua-11830	57	15	pathological	pathological	ADJ
aiua-11830	57	16	biopsy	biopsy	NOUN
aiua-11830	57	17	results	result	NOUN
aiua-11830	57	18	:	:	PUNCT
aiua-11830	57	19	benign	benign	ADJ
aiua-11830	57	20	,	,	PUNCT
aiua-11830	57	21	clinically	clinically	ADV
aiua-11830	57	22	insignificant	insignificant	ADJ
aiua-11830	57	23	disease	disease	NOUN
aiua-11830	57	24	(	(	PUNCT
aiua-11830	57	25	score	score	NOUN
aiua-11830	57	26	gleason	gleason	NOUN
aiua-11830	57	27	=	=	PUNCT
aiua-11830	57	28	6	6	NUM
aiua-11830	57	29	or	or	CCONJ
aiua-11830	57	30	isup	isup	ADJ
aiua-11830	57	31	1	1	NUM
aiua-11830	57	32	)	)	PUNCT
aiua-11830	57	33	and	and	CCONJ
aiua-11830	57	34	clinically	clinically	ADV
aiua-11830	57	35	significant	significant	ADJ
aiua-11830	57	36	cancer	cancer	NOUN
aiua-11830	57	37	(	(	PUNCT
aiua-11830	57	38	score	score	NOUN
aiua-11830	57	39	gleason	gleason	PROPN
aiua-11830	57	40	≥	≥	NUM
aiua-11830	57	41	7	7	NUM
aiua-11830	57	42	(	(	PUNCT
aiua-11830	57	43	3	3	NUM
aiua-11830	57	44	+	+	NOUN
aiua-11830	57	45	4	4	NUM
aiua-11830	57	46	)	)	PUNCT
aiua-11830	57	47	or	or	CCONJ
aiua-11830	57	48	isup	isup	ADJ
aiua-11830	57	49	≥	≥	NOUN
aiua-11830	57	50	2	2	NUM
aiua-11830	57	51	)	)	PUNCT
aiua-11830	57	52	according	accord	VERB
aiua-11830	57	53	to	to	ADP
aiua-11830	57	54	target	target	NOUN
aiua-11830	57	55	and	and	CCONJ
aiua-11830	57	56	non	non	ADJ
aiua-11830	57	57	-	-	ADJ
aiua-11830	57	58	target	target	ADJ
aiua-11830	57	59	group	group	NOUN
aiua-11830	57	60	.	.	PUNCT
aiua-11830	58	1	figure	figure	NOUN
aiua-11830	58	2	1	1	NUM
aiua-11830	58	3	.	.	PUNCT
aiua-11830	59	1	flowchart	flowchart	NOUN
aiua-11830	59	2	for	for	ADP
aiua-11830	59	3	study	study	NOUN
aiua-11830	59	4	inclusion	inclusion	NOUN
aiua-11830	59	5	among	among	ADP
aiua-11830	59	6	patients	patient	NOUN
aiua-11830	59	7	with	with	ADP
aiua-11830	59	8	pi	pi	NOUN
aiua-11830	59	9	-	-	PUNCT
aiua-11830	59	10	rads	rad	NOUN
aiua-11830	59	11	3	3	NUM
aiua-11830	59	12	index	index	NOUN
aiua-11830	59	13	lesions	lesion	NOUN
aiua-11830	59	14	with	with	ADP
aiua-11830	59	15	clinical	clinical	ADJ
aiua-11830	59	16	suspicion	suspicion	NOUN
aiua-11830	59	17	of	of	ADP
aiua-11830	59	18	prostate	prostate	NOUN
aiua-11830	59	19	cancer	cancer	NOUN
aiua-11830	59	20	.	.	PUNCT
aiua-11830	60	1	dre	dre	PROPN
aiua-11830	60	2	:	:	PUNCT
aiua-11830	60	3	digital	digital	ADJ
aiua-11830	60	4	rectal	rectal	ADJ
aiua-11830	60	5	examination	examination	NOUN
aiua-11830	60	6	;	;	PUNCT
aiua-11830	60	7	mpmri	mpmri	PROPN
aiua-11830	60	8	:	:	PUNCT
aiua-11830	60	9	multiparametric	multiparametric	PROPN
aiua-11830	60	10	magnetic	magnetic	ADJ
aiua-11830	60	11	resonance	resonance	NOUN
aiua-11830	60	12	imaging	imaging	NOUN
aiua-11830	60	13	;	;	PUNCT
aiua-11830	60	14	psa	psa	VERB
aiua-11830	60	15	:	:	PUNCT
aiua-11830	60	16	prostate	prostate	NOUN
aiua-11830	60	17	-	-	PUNCT
aiua-11830	60	18	specific	specific	ADJ
aiua-11830	60	19	antigen	antigen	NOUN
aiua-11830	60	20	.	.	PUNCT
aiua-11830	61	1	archivio	archivio	NOUN
aiua-11830	61	2	italiano	italiano	PROPN
aiua-11830	61	3	di	di	X
aiua-11830	61	4	urologia	urologia	PROPN
aiua-11830	61	5	e	e	PROPN
aiua-11830	61	6	andrologia	andrologia	NOUN
aiua-11830	61	7	2023	2023	NUM
aiua-11830	61	8	;	;	PUNCT
aiua-11830	61	9	95(4):11830	95(4):11830	NUM
aiua-11830	61	10	3	3	NUM
aiua-11830	61	11	mri	mri	NOUN
aiua-11830	61	12	pi	pi	NOUN
aiua-11830	61	13	-	-	PUNCT
aiua-11830	61	14	rads	rad	NOUN
aiua-11830	61	15	3	3	NUM
aiua-11830	61	16	lesions	lesion	NOUN
aiua-11830	61	17	statistical	statistical	ADJ
aiua-11830	61	18	analyses	analysis	NOUN
aiua-11830	61	19	were	be	AUX
aiua-11830	61	20	performed	perform	VERB
aiua-11830	61	21	using	use	VERB
aiua-11830	61	22	ibm	ibm	PROPN
aiua-11830	61	23	spss	spss	PROPN
aiua-11830	61	24	statistics	statistics	PROPN
aiua-11830	61	25	software	software	PROPN
aiua-11830	61	26	version	version	PROPN
aiua-11830	61	27	25	25	NUM
aiua-11830	61	28	.	.	PUNCT
aiua-11830	62	1	categorical	categorical	ADJ
aiua-11830	62	2	variables	variable	NOUN
aiua-11830	62	3	are	be	AUX
aiua-11830	62	4	presented	present	VERB
aiua-11830	62	5	as	as	ADP
aiua-11830	62	6	frequencies	frequency	NOUN
aiua-11830	62	7	and	and	CCONJ
aiua-11830	62	8	percentages	percentage	NOUN
aiua-11830	62	9	,	,	PUNCT
aiua-11830	62	10	and	and	CCONJ
aiua-11830	62	11	continuous	continuous	ADJ
aiua-11830	62	12	variables	variable	NOUN
aiua-11830	62	13	as	as	ADP
aiua-11830	62	14	means	mean	NOUN
aiua-11830	62	15	and	and	CCONJ
aiua-11830	62	16	standard	standard	ADJ
aiua-11830	62	17	deviations	deviation	NOUN
aiua-11830	62	18	,	,	PUNCT
aiua-11830	62	19	or	or	CCONJ
aiua-11830	62	20	medians	median	NOUN
aiua-11830	62	21	and	and	CCONJ
aiua-11830	62	22	interquartile	interquartile	NOUN
aiua-11830	62	23	ranges	range	NOUN
aiua-11830	62	24	for	for	ADP
aiua-11830	62	25	variables	variable	NOUN
aiua-11830	62	26	with	with	ADP
aiua-11830	62	27	skewed	skewed	ADJ
aiua-11830	62	28	distributions	distribution	NOUN
aiua-11830	62	29	.	.	PUNCT
aiua-11830	63	1	pearson	pearson	PROPN
aiua-11830	63	2	's	's	PART
aiua-11830	63	3	chi	chi	NOUN
aiua-11830	63	4	-	-	PUNCT
aiua-11830	63	5	squared	square	VERB
aiua-11830	63	6	or	or	CCONJ
aiua-11830	63	7	fisher	fisher	NOUN
aiua-11830	63	8	's	's	PART
aiua-11830	63	9	exact	exact	ADJ
aiua-11830	63	10	test	test	NOUN
aiua-11830	63	11	were	be	AUX
aiua-11830	63	12	used	use	VERB
aiua-11830	63	13	to	to	PART
aiua-11830	63	14	test	test	VERB
aiua-11830	63	15	for	for	ADP
aiua-11830	63	16	associations	association	NOUN
aiua-11830	63	17	in	in	ADP
aiua-11830	63	18	categorical	categorical	ADJ
aiua-11830	63	19	variables	variable	NOUN
aiua-11830	63	20	.	.	PUNCT
aiua-11830	64	1	continuous	continuous	ADJ
aiua-11830	64	2	variables	variable	NOUN
aiua-11830	64	3	were	be	AUX
aiua-11830	64	4	compared	compare	VERB
aiua-11830	64	5	with	with	ADP
aiua-11830	64	6	the	the	DET
aiua-11830	64	7	t	t	NOUN
aiua-11830	64	8	-	-	PUNCT
aiua-11830	64	9	test	test	NOUN
aiua-11830	64	10	student	student	NOUN
aiua-11830	64	11	and	and	CCONJ
aiua-11830	64	12	mann	mann	PROPN
aiua-11830	64	13	-	-	PUNCT
aiua-11830	64	14	whitney	whitney	PROPN
aiua-11830	64	15	u	u	PROPN
aiua-11830	64	16	test	test	NOUN
aiua-11830	64	17	.	.	PUNCT
aiua-11830	65	1	simple	simple	ADJ
aiua-11830	65	2	and	and	CCONJ
aiua-11830	65	3	multiple	multiple	ADJ
aiua-11830	65	4	logistic	logistic	ADJ
aiua-11830	65	5	regression	regression	NOUN
aiua-11830	65	6	were	be	AUX
aiua-11830	65	7	performed	perform	VERB
aiua-11830	65	8	to	to	PART
aiua-11830	65	9	determine	determine	VERB
aiua-11830	65	10	clinical	clinical	ADJ
aiua-11830	65	11	predictors	predictor	NOUN
aiua-11830	65	12	of	of	ADP
aiua-11830	65	13	cspca	cspca	NOUN
aiua-11830	65	14	.	.	PUNCT
aiua-11830	66	1	a	a	DET
aiua-11830	66	2	p	p	ADJ
aiua-11830	66	3	-	-	PUNCT
aiua-11830	66	4	value	value	NOUN
aiua-11830	66	5	≤	≤	NOUN
aiua-11830	66	6	0.05	0.05	NUM
aiua-11830	66	7	was	be	AUX
aiua-11830	66	8	considered	consider	VERB
aiua-11830	66	9	statistically	statistically	ADV
aiua-11830	66	10	significant	significant	ADJ
aiua-11830	66	11	.	.	PUNCT
aiua-11830	67	1	results	result	VERB
aiua-11830	67	2	one	one	NUM
aiua-11830	67	3	thousand	thousand	NUM
aiua-11830	67	4	six	six	NUM
aiua-11830	67	5	hundred	hundred	NUM
aiua-11830	67	6	sixty	sixty	NUM
aiua-11830	67	7	-	-	PUNCT
aiua-11830	67	8	one	one	NUM
aiua-11830	67	9	men	man	NOUN
aiua-11830	67	10	were	be	AUX
aiua-11830	67	11	submitted	submit	VERB
aiua-11830	67	12	to	to	ADP
aiua-11830	67	13	prostate	prostate	NOUN
aiua-11830	67	14	biopsy	biopsy	NOUN
aiua-11830	67	15	for	for	ADP
aiua-11830	67	16	altered	altered	ADJ
aiua-11830	67	17	psa	psa	NOUN
aiua-11830	67	18	or	or	CCONJ
aiua-11830	67	19	/	/	SYM
aiua-11830	67	20	and	and	CCONJ
aiua-11830	67	21	abnormal	abnormal	ADJ
aiua-11830	67	22	dre	dre	NOUN
aiua-11830	67	23	over	over	ADP
aiua-11830	67	24	the	the	DET
aiua-11830	67	25	last	last	ADJ
aiua-11830	67	26	6	6	NUM
aiua-11830	67	27	years	year	NOUN
aiua-11830	67	28	.	.	PUNCT
aiua-11830	68	1	patients	patient	NOUN
aiua-11830	68	2	without	without	ADP
aiua-11830	68	3	a	a	DET
aiua-11830	68	4	pre	pre	ADJ
aiua-11830	68	5	-	-	ADJ
aiua-11830	68	6	biopsy	biopsy	ADJ
aiua-11830	68	7	mpmri	mpmri	PROPN
aiua-11830	68	8	(	(	PUNCT
aiua-11830	68	9	n	n	NOUN
aiua-11830	68	10	=	=	SYM
aiua-11830	68	11	840	840	NUM
aiua-11830	68	12	)	)	PUNCT
aiua-11830	68	13	,	,	PUNCT
aiua-11830	68	14	without	without	ADP
aiua-11830	68	15	a	a	DET
aiua-11830	68	16	pi	pi	NOUN
aiua-11830	68	17	-	-	PUNCT
aiua-11830	68	18	rads	rad	NOUN
aiua-11830	68	19	classification	classification	NOUN
aiua-11830	68	20	in	in	ADP
aiua-11830	68	21	mpmri	mpmri	PROPN
aiua-11830	68	22	(	(	PUNCT
aiua-11830	68	23	n	n	NOUN
aiua-11830	68	24	=	=	SYM
aiua-11830	68	25	41	41	NUM
aiua-11830	68	26	)	)	PUNCT
aiua-11830	68	27	and	and	CCONJ
aiua-11830	68	28	patients	patient	NOUN
aiua-11830	68	29	submitted	submit	VERB
aiua-11830	68	30	to	to	ADP
aiua-11830	68	31	a	a	DET
aiua-11830	68	32	target	target	NOUN
aiua-11830	68	33	biopsy	biopsy	NOUN
aiua-11830	68	34	alone	alone	ADV
aiua-11830	68	35	(	(	PUNCT
aiua-11830	68	36	n	n	NOUN
aiua-11830	68	37	=	=	NUM
aiua-11830	68	38	80	80	NUM
aiua-11830	68	39	)	)	PUNCT
aiua-11830	68	40	were	be	AUX
aiua-11830	68	41	excluded	exclude	VERB
aiua-11830	68	42	.	.	PUNCT
aiua-11830	69	1	one	one	NUM
aiua-11830	69	2	hundred	hundred	NUM
aiua-11830	69	3	and	and	CCONJ
aiua-11830	69	4	twenty	twenty	NUM
aiua-11830	69	5	-	-	PUNCT
aiua-11830	69	6	two	two	NUM
aiua-11830	69	7	patients	patient	NOUN
aiua-11830	69	8	with	with	ADP
aiua-11830	69	9	a	a	DET
aiua-11830	69	10	pi	pi	NOUN
aiua-11830	69	11	-	-	PUNCT
aiua-11830	69	12	rads	rad	NOUN
aiua-11830	69	13	category	category	NOUN
aiua-11830	69	14	5	5	NUM
aiua-11830	69	15	lesions	lesion	NOUN
aiua-11830	69	16	(	(	PUNCT
aiua-11830	69	17	17.4	17.4	NUM
aiua-11830	69	18	%	%	NOUN
aiua-11830	69	19	)	)	PUNCT
aiua-11830	69	20	,	,	PUNCT
aiua-11830	69	21	330	330	NUM
aiua-11830	69	22	with	with	ADP
aiua-11830	69	23	a	a	DET
aiua-11830	69	24	pi	pi	NOUN
aiua-11830	69	25	-	-	PUNCT
aiua-11830	69	26	rads	rad	NOUN
aiua-11830	69	27	category	category	NOUN
aiua-11830	69	28	4	4	NUM
aiua-11830	69	29	lesions	lesion	NOUN
aiua-11830	69	30	(	(	PUNCT
aiua-11830	69	31	47.1	47.1	NUM
aiua-11830	69	32	%	%	NOUN
aiua-11830	69	33	)	)	PUNCT
aiua-11830	69	34	and	and	CCONJ
aiua-11830	69	35	118	118	NUM
aiua-11830	69	36	with	with	ADP
aiua-11830	69	37	pi	pi	NOUN
aiua-11830	69	38	-	-	PUNCT
aiua-11830	69	39	rads	rad	NOUN
aiua-11830	69	40	category	category	NOUN
aiua-11830	69	41	2	2	NUM
aiua-11830	69	42	lesions	lesion	NOUN
aiua-11830	69	43	(	(	PUNCT
aiua-11830	69	44	16.9	16.9	NUM
aiua-11830	69	45	%	%	NOUN
aiua-11830	69	46	)	)	PUNCT
aiua-11830	69	47	were	be	AUX
aiua-11830	69	48	not	not	PART
aiua-11830	69	49	included	include	VERB
aiua-11830	69	50	in	in	ADP
aiua-11830	69	51	the	the	DET
aiua-11830	69	52	cohort	cohort	NOUN
aiua-11830	69	53	.	.	PUNCT
aiua-11830	70	1	the	the	DET
aiua-11830	70	2	detailed	detailed	ADJ
aiua-11830	70	3	patient	patient	ADJ
aiua-11830	70	4	inclusion	inclusion	NOUN
aiua-11830	70	5	and	and	CCONJ
aiua-11830	70	6	exclusion	exclusion	NOUN
aiua-11830	70	7	flow	flow	NOUN
aiua-11830	70	8	charts	chart	NOUN
aiua-11830	70	9	are	be	AUX
aiua-11830	70	10	presented	present	VERB
aiua-11830	70	11	in	in	ADP
aiua-11830	70	12	figure	figure	NOUN
aiua-11830	70	13	1	1	NUM
aiua-11830	70	14	.	.	PUNCT
aiua-11830	71	1	a	a	DET
aiua-11830	71	2	total	total	NOUN
aiua-11830	71	3	of	of	ADP
aiua-11830	71	4	130	130	NUM
aiua-11830	71	5	men	man	NOUN
aiua-11830	71	6	(	(	PUNCT
aiua-11830	71	7	18.5	18.5	NUM
aiua-11830	71	8	%	%	NOUN
aiua-11830	71	9	)	)	PUNCT
aiua-11830	71	10	with	with	ADP
aiua-11830	71	11	pi	pi	NOUN
aiua-11830	71	12	-	-	PUNCT
aiua-11830	71	13	rads	rad	NOUN
aiua-11830	71	14	3	3	NUM
aiua-11830	71	15	index	index	NOUN
aiua-11830	71	16	lesions	lesion	NOUN
aiua-11830	71	17	were	be	AUX
aiua-11830	71	18	biopsied	biopsie	VERB
aiua-11830	71	19	and	and	CCONJ
aiua-11830	71	20	included	include	VERB
aiua-11830	71	21	in	in	ADP
aiua-11830	71	22	this	this	DET
aiua-11830	71	23	study	study	NOUN
aiua-11830	71	24	.	.	PUNCT
aiua-11830	72	1	one	one	NUM
aiua-11830	72	2	hundred	hundred	NUM
aiua-11830	72	3	fifty	fifty	NUM
aiua-11830	72	4	-	-	PUNCT
aiua-11830	72	5	three	three	NUM
aiua-11830	72	6	pi	pi	NOUN
aiua-11830	72	7	-	-	PUNCT
aiua-11830	72	8	rads	rad	NOUN
aiua-11830	72	9	3	3	NUM
aiua-11830	72	10	index	index	NOUN
aiua-11830	72	11	lesions	lesion	NOUN
aiua-11830	72	12	were	be	AUX
aiua-11830	72	13	observed	observe	VERB
aiua-11830	72	14	.	.	PUNCT
aiua-11830	73	1	general	general	ADJ
aiua-11830	73	2	characteristics	characteristic	NOUN
aiua-11830	73	3	of	of	ADP
aiua-11830	73	4	the	the	DET
aiua-11830	73	5	pi	pi	NOUN
aiua-11830	73	6	-	-	PUNCT
aiua-11830	73	7	rads	rad	NOUN
aiua-11830	73	8	3	3	NUM
aiua-11830	73	9	lesions	lesion	NOUN
aiua-11830	73	10	and	and	CCONJ
aiua-11830	73	11	patients	patient	NOUN
aiua-11830	73	12	are	be	AUX
aiua-11830	73	13	summarized	summarize	VERB
aiua-11830	73	14	in	in	ADP
aiua-11830	73	15	table	table	NOUN
aiua-11830	73	16	1	1	NUM
aiua-11830	73	17	.	.	PUNCT
aiua-11830	74	1	the	the	DET
aiua-11830	74	2	mean	mean	ADJ
aiua-11830	74	3	age	age	NOUN
aiua-11830	74	4	was	be	AUX
aiua-11830	74	5	65.2	65.2	NUM
aiua-11830	74	6	±	±	NUM
aiua-11830	74	7	6.9	6.9	NUM
aiua-11830	74	8	years	year	NOUN
aiua-11830	74	9	.	.	PUNCT
aiua-11830	75	1	median	median	ADJ
aiua-11830	75	2	total	total	ADJ
aiua-11830	75	3	psa	psa	NOUN
aiua-11830	75	4	was	be	AUX
aiua-11830	75	5	7.7	7.7	NUM
aiua-11830	75	6	ng	ng	PROPN
aiua-11830	75	7	/	/	SYM
aiua-11830	75	8	dl	dl	PROPN
aiua-11830	75	9	(	(	PUNCT
aiua-11830	75	10	iqr	iqr	PROPN
aiua-11830	75	11	5.43	5.43	NUM
aiua-11830	75	12	-	-	SYM
aiua-11830	75	13	9.77	9.77	NUM
aiua-11830	75	14	)	)	PUNCT
aiua-11830	75	15	,	,	PUNCT
aiua-11830	75	16	with	with	ADP
aiua-11830	75	17	a	a	DET
aiua-11830	75	18	median	median	NOUN
aiua-11830	75	19	of	of	ADP
aiua-11830	75	20	free	free	ADJ
aiua-11830	75	21	/	/	SYM
aiua-11830	75	22	total	total	ADJ
aiua-11830	75	23	psa	psa	NOUN
aiua-11830	75	24	of	of	ADP
aiua-11830	75	25	14.6	14.6	NUM
aiua-11830	75	26	%	%	NOUN
aiua-11830	75	27	(	(	PUNCT
aiua-11830	75	28	iqr	iqr	NOUN
aiua-11830	75	29	11.0	11.0	NUM
aiua-11830	75	30	-	-	SYM
aiua-11830	75	31	18.9	18.9	NUM
aiua-11830	75	32	)	)	PUNCT
aiua-11830	75	33	.	.	PUNCT
aiua-11830	76	1	seventeen	seventeen	NUM
aiua-11830	76	2	of	of	ADP
aiua-11830	76	3	121	121	NUM
aiua-11830	76	4	patients	patient	NOUN
aiua-11830	76	5	had	have	VERB
aiua-11830	76	6	an	an	DET
aiua-11830	76	7	abnormal	abnormal	ADJ
aiua-11830	76	8	dre	dre	NOUN
aiua-11830	76	9	(	(	PUNCT
aiua-11830	76	10	14.0	14.0	NUM
aiua-11830	76	11	%	%	NOUN
aiua-11830	76	12	)	)	PUNCT
aiua-11830	76	13	.	.	PUNCT
aiua-11830	77	1	mean	mean	VERB
aiua-11830	77	2	prostate	prostate	NOUN
aiua-11830	77	3	size	size	NOUN
aiua-11830	77	4	on	on	ADP
aiua-11830	77	5	mpmri	mpmri	PROPN
aiua-11830	77	6	was	be	AUX
aiua-11830	77	7	60.1	60.1	NUM
aiua-11830	77	8	±	±	NUM
aiua-11830	77	9	22.6	22.6	NUM
aiua-11830	77	10	ml	ml	NOUN
aiua-11830	77	11	.	.	PUNCT
aiua-11830	78	1	when	when	SCONJ
aiua-11830	78	2	calculated	calculate	VERB
aiua-11830	78	3	,	,	PUNCT
aiua-11830	78	4	median	median	ADJ
aiua-11830	78	5	psad	psad	NOUN
aiua-11830	78	6	was	be	AUX
aiua-11830	78	7	0.12	0.12	NUM
aiua-11830	78	8	ng	ng	PROPN
aiua-11830	78	9	/	/	SYM
aiua-11830	78	10	ml	ml	NOUN
aiua-11830	78	11	/	/	SYM
aiua-11830	78	12	ml	ml	PROPN
aiua-11830	78	13	(	(	PUNCT
aiua-11830	78	14	iqr	iqr	NOUN
aiua-11830	78	15	0.09	0.09	NUM
aiua-11830	78	16	-	-	PUNCT
aiua-11830	78	17	0.18	0.18	NUM
aiua-11830	78	18	)	)	PUNCT
aiua-11830	78	19	.	.	PUNCT
aiua-11830	79	1	median	median	ADJ
aiua-11830	79	2	maximum	maximum	ADJ
aiua-11830	79	3	lesion	lesion	NOUN
aiua-11830	79	4	diameter	diameter	NOUN
aiua-11830	79	5	was	be	AUX
aiua-11830	79	6	10.0	10.0	NUM
aiua-11830	79	7	mm	mm	NOUN
aiua-11830	79	8	(	(	PUNCT
aiua-11830	79	9	iqr	iqr	PROPN
aiua-11830	79	10	7.0	7.0	NUM
aiua-11830	79	11	-	-	SYM
aiua-11830	79	12	13.0	13.0	NUM
aiua-11830	79	13	)	)	PUNCT
aiua-11830	79	14	.	.	PUNCT
aiua-11830	80	1	the	the	DET
aiua-11830	80	2	majority	majority	NOUN
aiua-11830	80	3	of	of	ADP
aiua-11830	80	4	the	the	DET
aiua-11830	80	5	lesions	lesion	NOUN
aiua-11830	80	6	were	be	AUX
aiua-11830	80	7	located	locate	VERB
aiua-11830	80	8	on	on	ADP
aiua-11830	80	9	the	the	DET
aiua-11830	80	10	peripheral	peripheral	ADJ
aiua-11830	80	11	zone	zone	NOUN
aiua-11830	80	12	(	(	PUNCT
aiua-11830	80	13	pz	pz	NOUN
aiua-11830	80	14	)	)	PUNCT
aiua-11830	80	15	(	(	PUNCT
aiua-11830	80	16	64.9	64.9	NUM
aiua-11830	80	17	%	%	NOUN
aiua-11830	80	18	)	)	PUNCT
aiua-11830	80	19	followed	follow	VERB
aiua-11830	80	20	by	by	ADP
aiua-11830	80	21	transitional	transitional	ADJ
aiua-11830	80	22	(	(	PUNCT
aiua-11830	80	23	tz	tz	NOUN
aiua-11830	80	24	)	)	PUNCT
aiua-11830	80	25	and	and	CCONJ
aiua-11830	80	26	anterior	anterior	ADJ
aiua-11830	80	27	zone	zone	NOUN
aiua-11830	80	28	(	(	PUNCT
aiua-11830	80	29	33.1	33.1	NUM
aiua-11830	80	30	%	%	NOUN
aiua-11830	80	31	and	and	CCONJ
aiua-11830	80	32	1.9	1.9	NUM
aiua-11830	80	33	%	%	NOUN
aiua-11830	80	34	,	,	PUNCT
aiua-11830	80	35	respectively	respectively	ADV
aiua-11830	80	36	)	)	PUNCT
aiua-11830	80	37	.	.	PUNCT
aiua-11830	81	1	regarding	regard	VERB
aiua-11830	81	2	prostatic	prostatic	ADJ
aiua-11830	81	3	location	location	NOUN
aiua-11830	81	4	,	,	PUNCT
aiua-11830	81	5	most	most	ADJ
aiua-11830	81	6	were	be	AUX
aiua-11830	81	7	in	in	ADP
aiua-11830	81	8	the	the	DET
aiua-11830	81	9	middle	middle	NOUN
aiua-11830	81	10	of	of	ADP
aiua-11830	81	11	prostate	prostate	NOUN
aiua-11830	81	12	(	(	PUNCT
aiua-11830	81	13	54.3	54.3	NUM
aiua-11830	81	14	%	%	NOUN
aiua-11830	81	15	)	)	PUNCT
aiua-11830	81	16	.	.	PUNCT
aiua-11830	82	1	one	one	NUM
aiua-11830	82	2	hundred	hundred	NUM
aiua-11830	82	3	and	and	CCONJ
aiua-11830	82	4	eight	eight	NUM
aiua-11830	82	5	men	man	NOUN
aiua-11830	82	6	had	have	VERB
aiua-11830	82	7	prostates	prostate	NOUN
aiua-11830	82	8	with	with	ADP
aiua-11830	82	9	only	only	ADV
aiua-11830	82	10	one	one	NUM
aiua-11830	82	11	targeted	target	VERB
aiua-11830	82	12	lesion	lesion	NOUN
aiua-11830	82	13	(	(	PUNCT
aiua-11830	82	14	83.1	83.1	NUM
aiua-11830	82	15	%	%	NOUN
aiua-11830	82	16	)	)	PUNCT
aiua-11830	82	17	and	and	CCONJ
aiua-11830	82	18	22	22	NUM
aiua-11830	82	19	patients	patient	NOUN
aiua-11830	82	20	had	have	VERB
aiua-11830	82	21	more	more	ADJ
aiua-11830	82	22	than	than	ADP
aiua-11830	82	23	one	one	NUM
aiua-11830	82	24	pi	pi	NOUN
aiua-11830	82	25	-	-	PUNCT
aiua-11830	82	26	rads	rad	NOUN
aiua-11830	82	27	3	3	NUM
aiua-11830	82	28	lesion	lesion	NOUN
aiua-11830	82	29	(	(	PUNCT
aiua-11830	82	30	16.9	16.9	NUM
aiua-11830	82	31	%	%	NOUN
aiua-11830	82	32	)	)	PUNCT
aiua-11830	82	33	.	.	PUNCT
aiua-11830	83	1	the	the	DET
aiua-11830	83	2	number	number	NOUN
aiua-11830	83	3	of	of	ADP
aiua-11830	83	4	pi	pi	NOUN
aiua-11830	83	5	-	-	PUNCT
aiua-11830	83	6	rads	rad	NOUN
aiua-11830	83	7	3	3	NUM
aiua-11830	83	8	lesions	lesion	NOUN
aiua-11830	83	9	in	in	ADP
aiua-11830	83	10	the	the	DET
aiua-11830	83	11	prostate	prostate	NOUN
aiua-11830	83	12	ranged	range	VERB
aiua-11830	83	13	from	from	ADP
aiua-11830	83	14	1	1	NUM
aiua-11830	83	15	to	to	ADP
aiua-11830	83	16	4	4	NUM
aiua-11830	83	17	lesions	lesion	NOUN
aiua-11830	83	18	.	.	PUNCT
aiua-11830	84	1	pathologic	pathologic	ADJ
aiua-11830	84	2	results	result	NOUN
aiua-11830	84	3	in	in	ADP
aiua-11830	84	4	this	this	DET
aiua-11830	84	5	cohort	cohort	NOUN
aiua-11830	84	6	were	be	AUX
aiua-11830	84	7	benign	benign	ADJ
aiua-11830	84	8	in	in	ADP
aiua-11830	84	9	77	77	NUM
aiua-11830	84	10	lesions	lesion	NOUN
aiua-11830	84	11	(	(	PUNCT
aiua-11830	84	12	59.2	59.2	NUM
aiua-11830	84	13	%	%	NOUN
aiua-11830	84	14	)	)	PUNCT
aiua-11830	84	15	,	,	PUNCT
aiua-11830	84	16	19	19	NUM
aiua-11830	84	17	(	(	PUNCT
aiua-11830	84	18	14.6	14.6	NUM
aiua-11830	84	19	%	%	NOUN
aiua-11830	84	20	)	)	PUNCT
aiua-11830	84	21	were	be	AUX
aiua-11830	84	22	clinically	clinically	ADV
aiua-11830	84	23	insignificant	insignificant	ADJ
aiua-11830	84	24	(	(	PUNCT
aiua-11830	84	25	gleason	gleason	PROPN
aiua-11830	84	26	score	score	VERB
aiua-11830	84	27	6	6	NUM
aiua-11830	84	28	or	or	CCONJ
aiua-11830	84	29	isup	isup	ADJ
aiua-11830	84	30	1	1	NUM
aiua-11830	84	31	)	)	PUNCT
aiua-11830	84	32	and	and	CCONJ
aiua-11830	84	33	34	34	NUM
aiua-11830	84	34	(	(	PUNCT
aiua-11830	84	35	26.2	26.2	NUM
aiua-11830	84	36	%	%	NOUN
aiua-11830	84	37	)	)	PUNCT
aiua-11830	84	38	were	be	AUX
aiua-11830	84	39	cspca	cspca	ADJ
aiua-11830	84	40	(	(	PUNCT
aiua-11830	84	41	more	more	ADJ
aiua-11830	84	42	than	than	SCONJ
aiua-11830	84	43	gleason	gleason	PROPN
aiua-11830	84	44	score	score	VERB
aiua-11830	84	45	7	7	NUM
aiua-11830	84	46	or	or	CCONJ
aiua-11830	84	47	above	above	ADP
aiua-11830	84	48	isup	isup	NOUN
aiua-11830	84	49	2	2	NUM
aiua-11830	84	50	)	)	PUNCT
aiua-11830	84	51	.	.	PUNCT
aiua-11830	85	1	of	of	ADP
aiua-11830	85	2	the	the	DET
aiua-11830	85	3	34	34	NUM
aiua-11830	85	4	patients	patient	NOUN
aiua-11830	85	5	with	with	ADP
aiua-11830	85	6	cspca	cspca	NOUN
aiua-11830	85	7	,	,	PUNCT
aiua-11830	85	8	30	30	NUM
aiua-11830	85	9	patients	patient	NOUN
aiua-11830	85	10	had	have	VERB
aiua-11830	85	11	a	a	DET
aiua-11830	85	12	gleason	gleason	PROPN
aiua-11830	85	13	score	score	NOUN
aiua-11830	85	14	of	of	ADP
aiua-11830	85	15	7	7	NUM
aiua-11830	85	16	(	(	PUNCT
aiua-11830	85	17	3	3	NUM
aiua-11830	85	18	+	+	NOUN
aiua-11830	85	19	4	4	NUM
aiua-11830	85	20	)	)	PUNCT
aiua-11830	85	21	,	,	PUNCT
aiua-11830	85	22	3	3	NUM
aiua-11830	85	23	patients	patient	NOUN
aiua-11830	85	24	had	have	VERB
aiua-11830	85	25	a	a	DET
aiua-11830	85	26	gleason	gleason	PROPN
aiua-11830	85	27	score	score	NOUN
aiua-11830	85	28	of	of	ADP
aiua-11830	85	29	7	7	NUM
aiua-11830	85	30	(	(	PUNCT
aiua-11830	85	31	4	4	NUM
aiua-11830	85	32	+	+	NOUN
aiua-11830	85	33	3	3	NUM
aiua-11830	85	34	)	)	PUNCT
aiua-11830	85	35	and	and	CCONJ
aiua-11830	85	36	one	one	NUM
aiua-11830	85	37	patient	patient	NOUN
aiua-11830	85	38	had	have	VERB
aiua-11830	85	39	a	a	DET
aiua-11830	85	40	gleason	gleason	PROPN
aiua-11830	85	41	score	score	NOUN
aiua-11830	85	42	9	9	NUM
aiua-11830	85	43	(	(	PUNCT
aiua-11830	85	44	5	5	NUM
aiua-11830	85	45	+	+	NOUN
aiua-11830	85	46	4	4	NUM
aiua-11830	85	47	)	)	PUNCT
aiua-11830	85	48	.	.	PUNCT
aiua-11830	86	1	eighty	eighty	NUM
aiua-11830	86	2	-	-	PUNCT
aiua-11830	86	3	seven	seven	NUM
aiua-11830	86	4	of	of	ADP
aiua-11830	86	5	the	the	DET
aiua-11830	86	6	patients	patient	NOUN
aiua-11830	86	7	were	be	AUX
aiua-11830	86	8	included	include	VERB
aiua-11830	86	9	in	in	ADP
aiua-11830	86	10	the	the	DET
aiua-11830	86	11	target	target	NOUN
aiua-11830	86	12	group	group	NOUN
aiua-11830	86	13	(	(	PUNCT
aiua-11830	86	14	66.9	66.9	NUM
aiua-11830	86	15	%	%	NOUN
aiua-11830	86	16	)	)	PUNCT
aiua-11830	86	17	and	and	CCONJ
aiua-11830	86	18	43	43	NUM
aiua-11830	86	19	in	in	ADP
aiua-11830	86	20	the	the	DET
aiua-11830	86	21	non	non	ADJ
aiua-11830	86	22	-	-	ADJ
aiua-11830	86	23	target	target	ADJ
aiua-11830	86	24	group	group	NOUN
aiua-11830	86	25	(	(	PUNCT
aiua-11830	86	26	33.1	33.1	NUM
aiua-11830	86	27	%	%	NOUN
aiua-11830	86	28	)	)	PUNCT
aiua-11830	86	29	.	.	PUNCT
aiua-11830	87	1	the	the	DET
aiua-11830	87	2	pathologic	pathologic	ADJ
aiua-11830	87	3	outcomes	outcome	NOUN
aiua-11830	87	4	of	of	ADP
aiua-11830	87	5	pirads	pirad	NOUN
aiua-11830	87	6	3	3	NUM
aiua-11830	87	7	lesions	lesion	NOUN
aiua-11830	87	8	,	,	PUNCT
aiua-11830	87	9	considering	consider	VERB
aiua-11830	87	10	the	the	DET
aiua-11830	87	11	clinical	clinical	ADJ
aiua-11830	87	12	data	datum	NOUN
aiua-11830	87	13	and	and	CCONJ
aiua-11830	87	14	target	target	NOUN
aiua-11830	87	15	and	and	CCONJ
aiua-11830	87	16	non	non	ADJ
aiua-11830	87	17	-	-	NOUN
aiua-11830	87	18	target	target	ADJ
aiua-11830	87	19	group	group	NOUN
aiua-11830	87	20	,	,	PUNCT
aiua-11830	87	21	are	be	AUX
aiua-11830	87	22	described	describe	VERB
aiua-11830	87	23	in	in	ADP
aiua-11830	87	24	figure	figure	NOUN
aiua-11830	87	25	2	2	NUM
aiua-11830	87	26	.	.	PUNCT
aiua-11830	88	1	the	the	DET
aiua-11830	88	2	presence	presence	NOUN
aiua-11830	88	3	of	of	ADP
aiua-11830	88	4	benign	benign	ADJ
aiua-11830	88	5	histology	histology	NOUN
aiua-11830	88	6	was	be	AUX
aiua-11830	88	7	the	the	DET
aiua-11830	88	8	most	most	ADV
aiua-11830	88	9	common	common	ADJ
aiua-11830	88	10	result	result	NOUN
aiua-11830	88	11	in	in	ADP
aiua-11830	88	12	both	both	DET
aiua-11830	88	13	groups	group	NOUN
aiua-11830	88	14	.	.	PUNCT
aiua-11830	89	1	the	the	DET
aiua-11830	89	2	cspca	cspca	PROPN
aiua-11830	89	3	detection	detection	NOUN
aiua-11830	89	4	in	in	ADP
aiua-11830	89	5	patients	patient	NOUN
aiua-11830	89	6	with	with	ADP
aiua-11830	89	7	previous	previous	ADJ
aiua-11830	89	8	negative	negative	ADJ
aiua-11830	89	9	biopsy	biopsy	NOUN
aiua-11830	89	10	was	be	AUX
aiua-11830	89	11	inferior	inferior	ADJ
aiua-11830	89	12	compared	compare	VERB
aiua-11830	89	13	to	to	ADP
aiua-11830	89	14	naive	naive	ADJ
aiua-11830	89	15	or	or	CCONJ
aiua-11830	89	16	active	active	ADJ
aiua-11830	89	17	surveillance	surveillance	NOUN
aiua-11830	89	18	patients	patient	NOUN
aiua-11830	89	19	.	.	PUNCT
aiua-11830	90	1	the	the	DET
aiua-11830	90	2	difference	difference	NOUN
aiua-11830	90	3	in	in	ADP
aiua-11830	90	4	cspca	cspca	NOUN
aiua-11830	90	5	rates	rate	NOUN
aiua-11830	90	6	among	among	ADP
aiua-11830	90	7	the	the	DET
aiua-11830	90	8	three	three	NUM
aiua-11830	90	9	clinical	clinical	ADJ
aiua-11830	90	10	scenarios	scenario	NOUN
aiua-11830	90	11	was	be	AUX
aiua-11830	90	12	not	not	PART
aiua-11830	90	13	statistically	statistically	ADV
aiua-11830	90	14	significant	significant	ADJ
aiua-11830	90	15	(	(	PUNCT
aiua-11830	90	16	p	p	X
aiua-11830	90	17	=	=	NOUN
aiua-11830	90	18	0.32	0.32	NUM
aiua-11830	90	19	)	)	PUNCT
aiua-11830	90	20	.	.	PUNCT
aiua-11830	91	1	the	the	DET
aiua-11830	91	2	cspca	cspca	PROPN
aiua-11830	91	3	detection	detection	NOUN
aiua-11830	91	4	was	be	AUX
aiua-11830	91	5	higher	high	ADJ
aiua-11830	91	6	in	in	ADP
aiua-11830	91	7	the	the	DET
aiua-11830	91	8	non	non	ADJ
aiua-11830	91	9	-	-	ADJ
aiua-11830	91	10	target	target	ADJ
aiua-11830	91	11	group	group	NOUN
aiua-11830	91	12	(	(	PUNCT
aiua-11830	91	13	32.6	32.6	NUM
aiua-11830	91	14	%	%	NOUN
aiua-11830	91	15	,	,	PUNCT
aiua-11830	91	16	n	n	NOUN
aiua-11830	91	17	=	=	NUM
aiua-11830	91	18	14	14	NUM
aiua-11830	91	19	vs	vs	ADP
aiua-11830	91	20	23.0	23.0	NUM
aiua-11830	91	21	%	%	NOUN
aiua-11830	91	22	,	,	PUNCT
aiua-11830	91	23	n	n	NOUN
aiua-11830	91	24	=	=	NUM
aiua-11830	91	25	20	20	NUM
aiua-11830	91	26	respectively	respectively	ADV
aiua-11830	91	27	)	)	PUNCT
aiua-11830	91	28	.	.	PUNCT
aiua-11830	92	1	regarding	regard	VERB
aiua-11830	92	2	the	the	DET
aiua-11830	92	3	target	target	NOUN
aiua-11830	92	4	group	group	NOUN
aiua-11830	92	5	,	,	PUNCT
aiua-11830	92	6	11	11	NUM
aiua-11830	92	7	patients	patient	NOUN
aiua-11830	92	8	with	with	ADP
aiua-11830	92	9	pirads	pirad	NOUN
aiua-11830	92	10	3	3	NUM
aiua-11830	92	11	lesions	lesion	NOUN
aiua-11830	92	12	had	have	VERB
aiua-11830	92	13	cspca	cspca	NOUN
aiua-11830	92	14	in	in	ADP
aiua-11830	92	15	both	both	CCONJ
aiua-11830	92	16	systematic	systematic	ADJ
aiua-11830	92	17	and	and	CCONJ
aiua-11830	92	18	target	target	NOUN
aiua-11830	92	19	biopsy	biopsy	NOUN
aiua-11830	92	20	(	(	PUNCT
aiua-11830	92	21	55.0	55.0	NUM
aiua-11830	92	22	%	%	NOUN
aiua-11830	92	23	)	)	PUNCT
aiua-11830	92	24	.	.	PUNCT
aiua-11830	93	1	nine	nine	NUM
aiua-11830	93	2	patients	patient	NOUN
aiua-11830	93	3	had	have	VERB
aiua-11830	93	4	a	a	DET
aiua-11830	93	5	positive	positive	ADJ
aiua-11830	93	6	systematic	systematic	ADJ
aiua-11830	93	7	and	and	CCONJ
aiua-11830	93	8	negative	negative	ADJ
aiua-11830	93	9	target	target	NOUN
aiua-11830	93	10	biopsy	biopsy	NOUN
aiua-11830	93	11	.	.	PUNCT
aiua-11830	94	1	no	no	DET
aiua-11830	94	2	case	case	NOUN
aiua-11830	94	3	of	of	ADP
aiua-11830	94	4	a	a	DET
aiua-11830	94	5	positive	positive	ADJ
aiua-11830	94	6	target	target	NOUN
aiua-11830	94	7	biopsy	biopsy	NOUN
aiua-11830	94	8	and	and	CCONJ
aiua-11830	94	9	a	a	DET
aiua-11830	94	10	negative	negative	ADJ
aiua-11830	94	11	systematic	systematic	ADJ
aiua-11830	94	12	biopsy	biopsy	NOUN
aiua-11830	94	13	was	be	AUX
aiua-11830	94	14	identified	identify	VERB
aiua-11830	94	15	.	.	PUNCT
aiua-11830	95	1	in	in	ADP
aiua-11830	95	2	all	all	DET
aiua-11830	95	3	patients	patient	NOUN
aiua-11830	95	4	,	,	PUNCT
aiua-11830	95	5	the	the	DET
aiua-11830	95	6	presence	presence	NOUN
aiua-11830	95	7	of	of	ADP
aiua-11830	95	8	positive	positive	ADJ
aiua-11830	95	9	pathologic	pathologic	ADJ
aiua-11830	95	10	findings	finding	NOUN
aiua-11830	95	11	in	in	ADP
aiua-11830	95	12	systemic	systemic	ADJ
aiua-11830	95	13	and	and	CCONJ
aiua-11830	95	14	target	target	NOUN
aiua-11830	95	15	biopsy	biopsy	NOUN
aiua-11830	95	16	,	,	PUNCT
aiua-11830	95	17	equivalent	equivalent	ADJ
aiua-11830	95	18	histological	histological	ADJ
aiua-11830	95	19	results	result	NOUN
aiua-11830	95	20	for	for	ADP
aiua-11830	95	21	both	both	DET
aiua-11830	95	22	specimens	specimen	NOUN
aiua-11830	95	23	were	be	AUX
aiua-11830	95	24	found	find	VERB
aiua-11830	95	25	.	.	PUNCT
aiua-11830	96	1	when	when	SCONJ
aiua-11830	96	2	systematic	systematic	ADJ
aiua-11830	96	3	and	and	CCONJ
aiua-11830	96	4	target	target	NOUN
aiua-11830	96	5	biopsies	biopsy	NOUN
aiua-11830	96	6	were	be	AUX
aiua-11830	96	7	jointly	jointly	ADV
aiua-11830	96	8	performed	perform	VERB
aiua-11830	96	9	,	,	PUNCT
aiua-11830	96	10	if	if	SCONJ
aiua-11830	96	11	the	the	DET
aiua-11830	96	12	results	result	NOUN
aiua-11830	96	13	of	of	ADP
aiua-11830	96	14	systematic	systematic	ADJ
aiua-11830	96	15	biopsies	biopsy	NOUN
aiua-11830	96	16	are	be	AUX
aiua-11830	96	17	not	not	PART
aiua-11830	96	18	considered	consider	VERB
aiua-11830	96	19	and	and	CCONJ
aiua-11830	96	20	only	only	ADV
aiua-11830	96	21	the	the	DET
aiua-11830	96	22	results	result	NOUN
aiua-11830	96	23	of	of	ADP
aiua-11830	96	24	target	target	NOUN
aiua-11830	96	25	biopsies	biopsy	NOUN
aiua-11830	96	26	are	be	AUX
aiua-11830	96	27	taken	take	VERB
aiua-11830	96	28	into	into	ADP
aiua-11830	96	29	account	account	NOUN
aiua-11830	96	30	,	,	PUNCT
aiua-11830	96	31	a	a	DET
aiua-11830	96	32	cspca	cspca	NOUN
aiua-11830	96	33	diagnosis	diagnosis	NOUN
aiua-11830	96	34	would	would	AUX
aiua-11830	96	35	be	be	AUX
aiua-11830	96	36	missed	miss	VERB
aiua-11830	96	37	on	on	ADP
aiua-11830	96	38	9	9	NUM
aiua-11830	96	39	patients	patient	NOUN
aiua-11830	96	40	.	.	PUNCT
aiua-11830	97	1	the	the	DET
aiua-11830	97	2	difference	difference	NOUN
aiua-11830	97	3	of	of	ADP
aiua-11830	97	4	insignificant	insignificant	ADJ
aiua-11830	97	5	cancer	cancer	NOUN
aiua-11830	97	6	and	and	CCONJ
aiua-11830	97	7	cspca	cspca	NOUN
aiua-11830	97	8	rates	rate	NOUN
aiua-11830	97	9	among	among	ADP
aiua-11830	97	10	the	the	DET
aiua-11830	97	11	target	target	NOUN
aiua-11830	97	12	or	or	CCONJ
aiua-11830	97	13	non	non	ADJ
aiua-11830	97	14	-	-	ADJ
aiua-11830	97	15	target	target	ADJ
aiua-11830	97	16	group	group	NOUN
aiua-11830	97	17	was	be	AUX
aiua-11830	97	18	not	not	PART
aiua-11830	97	19	statistically	statistically	ADV
aiua-11830	97	20	significant	significant	ADJ
aiua-11830	97	21	(	(	PUNCT
aiua-11830	97	22	p	p	X
aiua-11830	97	23	=	=	NOUN
aiua-11830	97	24	0.50	0.50	NUM
aiua-11830	97	25	and	and	CCONJ
aiua-11830	97	26	p	p	NOUN
aiua-11830	97	27	=	=	NOUN
aiua-11830	97	28	0.24	0.24	NUM
aiua-11830	97	29	,	,	PUNCT
aiua-11830	97	30	respectively	respectively	ADV
aiua-11830	97	31	)	)	PUNCT
aiua-11830	97	32	.	.	PUNCT
aiua-11830	98	1	psad	psad	ADJ
aiua-11830	98	2	,	,	PUNCT
aiua-11830	98	3	abnormal	abnormal	ADJ
aiua-11830	98	4	dre	dre	NOUN
aiua-11830	98	5	and	and	CCONJ
aiua-11830	98	6	peripheral	peripheral	ADJ
aiua-11830	98	7	target	target	NOUN
aiua-11830	98	8	lesion	lesion	NOUN
aiua-11830	98	9	location	location	NOUN
aiua-11830	98	10	were	be	AUX
aiua-11830	98	11	significantly	significantly	ADV
aiua-11830	98	12	associated	associate	VERB
aiua-11830	98	13	with	with	ADP
aiua-11830	98	14	cspca	cspca	NOUN
aiua-11830	98	15	in	in	ADP
aiua-11830	98	16	pi	pi	NOUN
aiua-11830	98	17	-	-	PUNCT
aiua-11830	98	18	rads	rad	NOUN
aiua-11830	98	19	3	3	NUM
aiua-11830	98	20	lesions	lesion	NOUN
aiua-11830	98	21	(	(	PUNCT
aiua-11830	98	22	p	p	X
aiua-11830	98	23	=	=	NOUN
aiua-11830	98	24	0.05	0.05	NUM
aiua-11830	98	25	,	,	PUNCT
aiua-11830	98	26	0.01	0.01	NUM
aiua-11830	98	27	and	and	CCONJ
aiua-11830	98	28	0.01	0.01	NUM
aiua-11830	98	29	,	,	PUNCT
aiua-11830	98	30	respectively	respectively	ADV
aiua-11830	98	31	)	)	PUNCT
aiua-11830	98	32	.	.	PUNCT
aiua-11830	99	1	clinical	clinical	ADJ
aiua-11830	99	2	,	,	PUNCT
aiua-11830	99	3	mpmri	mpmri	PROPN
aiua-11830	99	4	and	and	CCONJ
aiua-11830	99	5	pathologic	pathologic	ADJ
aiua-11830	99	6	findings	finding	NOUN
aiua-11830	99	7	on	on	ADP
aiua-11830	99	8	cspca	cspca	NOUN
aiua-11830	99	9	lesions	lesion	NOUN
aiua-11830	99	10	are	be	AUX
aiua-11830	99	11	reported	report	VERB
aiua-11830	99	12	in	in	ADP
aiua-11830	99	13	table	table	NOUN
aiua-11830	99	14	3	3	NUM
aiua-11830	99	15	.	.	PUNCT
aiua-11830	100	1	on	on	ADP
aiua-11830	100	2	multivariate	multivariate	NOUN
aiua-11830	100	3	analysis	analysis	NOUN
aiua-11830	100	4	,	,	PUNCT
aiua-11830	100	5	the	the	DET
aiua-11830	100	6	abnormal	abnormal	ADJ
aiua-11830	100	7	dre	dre	NOUN
aiua-11830	100	8	and	and	CCONJ
aiua-11830	100	9	lesions	lesion	NOUN
aiua-11830	100	10	localized	localize	VERB
aiua-11830	100	11	in	in	ADP
aiua-11830	100	12	peripheral	peripheral	ADJ
aiua-11830	100	13	zone	zone	NOUN
aiua-11830	100	14	(	(	PUNCT
aiua-11830	100	15	pz	pz	NOUN
aiua-11830	100	16	)	)	PUNCT
aiua-11830	100	17	were	be	AUX
aiua-11830	100	18	significantly	significantly	ADV
aiua-11830	100	19	associated	associate	VERB
aiua-11830	100	20	with	with	ADP
aiua-11830	100	21	a	a	DET
aiua-11830	100	22	presence	presence	NOUN
aiua-11830	100	23	of	of	ADP
aiua-11830	100	24	cspca	cspca	NOUN
aiua-11830	100	25	in	in	ADP
aiua-11830	100	26	pirads	pirad	NOUN
aiua-11830	100	27	3	3	NUM
aiua-11830	100	28	lesions	lesion	NOUN
aiua-11830	100	29	(	(	PUNCT
aiua-11830	100	30	or	or	CCONJ
aiua-11830	100	31	=	=	NUM
aiua-11830	100	32	3.61	3.61	NUM
aiua-11830	100	33	,	,	PUNCT
aiua-11830	100	34	95	95	NUM
aiua-11830	100	35	%	%	NOUN
aiua-11830	100	36	ci	ci	NOUN
aiua-11830	101	1	[	[	X
aiua-11830	101	2	1.22	1.22	NUM
aiua-11830	101	3	,	,	PUNCT
aiua-11830	101	4	10.72	10.72	NUM
aiua-11830	101	5	]	]	PUNCT
aiua-11830	101	6	,	,	PUNCT
aiua-11830	101	7	p	p	X
aiua-11830	101	8	=	=	NOUN
aiua-11830	101	9	0.02	0.02	NUM
aiua-11830	101	10	and	and	CCONJ
aiua-11830	101	11	or	or	CCONJ
aiua-11830	101	12	=	=	SYM
aiua-11830	101	13	3.31	3.31	NUM
aiua-11830	101	14	,	,	PUNCT
aiua-11830	101	15	95	95	NUM
aiua-11830	101	16	%	%	NOUN
aiua-11830	101	17	ci	ci	NOUN
aiua-11830	102	1	[	[	X
aiua-11830	102	2	1.35	1.35	NUM
aiua-11830	102	3	,	,	PUNCT
aiua-11830	102	4	8.11	8.11	NUM
aiua-11830	102	5	]	]	PUNCT
aiua-11830	102	6	,	,	PUNCT
aiua-11830	102	7	p=	p=	NOUN
aiua-11830	102	8	0.01	0.01	NUM
aiua-11830	102	9	,	,	PUNCT
aiua-11830	102	10	respectively	respectively	ADV
aiua-11830	102	11	)	)	PUNCT
aiua-11830	102	12	.	.	PUNCT
aiua-11830	103	1	the	the	DET
aiua-11830	103	2	frequency	frequency	NOUN
aiua-11830	103	3	of	of	ADP
aiua-11830	103	4	abnormal	abnormal	ADJ
aiua-11830	103	5	dre	dre	NOUN
aiua-11830	103	6	was	be	AUX
aiua-11830	103	7	superior	superior	ADJ
aiua-11830	103	8	in	in	ADP
aiua-11830	103	9	the	the	DET
aiua-11830	103	10	group	group	NOUN
aiua-11830	103	11	of	of	ADP
aiua-11830	103	12	cspca	cspca	PROPN
aiua-11830	103	13	patients	patient	NOUN
aiua-11830	103	14	(	(	PUNCT
aiua-11830	103	15	29.0	29.0	NUM
aiua-11830	103	16	%	%	NOUN
aiua-11830	103	17	vs	vs	ADP
aiua-11830	103	18	14.0	14.0	NUM
aiua-11830	103	19	%	%	NOUN
aiua-11830	103	20	,	,	PUNCT
aiua-11830	103	21	respectively	respectively	ADV
aiua-11830	103	22	)	)	PUNCT
aiua-11830	103	23	.	.	PUNCT
aiua-11830	104	1	the	the	DET
aiua-11830	104	2	median	median	PROPN
aiua-11830	104	3	psad	psad	NOUN
aiua-11830	104	4	was	be	AUX
aiua-11830	104	5	similar	similar	ADJ
aiua-11830	104	6	in	in	ADP
aiua-11830	104	7	cspca	cspca	ADJ
aiua-11830	104	8	positive	positive	ADJ
aiua-11830	104	9	patients	patient	NOUN
aiua-11830	104	10	and	and	CCONJ
aiua-11830	104	11	the	the	DET
aiua-11830	104	12	overall	overall	ADJ
aiua-11830	104	13	pi	pi	NOUN
aiua-11830	104	14	-	-	PUNCT
aiua-11830	104	15	rads	rad	NOUN
aiua-11830	104	16	3	3	NUM
aiua-11830	104	17	lesions	lesion	NOUN
aiua-11830	104	18	group	group	NOUN
aiua-11830	104	19	.	.	PUNCT
aiua-11830	105	1	a	a	DET
aiua-11830	105	2	higher	high	ADJ
aiua-11830	105	3	median	median	NOUN
aiua-11830	105	4	psad	psad	NOUN
aiua-11830	105	5	significantly	significantly	ADV
aiua-11830	105	6	predisposed	predispose	VERB
aiua-11830	105	7	for	for	ADP
aiua-11830	105	8	cspca	cspca	NOUN
aiua-11830	105	9	on	on	ADP
aiua-11830	105	10	table	table	NOUN
aiua-11830	105	11	1	1	NUM
aiua-11830	105	12	.	.	PUNCT
aiua-11830	106	1	clinical	clinical	ADJ
aiua-11830	106	2	and	and	CCONJ
aiua-11830	106	3	imagiological	imagiological	ADJ
aiua-11830	106	4	characteristics	characteristic	NOUN
aiua-11830	106	5	of	of	ADP
aiua-11830	106	6	the	the	DET
aiua-11830	106	7	pi	pi	NOUN
aiua-11830	106	8	-	-	PUNCT
aiua-11830	106	9	rads	rad	NOUN
aiua-11830	106	10	categoric	categoric	ADJ
aiua-11830	106	11	3	3	NUM
aiua-11830	106	12	cohort	cohort	NOUN
aiua-11830	106	13	population	population	NOUN
aiua-11830	106	14	.	.	PUNCT
aiua-11830	107	1	variables	variable	NOUN
aiua-11830	107	2	no	no	INTJ
aiua-11830	107	3	.	.	PUNCT
aiua-11830	108	1	(	(	PUNCT
aiua-11830	108	2	%	%	NOUN
aiua-11830	108	3	)	)	PUNCT
aiua-11830	108	4	age	age	NOUN
aiua-11830	108	5	(	(	PUNCT
aiua-11830	108	6	years	year	NOUN
aiua-11830	108	7	)	)	PUNCT
aiua-11830	109	1	[	[	X
aiua-11830	109	2	mean	mean	X
aiua-11830	109	3	±	±	NUM
aiua-11830	109	4	sd	sd	NOUN
aiua-11830	109	5	]	]	PUNCT
aiua-11830	109	6	65.2	65.2	NUM
aiua-11830	109	7	±	±	NUM
aiua-11830	109	8	6.9	6.9	NUM
aiua-11830	109	9	total	total	NOUN
aiua-11830	109	10	psa	psa	NOUN
aiua-11830	109	11	(	(	PUNCT
aiua-11830	109	12	ng	ng	PROPN
aiua-11830	109	13	/	/	SYM
aiua-11830	109	14	dl	dl	PROPN
aiua-11830	109	15	)	)	PUNCT
aiua-11830	110	1	[	[	X
aiua-11830	110	2	median	median	ADJ
aiua-11830	110	3	(	(	PUNCT
aiua-11830	110	4	iqr	iqr	NOUN
aiua-11830	110	5	)	)	PUNCT
aiua-11830	110	6	]	]	PUNCT
aiua-11830	111	1	7.7	7.7	NUM
aiua-11830	111	2	(	(	PUNCT
aiua-11830	111	3	5.43	5.43	NUM
aiua-11830	111	4	-	-	SYM
aiua-11830	111	5	9.77	9.77	NUM
aiua-11830	111	6	)	)	PUNCT
aiua-11830	111	7	free	free	ADJ
aiua-11830	111	8	/	/	SYM
aiua-11830	111	9	total	total	ADJ
aiua-11830	111	10	psa	psa	NOUN
aiua-11830	111	11	(	(	PUNCT
aiua-11830	111	12	%	%	INTJ
aiua-11830	111	13	)	)	PUNCT
aiua-11830	112	1	[	[	X
aiua-11830	112	2	median	median	ADJ
aiua-11830	112	3	(	(	PUNCT
aiua-11830	112	4	iqr	iqr	NOUN
aiua-11830	112	5	)	)	PUNCT
aiua-11830	112	6	]	]	PUNCT
aiua-11830	112	7	14.6	14.6	NUM
aiua-11830	112	8	(	(	PUNCT
aiua-11830	112	9	11.0	11.0	NUM
aiua-11830	112	10	-	-	SYM
aiua-11830	112	11	18.9	18.9	NUM
aiua-11830	112	12	)	)	PUNCT
aiua-11830	112	13	prostate	prostate	NOUN
aiua-11830	112	14	volume	volume	NOUN
aiua-11830	112	15	(	(	PUNCT
aiua-11830	112	16	ml	ml	NOUN
aiua-11830	112	17	)	)	PUNCT
aiua-11830	113	1	[	[	X
aiua-11830	113	2	mean	mean	X
aiua-11830	113	3	±	±	NUM
aiua-11830	113	4	sd	sd	NOUN
aiua-11830	113	5	]	]	PUNCT
aiua-11830	113	6	60.1	60.1	NUM
aiua-11830	113	7	±	±	NUM
aiua-11830	113	8	22.6	22.6	NUM
aiua-11830	113	9	psa	psa	NOUN
aiua-11830	113	10	density	density	NOUN
aiua-11830	113	11	(	(	PUNCT
aiua-11830	113	12	ng	ng	PROPN
aiua-11830	113	13	/	/	SYM
aiua-11830	113	14	ml	ml	NOUN
aiua-11830	113	15	/	/	SYM
aiua-11830	113	16	ml	ml	NOUN
aiua-11830	113	17	)	)	PUNCT
aiua-11830	114	1	[	[	X
aiua-11830	114	2	median	median	ADJ
aiua-11830	114	3	(	(	PUNCT
aiua-11830	114	4	iqr	iqr	NOUN
aiua-11830	114	5	)	)	PUNCT
aiua-11830	114	6	]	]	PUNCT
aiua-11830	114	7	0.12	0.12	NUM
aiua-11830	114	8	(	(	PUNCT
aiua-11830	114	9	0.09	0.09	NUM
aiua-11830	114	10	-	-	PUNCT
aiua-11830	114	11	0.18	0.18	NUM
aiua-11830	114	12	)	)	PUNCT
aiua-11830	114	13	abnormal	abnormal	ADJ
aiua-11830	114	14	dre	dre	NOUN
aiua-11830	114	15	(	(	PUNCT
aiua-11830	114	16	n	n	CCONJ
aiua-11830	114	17	,	,	PUNCT
aiua-11830	114	18	%	%	INTJ
aiua-11830	114	19	)	)	PUNCT
aiua-11830	114	20	17	17	NUM
aiua-11830	114	21	(	(	PUNCT
aiua-11830	114	22	14.0	14.0	NUM
aiua-11830	114	23	)	)	PUNCT
aiua-11830	114	24	clinical	clinical	ADJ
aiua-11830	114	25	scenario	scenario	NOUN
aiua-11830	114	26	(	(	PUNCT
aiua-11830	114	27	n	n	CCONJ
aiua-11830	114	28	,	,	PUNCT
aiua-11830	114	29	%	%	INTJ
aiua-11830	114	30	)	)	PUNCT
aiua-11830	114	31	–	–	PUNCT
aiua-11830	114	32	biopsy	biopsy	VERB
aiua-11830	114	33	naive	naive	ADJ
aiua-11830	114	34	84	84	NUM
aiua-11830	114	35	(	(	PUNCT
aiua-11830	114	36	64.6	64.6	NUM
aiua-11830	114	37	)	)	PUNCT
aiua-11830	114	38	–	–	PUNCT
aiua-11830	114	39	previous	previous	ADJ
aiua-11830	114	40	negative	negative	ADJ
aiua-11830	114	41	biopsy	biopsy	NOUN
aiua-11830	114	42	34	34	NUM
aiua-11830	114	43	(	(	PUNCT
aiua-11830	114	44	26.2	26.2	NUM
aiua-11830	114	45	)	)	PUNCT
aiua-11830	114	46	–	–	PUNCT
aiua-11830	114	47	active	active	ADJ
aiua-11830	114	48	surveillance	surveillance	NOUN
aiua-11830	114	49	12	12	NUM
aiua-11830	114	50	(	(	PUNCT
aiua-11830	114	51	9.2	9.2	NUM
aiua-11830	114	52	)	)	PUNCT
aiua-11830	114	53	maximum	maximum	ADJ
aiua-11830	114	54	lesion	lesion	NOUN
aiua-11830	114	55	diameter	diameter	NOUN
aiua-11830	114	56	(	(	PUNCT
aiua-11830	114	57	ml	ml	NOUN
aiua-11830	114	58	)	)	PUNCT
aiua-11830	115	1	[	[	X
aiua-11830	115	2	median	median	ADJ
aiua-11830	115	3	(	(	PUNCT
aiua-11830	115	4	iqr	iqr	NOUN
aiua-11830	115	5	)	)	PUNCT
aiua-11830	115	6	]	]	PUNCT
aiua-11830	115	7	10.0	10.0	NUM
aiua-11830	115	8	(	(	PUNCT
aiua-11830	115	9	7.0	7.0	NUM
aiua-11830	115	10	-	-	SYM
aiua-11830	115	11	13.0	13.0	NUM
aiua-11830	115	12	)	)	PUNCT
aiua-11830	115	13	number	number	NOUN
aiua-11830	115	14	of	of	ADP
aiua-11830	115	15	pi	pi	NOUN
aiua-11830	115	16	-	-	PUNCT
aiua-11830	115	17	rads	rad	NOUN
aiua-11830	115	18	3	3	NUM
aiua-11830	115	19	index	index	NOUN
aiua-11830	115	20	lesions	lesion	NOUN
aiua-11830	115	21	(	(	PUNCT
aiua-11830	115	22	n	n	CCONJ
aiua-11830	115	23	,	,	PUNCT
aiua-11830	115	24	%	%	INTJ
aiua-11830	115	25	)	)	PUNCT
aiua-11830	115	26	–	–	PUNCT
aiua-11830	115	27	single	single	ADJ
aiua-11830	115	28	108	108	NUM
aiua-11830	115	29	(	(	PUNCT
aiua-11830	115	30	83.1	83.1	NUM
aiua-11830	115	31	)	)	PUNCT
aiua-11830	115	32	–	–	PUNCT
aiua-11830	115	33	multiple	multiple	ADJ
aiua-11830	115	34	22	22	NUM
aiua-11830	115	35	(	(	PUNCT
aiua-11830	115	36	16.9	16.9	NUM
aiua-11830	115	37	)	)	PUNCT
aiua-11830	115	38	target	target	NOUN
aiua-11830	115	39	lesion	lesion	NOUN
aiua-11830	115	40	zonal	zonal	ADJ
aiua-11830	115	41	location	location	NOUN
aiua-11830	115	42	(	(	PUNCT
aiua-11830	115	43	n	n	NOUN
aiua-11830	115	44	=	=	SYM
aiua-11830	115	45	154	154	NUM
aiua-11830	115	46	)	)	PUNCT
aiua-11830	115	47	(	(	PUNCT
aiua-11830	115	48	n	n	CCONJ
aiua-11830	115	49	,	,	PUNCT
aiua-11830	115	50	%	%	INTJ
aiua-11830	115	51	)	)	PUNCT
aiua-11830	115	52	–	–	PUNCT
aiua-11830	115	53	peripheral	peripheral	ADJ
aiua-11830	115	54	zone	zone	NOUN
aiua-11830	115	55	100	100	NUM
aiua-11830	115	56	(	(	PUNCT
aiua-11830	115	57	64.9	64.9	NUM
aiua-11830	115	58	)	)	PUNCT
aiua-11830	115	59	–	–	PUNCT
aiua-11830	115	60	transition	transition	NOUN
aiua-11830	115	61	/	/	SYM
aiua-11830	115	62	central	central	ADJ
aiua-11830	115	63	zone	zone	NOUN
aiua-11830	115	64	51	51	NUM
aiua-11830	115	65	(	(	PUNCT
aiua-11830	115	66	33.1	33.1	NUM
aiua-11830	115	67	)	)	PUNCT
aiua-11830	115	68	–	–	PUNCT
aiua-11830	115	69	anterior	anterior	ADJ
aiua-11830	115	70	fibromuscular	fibromuscular	ADJ
aiua-11830	115	71	stroma	stroma	NOUN
aiua-11830	115	72	3	3	NUM
aiua-11830	115	73	(	(	PUNCT
aiua-11830	115	74	1.9	1.9	NUM
aiua-11830	115	75	)	)	PUNCT
aiua-11830	115	76	target	target	NOUN
aiua-11830	115	77	lesion	lesion	NOUN
aiua-11830	115	78	quadrantal	quadrantal	ADJ
aiua-11830	115	79	location	location	NOUN
aiua-11830	115	80	(	(	PUNCT
aiua-11830	115	81	n	n	NOUN
aiua-11830	115	82	=	=	SYM
aiua-11830	115	83	140	140	NUM
aiua-11830	115	84	)	)	PUNCT
aiua-11830	115	85	(	(	PUNCT
aiua-11830	115	86	n	n	CCONJ
aiua-11830	115	87	,	,	PUNCT
aiua-11830	115	88	%	%	INTJ
aiua-11830	115	89	)	)	PUNCT
aiua-11830	115	90	–	–	PUNCT
aiua-11830	115	91	base	base	NOUN
aiua-11830	115	92	30	30	NUM
aiua-11830	115	93	(	(	PUNCT
aiua-11830	115	94	21.4	21.4	NUM
aiua-11830	115	95	)	)	PUNCT
aiua-11830	115	96	–	–	PUNCT
aiua-11830	115	97	middle	middle	NOUN
aiua-11830	115	98	76	76	NUM
aiua-11830	115	99	(	(	PUNCT
aiua-11830	115	100	54.3	54.3	NUM
aiua-11830	115	101	)	)	PUNCT
aiua-11830	115	102	–	–	PUNCT
aiua-11830	115	103	apex	apex	NOUN
aiua-11830	115	104	34	34	NUM
aiua-11830	115	105	(	(	PUNCT
aiua-11830	115	106	24.3	24.3	NUM
aiua-11830	115	107	)	)	PUNCT
aiua-11830	115	108	dre	dre	NOUN
aiua-11830	115	109	:	:	PUNCT
aiua-11830	115	110	digital	digital	ADJ
aiua-11830	115	111	rectal	rectal	ADJ
aiua-11830	115	112	examination	examination	NOUN
aiua-11830	115	113	;	;	PUNCT
aiua-11830	115	114	iqr	iqr	PROPN
aiua-11830	115	115	:	:	PUNCT
aiua-11830	115	116	interquartile	interquartile	NOUN
aiua-11830	115	117	range	range	NOUN
aiua-11830	115	118	;	;	PUNCT
aiua-11830	115	119	sd	sd	X
aiua-11830	115	120	:	:	PUNCT
aiua-11830	115	121	standard	standard	ADJ
aiua-11830	115	122	deviation	deviation	NOUN
aiua-11830	115	123	;	;	PUNCT
aiua-11830	115	124	psa	psa	VERB
aiua-11830	115	125	:	:	PUNCT
aiua-11830	115	126	prostate	prostate	NOUN
aiua-11830	115	127	-	-	PUNCT
aiua-11830	115	128	specific	specific	ADJ
aiua-11830	115	129	antigen	antigen	NOUN
aiua-11830	115	130	.	.	PUNCT
aiua-11830	116	1	archivio	archivio	NOUN
aiua-11830	116	2	italiano	italiano	PROPN
aiua-11830	116	3	di	di	X
aiua-11830	116	4	urologia	urologia	PROPN
aiua-11830	116	5	e	e	PROPN
aiua-11830	116	6	andrologia	andrologia	NOUN
aiua-11830	116	7	2023	2023	NUM
aiua-11830	116	8	;	;	PUNCT
aiua-11830	116	9	95(4):11830	95(4):11830	NUM
aiua-11830	116	10	d.	d.	PROPN
aiua-11830	116	11	araújo	araújo	PROPN
aiua-11830	116	12	,	,	PUNCT
aiua-11830	116	13	a.	a.	NOUN
aiua-11830	116	14	gromicho	gromicho	NOUN
aiua-11830	116	15	,	,	PUNCT
aiua-11830	116	16	j.	j.	PROPN
aiua-11830	116	17	dias	dias	PROPN
aiua-11830	116	18	,	,	PUNCT
aiua-11830	116	19	s.	s.	PROPN
aiua-11830	116	20	bastos	bastos	PROPN
aiua-11830	116	21	,	,	PUNCT
aiua-11830	116	22	r.	r.	PROPN
aiua-11830	116	23	miguel	miguel	PROPN
aiua-11830	116	24	maciel	maciel	PROPN
aiua-11830	116	25	,	,	PUNCT
aiua-11830	116	26	a.	a.	NOUN
aiua-11830	116	27	sabença	sabença	PROPN
aiua-11830	116	28	,	,	PUNCT
aiua-11830	116	29	l.	l.	PROPN
aiua-11830	116	30	xambre	xambre	PROPN
aiua-11830	116	31	4	4	NUM
aiua-11830	116	32	univariate	univariate	ADJ
aiua-11830	116	33	analyses	analysis	NOUN
aiua-11830	116	34	(	(	PUNCT
aiua-11830	116	35	p	p	X
aiua-11830	116	36	=	=	NOUN
aiua-11830	116	37	0.05	0.05	NUM
aiua-11830	116	38	)	)	PUNCT
aiua-11830	116	39	but	but	CCONJ
aiua-11830	116	40	was	be	AUX
aiua-11830	116	41	not	not	PART
aiua-11830	116	42	significant	significant	ADJ
aiua-11830	116	43	in	in	ADP
aiua-11830	116	44	the	the	DET
aiua-11830	116	45	multivariate	multivariate	NOUN
aiua-11830	116	46	analysis	analysis	NOUN
aiua-11830	116	47	(	(	PUNCT
aiua-11830	116	48	p	p	X
aiua-11830	116	49	=	=	NOUN
aiua-11830	116	50	0.76	0.76	NUM
aiua-11830	116	51	)	)	PUNCT
aiua-11830	116	52	.	.	PUNCT
aiua-11830	117	1	in	in	ADP
aiua-11830	117	2	our	our	PRON
aiua-11830	117	3	population	population	NOUN
aiua-11830	117	4	,	,	PUNCT
aiua-11830	117	5	using	use	VERB
aiua-11830	117	6	0.10	0.10	NUM
aiua-11830	117	7	ng	ng	NOUN
aiua-11830	117	8	/	/	SYM
aiua-11830	117	9	ml	ml	NOUN
aiua-11830	117	10	/	/	SYM
aiua-11830	117	11	ml	ml	NOUN
aiua-11830	117	12	as	as	ADP
aiua-11830	117	13	a	a	DET
aiua-11830	117	14	cut	cut	NOUN
aiua-11830	117	15	-	-	PUNCT
aiua-11830	117	16	off	off	NOUN
aiua-11830	117	17	to	to	PART
aiua-11830	117	18	perform	perform	VERB
aiua-11830	117	19	biopsy	biopsy	NOUN
aiua-11830	117	20	,	,	PUNCT
aiua-11830	117	21	41	41	NUM
aiua-11830	117	22	patients	patient	NOUN
aiua-11830	117	23	would	would	AUX
aiua-11830	117	24	have	have	AUX
aiua-11830	117	25	avoided	avoid	VERB
aiua-11830	117	26	biopsy	biopsy	NOUN
aiua-11830	117	27	(	(	PUNCT
aiua-11830	117	28	31.5	31.5	NUM
aiua-11830	117	29	%	%	NOUN
aiua-11830	117	30	)	)	PUNCT
aiua-11830	117	31	,	,	PUNCT
aiua-11830	117	32	but	but	CCONJ
aiua-11830	117	33	5	5	NUM
aiua-11830	117	34	cases	case	NOUN
aiua-11830	117	35	of	of	ADP
aiua-11830	117	36	cspca	cspca	NOUN
aiua-11830	117	37	would	would	AUX
aiua-11830	117	38	not	not	PART
aiua-11830	117	39	have	have	AUX
aiua-11830	117	40	been	be	AUX
aiua-11830	117	41	detected	detect	VERB
aiua-11830	117	42	(	(	PUNCT
aiua-11830	117	43	3.4	3.4	NUM
aiua-11830	117	44	%	%	NOUN
aiua-11830	117	45	)	)	PUNCT
aiua-11830	117	46	.	.	PUNCT
aiua-11830	118	1	we	we	PRON
aiua-11830	118	2	could	could	AUX
aiua-11830	118	3	not	not	PART
aiua-11830	118	4	identify	identify	VERB
aiua-11830	118	5	statistical	statistical	ADJ
aiua-11830	118	6	significance	significance	NOUN
aiua-11830	118	7	between	between	ADP
aiua-11830	118	8	others	other	NOUN
aiua-11830	118	9	clinical	clinical	ADJ
aiua-11830	118	10	and	and	CCONJ
aiua-11830	118	11	imagiological	imagiological	ADJ
aiua-11830	118	12	variables	variable	NOUN
aiua-11830	118	13	and	and	CCONJ
aiua-11830	118	14	cspca	cspca	PROPN
aiua-11830	118	15	detection	detection	NOUN
aiua-11830	118	16	.	.	PUNCT
aiua-11830	119	1	discussion	discussion	NOUN
aiua-11830	119	2	the	the	DET
aiua-11830	119	3	evaluation	evaluation	NOUN
aiua-11830	119	4	of	of	ADP
aiua-11830	119	5	pi	pi	NOUN
aiua-11830	119	6	-	-	PUNCT
aiua-11830	119	7	rads	rad	NOUN
aiua-11830	119	8	3	3	NUM
aiua-11830	119	9	lesions	lesion	NOUN
aiua-11830	119	10	does	do	AUX
aiua-11830	119	11	not	not	PART
aiua-11830	119	12	represent	represent	VERB
aiua-11830	119	13	the	the	DET
aiua-11830	119	14	primary	primary	ADJ
aiua-11830	119	15	endpoint	endpoint	NOUN
aiua-11830	119	16	in	in	ADP
aiua-11830	119	17	most	most	ADJ
aiua-11830	119	18	studies	study	NOUN
aiua-11830	119	19	of	of	ADP
aiua-11830	119	20	prostate	prostate	NOUN
aiua-11830	119	21	cancer	cancer	NOUN
aiua-11830	119	22	diagnosis	diagnosis	NOUN
aiua-11830	119	23	,	,	PUNCT
aiua-11830	119	24	and	and	CCONJ
aiua-11830	119	25	,	,	PUNCT
aiua-11830	119	26	currently	currently	ADV
aiua-11830	119	27	,	,	PUNCT
aiua-11830	119	28	the	the	DET
aiua-11830	119	29	quality	quality	NOUN
aiua-11830	119	30	of	of	ADP
aiua-11830	119	31	the	the	DET
aiua-11830	119	32	studies	study	NOUN
aiua-11830	119	33	focusing	focus	VERB
aiua-11830	119	34	on	on	ADP
aiua-11830	119	35	this	this	DET
aiua-11830	119	36	pi	pi	NOUN
aiua-11830	119	37	-	-	PUNCT
aiua-11830	119	38	rads	rad	NOUN
aiua-11830	119	39	subset	subset	NOUN
aiua-11830	119	40	remains	remain	VERB
aiua-11830	119	41	low	low	ADJ
aiua-11830	119	42	.	.	PUNCT
aiua-11830	120	1	pi	pi	NOUN
aiua-11830	120	2	-	-	PUNCT
aiua-11830	120	3	rads	rad	NOUN
aiua-11830	120	4	classification	classification	NOUN
aiua-11830	120	5	was	be	AUX
aiua-11830	120	6	designed	design	VERB
aiua-11830	120	7	to	to	PART
aiua-11830	120	8	reduce	reduce	VERB
aiua-11830	120	9	the	the	DET
aiua-11830	120	10	mpmri	mpmri	PROPN
aiua-11830	120	11	inter	inter	ADJ
aiua-11830	120	12	-	-	ADJ
aiua-11830	120	13	reader	reader	ADJ
aiua-11830	120	14	reproducibility	reproducibility	NOUN
aiua-11830	120	15	,	,	PUNCT
aiua-11830	120	16	however	however	ADV
aiua-11830	120	17	,	,	PUNCT
aiua-11830	120	18	it	it	PRON
aiua-11830	120	19	does	do	AUX
aiua-11830	120	20	not	not	PART
aiua-11830	120	21	provide	provide	VERB
aiua-11830	120	22	a	a	DET
aiua-11830	120	23	specific	specific	ADJ
aiua-11830	120	24	management	management	NOUN
aiua-11830	120	25	algorithm	algorithm	NOUN
aiua-11830	120	26	for	for	ADP
aiua-11830	120	27	each	each	DET
aiua-11830	120	28	category	category	NOUN
aiua-11830	120	29	(	(	PUNCT
aiua-11830	120	30	11	11	NUM
aiua-11830	120	31	)	)	PUNCT
aiua-11830	120	32	.	.	PUNCT
aiua-11830	121	1	concerning	concern	VERB
aiua-11830	121	2	the	the	DET
aiua-11830	121	3	pi	pi	NOUN
aiua-11830	121	4	-	-	PUNCT
aiua-11830	121	5	rads	rad	NOUN
aiua-11830	121	6	3	3	NUM
aiua-11830	121	7	lesions	lesion	NOUN
aiua-11830	121	8	,	,	PUNCT
aiua-11830	121	9	there	there	PRON
aiua-11830	121	10	is	be	VERB
aiua-11830	121	11	no	no	DET
aiua-11830	121	12	agreement	agreement	NOUN
aiua-11830	121	13	on	on	ADP
aiua-11830	121	14	the	the	DET
aiua-11830	121	15	best	good	ADJ
aiua-11830	121	16	clinical	clinical	ADJ
aiua-11830	121	17	management	management	NOUN
aiua-11830	121	18	biopsy	biopsy	NOUN
aiua-11830	121	19	or	or	CCONJ
aiua-11830	121	20	clinical	clinical	ADJ
aiua-11830	121	21	surveillance	surveillance	NOUN
aiua-11830	121	22	(	(	PUNCT
aiua-11830	121	23	12	12	NUM
aiua-11830	121	24	,	,	PUNCT
aiua-11830	121	25	13	13	NUM
aiua-11830	121	26	)	)	PUNCT
aiua-11830	121	27	.	.	PUNCT
aiua-11830	122	1	prostate	prostate	NOUN
aiua-11830	122	2	biopsy	biopsy	NOUN
aiua-11830	122	3	is	be	AUX
aiua-11830	122	4	the	the	DET
aiua-11830	122	5	standard	standard	ADJ
aiua-11830	122	6	recommendation	recommendation	NOUN
aiua-11830	122	7	,	,	PUNCT
aiua-11830	122	8	however	however	ADV
aiua-11830	122	9	,	,	PUNCT
aiua-11830	122	10	in	in	ADP
aiua-11830	122	11	some	some	DET
aiua-11830	122	12	cases	case	NOUN
aiua-11830	122	13	a	a	DET
aiua-11830	122	14	follow	follow	VERB
aiua-11830	122	15	-	-	PUNCT
aiua-11830	122	16	up	up	ADP
aiua-11830	122	17	strategy	strategy	NOUN
aiua-11830	122	18	could	could	AUX
aiua-11830	122	19	be	be	AUX
aiua-11830	122	20	an	an	DET
aiua-11830	122	21	acceptable	acceptable	ADJ
aiua-11830	122	22	option	option	NOUN
aiua-11830	122	23	(	(	PUNCT
aiua-11830	122	24	10	10	NUM
aiua-11830	122	25	,	,	PUNCT
aiua-11830	122	26	11	11	NUM
aiua-11830	122	27	)	)	PUNCT
aiua-11830	122	28	.	.	PUNCT
aiua-11830	123	1	in	in	ADP
aiua-11830	123	2	our	our	PRON
aiua-11830	123	3	institution	institution	NOUN
aiua-11830	123	4	,	,	PUNCT
aiua-11830	123	5	the	the	DET
aiua-11830	123	6	prevalence	prevalence	NOUN
aiua-11830	123	7	of	of	ADP
aiua-11830	123	8	pi	pi	NOUN
aiua-11830	123	9	-	-	PUNCT
aiua-11830	123	10	rads	rad	NOUN
aiua-11830	123	11	3	3	NUM
aiua-11830	123	12	lesions	lesion	NOUN
aiua-11830	123	13	was	be	AUX
aiua-11830	123	14	18.5	18.5	NUM
aiua-11830	123	15	%	%	NOUN
aiua-11830	123	16	.	.	PUNCT
aiua-11830	124	1	maggi	maggi	PROPN
aiua-11830	124	2	et	et	PROPN
aiua-11830	124	3	al	al	PROPN
aiua-11830	124	4	.	.	PROPN
aiua-11830	124	5	,	,	PUNCT
aiua-11830	124	6	in	in	ADP
aiua-11830	124	7	a	a	DET
aiua-11830	124	8	review	review	NOUN
aiua-11830	124	9	of	of	ADP
aiua-11830	124	10	23	23	NUM
aiua-11830	124	11	studies	study	NOUN
aiua-11830	124	12	,	,	PUNCT
aiua-11830	124	13	reported	report	VERB
aiua-11830	124	14	a	a	DET
aiua-11830	124	15	prevalence	prevalence	NOUN
aiua-11830	124	16	of	of	ADP
aiua-11830	124	17	pi	pi	NOUN
aiua-11830	124	18	-	-	PUNCT
aiua-11830	124	19	rads	rad	NOUN
aiua-11830	124	20	3	3	NUM
aiua-11830	124	21	cases	case	NOUN
aiua-11830	124	22	of	of	ADP
aiua-11830	124	23	17.3	17.3	NUM
aiua-11830	124	24	%	%	NOUN
aiua-11830	124	25	(	(	PUNCT
aiua-11830	124	26	range	range	NOUN
aiua-11830	124	27	6.445.7	6.445.7	NUM
aiua-11830	124	28	%	%	NOUN
aiua-11830	124	29	)	)	PUNCT
aiua-11830	124	30	(	(	PUNCT
aiua-11830	124	31	11	11	NUM
aiua-11830	124	32	)	)	PUNCT
aiua-11830	124	33	.	.	PUNCT
aiua-11830	125	1	given	give	VERB
aiua-11830	125	2	the	the	DET
aiua-11830	125	3	incidence	incidence	NOUN
aiua-11830	125	4	of	of	ADP
aiua-11830	125	5	these	these	DET
aiua-11830	125	6	lesions	lesion	NOUN
aiua-11830	125	7	,	,	PUNCT
aiua-11830	125	8	choosing	choose	VERB
aiua-11830	125	9	the	the	DET
aiua-11830	125	10	best	good	ADJ
aiua-11830	125	11	approach	approach	NOUN
aiua-11830	125	12	is	be	AUX
aiua-11830	125	13	essential	essential	ADJ
aiua-11830	125	14	.	.	PUNCT
aiua-11830	126	1	we	we	PRON
aiua-11830	126	2	demonstrated	demonstrate	VERB
aiua-11830	126	3	that	that	SCONJ
aiua-11830	126	4	pi	pi	NOUN
aiua-11830	126	5	-	-	PUNCT
aiua-11830	126	6	rads	rad	VERB
aiua-11830	126	7	3	3	NUM
aiua-11830	126	8	lesions	lesion	NOUN
aiua-11830	126	9	were	be	AUX
aiua-11830	126	10	associated	associate	VERB
aiua-11830	126	11	with	with	ADP
aiua-11830	126	12	a	a	DET
aiua-11830	126	13	low	low	ADJ
aiua-11830	126	14	risk	risk	NOUN
aiua-11830	126	15	of	of	ADP
aiua-11830	126	16	prostate	prostate	NOUN
aiua-11830	126	17	cancer	cancer	NOUN
aiua-11830	126	18	(	(	PUNCT
aiua-11830	126	19	40.8	40.8	NUM
aiua-11830	126	20	%	%	NOUN
aiua-11830	126	21	)	)	PUNCT
aiua-11830	126	22	,	,	PUNCT
aiua-11830	126	23	especially	especially	ADV
aiua-11830	126	24	when	when	SCONJ
aiua-11830	126	25	considering	consider	VERB
aiua-11830	126	26	cspca	cspca	NOUN
aiua-11830	126	27	.	.	PUNCT
aiua-11830	127	1	in	in	ADP
aiua-11830	127	2	our	our	PRON
aiua-11830	127	3	study	study	NOUN
aiua-11830	127	4	,	,	PUNCT
aiua-11830	127	5	most	most	ADJ
aiua-11830	127	6	pi	pi	NOUN
aiua-11830	127	7	-	-	PUNCT
aiua-11830	127	8	rads	rad	VERB
aiua-11830	127	9	3	3	NUM
aiua-11830	127	10	lesions	lesion	NOUN
aiua-11830	127	11	were	be	AUX
aiua-11830	127	12	benign	benign	ADJ
aiua-11830	127	13	(	(	PUNCT
aiua-11830	127	14	59.2	59.2	NUM
aiua-11830	127	15	%	%	NOUN
aiua-11830	127	16	)	)	PUNCT
aiua-11830	127	17	and	and	CCONJ
aiua-11830	127	18	only	only	ADV
aiua-11830	127	19	26.2	26.2	NUM
aiua-11830	127	20	%	%	NOUN
aiua-11830	127	21	were	be	AUX
aiua-11830	127	22	cspca	cspca	ADJ
aiua-11830	127	23	.	.	PUNCT
aiua-11830	128	1	the	the	DET
aiua-11830	128	2	most	most	ADV
aiua-11830	128	3	common	common	ADJ
aiua-11830	128	4	gleason	gleason	NOUN
aiua-11830	128	5	scored	score	VERB
aiua-11830	128	6	diagnosed	diagnose	VERB
aiua-11830	128	7	was	be	AUX
aiua-11830	128	8	score	score	NOUN
aiua-11830	128	9	7	7	NUM
aiua-11830	128	10	(	(	PUNCT
aiua-11830	128	11	3	3	NUM
aiua-11830	128	12	+	+	NOUN
aiua-11830	128	13	4	4	NUM
aiua-11830	128	14	)	)	PUNCT
aiua-11830	128	15	or	or	CCONJ
aiua-11830	128	16	isup	isup	ADJ
aiua-11830	128	17	2	2	NUM
aiua-11830	128	18	(	(	PUNCT
aiua-11830	128	19	30/34	30/34	NUM
aiua-11830	128	20	)	)	PUNCT
aiua-11830	128	21	.	.	PUNCT
aiua-11830	129	1	regarding	regard	VERB
aiua-11830	129	2	the	the	DET
aiua-11830	129	3	diagnosis	diagnosis	NOUN
aiua-11830	129	4	of	of	ADP
aiua-11830	129	5	isup	isup	NOUN
aiua-11830	129	6	4	4	NUM
aiua-11830	129	7	or	or	CCONJ
aiua-11830	129	8	higher	high	ADJ
aiua-11830	129	9	,	,	PUNCT
aiua-11830	129	10	only	only	ADV
aiua-11830	129	11	one	one	NUM
aiua-11830	129	12	case	case	NOUN
aiua-11830	129	13	was	be	AUX
aiua-11830	129	14	identified	identify	VERB
aiua-11830	129	15	on	on	ADP
aiua-11830	129	16	pi	pi	NOUN
aiua-11830	129	17	-	-	PUNCT
aiua-11830	129	18	rads	rad	NOUN
aiua-11830	129	19	3	3	NUM
aiua-11830	129	20	lesions	lesion	NOUN
aiua-11830	129	21	.	.	PUNCT
aiua-11830	130	1	the	the	DET
aiua-11830	130	2	cspca	cspca	PROPN
aiua-11830	130	3	rate	rate	NOUN
aiua-11830	130	4	was	be	AUX
aiua-11830	130	5	significantly	significantly	ADV
aiua-11830	130	6	variable	variable	ADJ
aiua-11830	130	7	between	between	ADP
aiua-11830	130	8	published	publish	VERB
aiua-11830	130	9	studies	study	NOUN
aiua-11830	130	10	.	.	PUNCT
aiua-11830	131	1	this	this	PRON
aiua-11830	131	2	can	can	AUX
aiua-11830	131	3	be	be	AUX
aiua-11830	131	4	explained	explain	VERB
aiua-11830	131	5	based	base	VERB
aiua-11830	131	6	on	on	ADP
aiua-11830	131	7	the	the	DET
aiua-11830	131	8	population	population	NOUN
aiua-11830	131	9	heterogeneity	heterogeneity	NOUN
aiua-11830	131	10	,	,	PUNCT
aiua-11830	131	11	mri	mri	NOUN
aiua-11830	131	12	protocols	protocol	NOUN
aiua-11830	131	13	,	,	PUNCT
aiua-11830	131	14	type	type	NOUN
aiua-11830	131	15	of	of	ADP
aiua-11830	131	16	mpmri	mpmri	NOUN
aiua-11830	131	17	-	-	PUNCT
aiua-11830	131	18	targeted	target	VERB
aiua-11830	131	19	biopsy	biopsy	NOUN
aiua-11830	131	20	(	(	PUNCT
aiua-11830	131	21	cognitive	cognitive	ADJ
aiua-11830	131	22	guidance	guidance	NOUN
aiua-11830	131	23	,	,	PUNCT
aiua-11830	131	24	ultrasound	ultrasound	NOUN
aiua-11830	131	25	or	or	CCONJ
aiua-11830	131	26	mri	mri	NOUN
aiua-11830	131	27	fusion	fusion	NOUN
aiua-11830	131	28	software	software	NOUN
aiua-11830	131	29	or	or	CCONJ
aiua-11830	131	30	direct	direct	ADJ
aiua-11830	131	31	in	in	ADP
aiua-11830	131	32	-	-	PUNCT
aiua-11830	131	33	bore	bore	NOUN
aiua-11830	131	34	guidance	guidance	NOUN
aiua-11830	131	35	)	)	PUNCT
aiua-11830	131	36	and	and	CCONJ
aiua-11830	131	37	cspca	cspca	NOUN
aiua-11830	131	38	definitions	definition	NOUN
aiua-11830	131	39	.	.	PUNCT
aiua-11830	132	1	oerther	oerther	ADJ
aiua-11830	132	2	et	et	PROPN
aiua-11830	132	3	al	al	PROPN
aiua-11830	132	4	.	.	PROPN
aiua-11830	132	5	reported	report	VERB
aiua-11830	132	6	a	a	DET
aiua-11830	132	7	cancer	cancer	NOUN
aiua-11830	132	8	detection	detection	NOUN
aiua-11830	132	9	rate	rate	NOUN
aiua-11830	132	10	of	of	ADP
aiua-11830	132	11	16	16	NUM
aiua-11830	132	12	%	%	NOUN
aiua-11830	132	13	(	(	PUNCT
aiua-11830	132	14	7	7	NUM
aiua-11830	132	15	-	-	SYM
aiua-11830	132	16	27	27	NUM
aiua-11830	132	17	%	%	NOUN
aiua-11830	132	18	)	)	PUNCT
aiua-11830	132	19	in	in	ADP
aiua-11830	132	20	patients	patient	NOUN
aiua-11830	132	21	with	with	ADP
aiua-11830	132	22	pi	pi	NOUN
aiua-11830	132	23	-	-	PUNCT
aiua-11830	132	24	rads	rad	NOUN
aiua-11830	132	25	3	3	NUM
aiua-11830	132	26	lesions	lesion	NOUN
aiua-11830	132	27	(	(	PUNCT
aiua-11830	132	28	9	9	NUM
aiua-11830	132	29	)	)	PUNCT
aiua-11830	132	30	.	.	PUNCT
aiua-11830	133	1	schoots	schoot	NOUN
aiua-11830	133	2	et	et	PROPN
aiua-11830	133	3	al	al	PROPN
aiua-11830	133	4	.	.	PROPN
aiua-11830	133	5	reviewed	review	VERB
aiua-11830	133	6	3006	3006	NUM
aiua-11830	133	7	biopsy	biopsy	NOUN
aiua-11830	133	8	-	-	PUNCT
aiua-11830	133	9	naive	naive	ADJ
aiua-11830	133	10	men	man	NOUN
aiua-11830	133	11	in	in	ADP
aiua-11830	133	12	five	five	NUM
aiua-11830	133	13	studies	study	NOUN
aiua-11830	133	14	and	and	CCONJ
aiua-11830	133	15	found	find	VERB
aiua-11830	133	16	the	the	DET
aiua-11830	133	17	percentage	percentage	NOUN
aiua-11830	133	18	of	of	ADP
aiua-11830	133	19	isup	isup	ADJ
aiua-11830	133	20	≥	≥	NUM
aiua-11830	133	21	2	2	NUM
aiua-11830	133	22	detection	detection	NOUN
aiua-11830	133	23	rate	rate	NOUN
aiua-11830	133	24	in	in	ADP
aiua-11830	133	25	lesions	lesion	NOUN
aiua-11830	133	26	pirads	pirad	NOUN
aiua-11830	133	27	3	3	NUM
aiua-11830	133	28	was	be	AUX
aiua-11830	133	29	16	16	NUM
aiua-11830	133	30	%	%	NOUN
aiua-11830	133	31	(	(	PUNCT
aiua-11830	133	32	10	10	NUM
aiua-11830	133	33	)	)	PUNCT
aiua-11830	133	34	.	.	PUNCT
aiua-11830	134	1	in	in	ADP
aiua-11830	134	2	a	a	DET
aiua-11830	134	3	review	review	NOUN
aiua-11830	134	4	of	of	ADP
aiua-11830	134	5	thirteen	thirteen	NUM
aiua-11830	134	6	prospective	prospective	ADJ
aiua-11830	134	7	studies	study	NOUN
aiua-11830	134	8	of	of	ADP
aiua-11830	134	9	pi	pi	NOUN
aiua-11830	134	10	-	-	PUNCT
aiua-11830	134	11	rads	rad	NOUN
aiua-11830	134	12	3	3	NUM
aiua-11830	134	13	lesions	lesion	NOUN
aiua-11830	134	14	,	,	PUNCT
aiua-11830	134	15	the	the	DET
aiua-11830	134	16	overall	overall	ADJ
aiua-11830	134	17	pca	pca	NOUN
aiua-11830	134	18	detection	detection	NOUN
aiua-11830	134	19	rate	rate	NOUN
aiua-11830	134	20	was	be	AUX
aiua-11830	134	21	37	37	NUM
aiua-11830	134	22	%	%	NOUN
aiua-11830	134	23	,	,	PUNCT
aiua-11830	134	24	while	while	SCONJ
aiua-11830	134	25	for	for	ADP
aiua-11830	134	26	cspca	cspca	NOUN
aiua-11830	134	27	it	it	PRON
aiua-11830	134	28	was	be	AUX
aiua-11830	134	29	21	21	NUM
aiua-11830	134	30	%	%	NOUN
aiua-11830	134	31	(	(	PUNCT
aiua-11830	134	32	14	14	NUM
aiua-11830	134	33	)	)	PUNCT
aiua-11830	134	34	.	.	PUNCT
aiua-11830	135	1	magui	magui	PROPN
aiua-11830	135	2	et	et	PROPN
aiua-11830	135	3	al	al	PROPN
aiua-11830	135	4	.	.	PROPN
aiua-11830	135	5	,	,	PUNCT
aiua-11830	135	6	in	in	ADP
aiua-11830	135	7	a	a	DET
aiua-11830	135	8	systematic	systematic	ADJ
aiua-11830	135	9	review	review	NOUN
aiua-11830	135	10	of	of	ADP
aiua-11830	135	11	28	28	NUM
aiua-11830	135	12	studies	study	NOUN
aiua-11830	135	13	with	with	ADP
aiua-11830	135	14	a	a	DET
aiua-11830	135	15	total	total	NOUN
aiua-11830	135	16	of	of	ADP
aiua-11830	135	17	1759	1759	NUM
aiua-11830	135	18	cases	case	NOUN
aiua-11830	135	19	of	of	ADP
aiua-11830	135	20	pirads	pirad	NOUN
aiua-11830	135	21	3	3	NUM
aiua-11830	135	22	lesions	lesion	NOUN
aiua-11830	135	23	,	,	PUNCT
aiua-11830	135	24	reported	report	VERB
aiua-11830	135	25	a	a	DET
aiua-11830	135	26	prostate	prostate	NOUN
aiua-11830	135	27	cancer	cancer	NOUN
aiua-11830	135	28	detection	detection	NOUN
aiua-11830	135	29	rate	rate	NOUN
aiua-11830	135	30	of	of	ADP
aiua-11830	135	31	36	36	NUM
aiua-11830	135	32	%	%	NOUN
aiua-11830	135	33	(	(	PUNCT
aiua-11830	135	34	range	range	NOUN
aiua-11830	135	35	10.3	10.3	NUM
aiua-11830	135	36	-	-	SYM
aiua-11830	135	37	55.8	55.8	NUM
aiua-11830	135	38	%	%	NOUN
aiua-11830	135	39	)	)	PUNCT
aiua-11830	135	40	and	and	CCONJ
aiua-11830	135	41	cspca	cspca	NOUN
aiua-11830	135	42	rate	rate	NOUN
aiua-11830	135	43	of	of	ADP
aiua-11830	135	44	18.5	18.5	NUM
aiua-11830	135	45	%	%	NOUN
aiua-11830	135	46	(	(	PUNCT
aiua-11830	135	47	range	range	NOUN
aiua-11830	135	48	3.4	3.4	NUM
aiua-11830	135	49	-	-	SYM
aiua-11830	135	50	46.5	46.5	NUM
aiua-11830	135	51	%	%	NOUN
aiua-11830	135	52	)	)	PUNCT
aiua-11830	135	53	(	(	PUNCT
aiua-11830	135	54	11	11	NUM
aiua-11830	135	55	)	)	PUNCT
aiua-11830	135	56	.	.	PUNCT
aiua-11830	136	1	the	the	DET
aiua-11830	136	2	best	good	ADJ
aiua-11830	136	3	biopsy	biopsy	NOUN
aiua-11830	136	4	strategy	strategy	NOUN
aiua-11830	136	5	also	also	ADV
aiua-11830	136	6	remains	remain	VERB
aiua-11830	136	7	controversial	controversial	ADJ
aiua-11830	136	8	.	.	PUNCT
aiua-11830	137	1	the	the	DET
aiua-11830	137	2	inclusion	inclusion	NOUN
aiua-11830	137	3	of	of	ADP
aiua-11830	137	4	the	the	DET
aiua-11830	137	5	mri	mri	NOUN
aiua-11830	137	6	previously	previously	ADV
aiua-11830	137	7	to	to	ADP
aiua-11830	137	8	prostate	prostate	NOUN
aiua-11830	137	9	biopsy	biopsy	NOUN
aiua-11830	137	10	increased	increase	VERB
aiua-11830	137	11	the	the	DET
aiua-11830	137	12	number	number	NOUN
aiua-11830	137	13	of	of	ADP
aiua-11830	137	14	cspca	cspca	NOUN
aiua-11830	137	15	detected	detect	VERB
aiua-11830	137	16	and	and	CCONJ
aiua-11830	137	17	reduced	reduce	VERB
aiua-11830	137	18	the	the	DET
aiua-11830	137	19	number	number	NOUN
aiua-11830	137	20	of	of	ADP
aiua-11830	137	21	insignificant	insignificant	ADJ
aiua-11830	137	22	cancer	cancer	NOUN
aiua-11830	137	23	.	.	PUNCT
aiua-11830	138	1	however	however	ADV
aiua-11830	138	2	,	,	PUNCT
aiua-11830	138	3	omitting	omit	VERB
aiua-11830	138	4	systematic	systematic	ADJ
aiua-11830	138	5	biopsy	biopsy	NOUN
aiua-11830	138	6	would	would	AUX
aiua-11830	138	7	miss	miss	VERB
aiua-11830	138	8	approximately	approximately	ADV
aiua-11830	138	9	16	16	NUM
aiua-11830	138	10	%	%	NOUN
aiua-11830	138	11	and	and	CCONJ
aiua-11830	138	12	10	10	NUM
aiua-11830	138	13	%	%	NOUN
aiua-11830	138	14	of	of	ADP
aiua-11830	138	15	all	all	DET
aiua-11830	138	16	detected	detect	VERB
aiua-11830	138	17	isup	isup	ADJ
aiua-11830	138	18	grade	grade	NOUN
aiua-11830	138	19	≥	≥	NOUN
aiua-11830	138	20	2	2	NUM
aiua-11830	138	21	in	in	ADP
aiua-11830	138	22	biopsy	biopsy	NOUN
aiua-11830	138	23	-	-	PUNCT
aiua-11830	138	24	naive	naive	ADJ
aiua-11830	138	25	and	and	CCONJ
aiua-11830	138	26	repeatbiopsy	repeatbiopsy	NOUN
aiua-11830	138	27	patients	patient	NOUN
aiua-11830	138	28	,	,	PUNCT
aiua-11830	138	29	respectively	respectively	ADV
aiua-11830	138	30	(	(	PUNCT
aiua-11830	138	31	1	1	NUM
aiua-11830	138	32	-	-	SYM
aiua-11830	138	33	4	4	NUM
aiua-11830	138	34	)	)	PUNCT
aiua-11830	138	35	in	in	ADP
aiua-11830	138	36	our	our	PRON
aiua-11830	138	37	population	population	NOUN
aiua-11830	138	38	,	,	PUNCT
aiua-11830	138	39	the	the	DET
aiua-11830	138	40	cspca	cspca	NOUN
aiua-11830	138	41	rate	rate	NOUN
aiua-11830	138	42	was	be	AUX
aiua-11830	138	43	slightly	slightly	ADV
aiua-11830	138	44	higher	high	ADJ
aiua-11830	138	45	in	in	ADP
aiua-11830	138	46	non	non	ADJ
aiua-11830	138	47	-	-	ADJ
aiua-11830	138	48	target	target	ADJ
aiua-11830	138	49	group	group	NOUN
aiua-11830	138	50	(	(	PUNCT
aiua-11830	138	51	32.6	32.6	NUM
aiua-11830	138	52	vs.	vs.	ADP
aiua-11830	138	53	23	23	NUM
aiua-11830	138	54	%	%	NOUN
aiua-11830	138	55	,	,	PUNCT
aiua-11830	138	56	respectively	respectively	ADV
aiua-11830	138	57	)	)	PUNCT
aiua-11830	138	58	;	;	PUNCT
aiua-11830	138	59	and	and	CCONJ
aiua-11830	138	60	paradoxically	paradoxically	ADV
aiua-11830	138	61	,	,	PUNCT
aiua-11830	138	62	insignificantly	insignificantly	ADV
aiua-11830	138	63	cancer	cancer	NOUN
aiua-11830	138	64	rate	rate	NOUN
aiua-11830	138	65	was	be	AUX
aiua-11830	138	66	slightly	slightly	ADV
aiua-11830	138	67	higher	high	ADJ
aiua-11830	138	68	in	in	ADP
aiua-11830	138	69	the	the	DET
aiua-11830	138	70	target	target	NOUN
aiua-11830	138	71	group	group	NOUN
aiua-11830	138	72	(	(	PUNCT
aiua-11830	138	73	16.1	16.1	NUM
aiua-11830	138	74	vs.	vs.	ADP
aiua-11830	138	75	11.6	11.6	NUM
aiua-11830	138	76	%	%	NOUN
aiua-11830	138	77	,	,	PUNCT
aiua-11830	138	78	respectively	respectively	ADV
aiua-11830	138	79	)	)	PUNCT
aiua-11830	138	80	.	.	PUNCT
aiua-11830	139	1	however	however	ADV
aiua-11830	139	2	,	,	PUNCT
aiua-11830	139	3	both	both	DET
aiua-11830	139	4	results	result	NOUN
aiua-11830	139	5	were	be	AUX
aiua-11830	139	6	not	not	PART
aiua-11830	139	7	statistically	statistically	ADV
aiua-11830	139	8	significant	significant	ADJ
aiua-11830	139	9	(	(	PUNCT
aiua-11830	139	10	p	p	X
aiua-11830	139	11	=	=	NOUN
aiua-11830	139	12	0.50	0.50	NUM
aiua-11830	139	13	and	and	CCONJ
aiua-11830	139	14	p	p	NOUN
aiua-11830	139	15	=	=	NOUN
aiua-11830	139	16	0.24	0.24	NUM
aiua-11830	139	17	,	,	PUNCT
aiua-11830	139	18	respectively	respectively	ADV
aiua-11830	139	19	)	)	PUNCT
aiua-11830	139	20	.	.	PUNCT
aiua-11830	140	1	nevertheless	nevertheless	ADV
aiua-11830	140	2	,	,	PUNCT
aiua-11830	140	3	a	a	DET
aiua-11830	140	4	cspca	cspca	NOUN
aiua-11830	140	5	diagnosis	diagnosis	NOUN
aiua-11830	140	6	would	would	AUX
aiua-11830	140	7	be	be	AUX
aiua-11830	140	8	missed	miss	VERB
aiua-11830	140	9	in	in	ADP
aiua-11830	140	10	9	9	NUM
aiua-11830	140	11	patients	patient	NOUN
aiua-11830	140	12	if	if	SCONJ
aiua-11830	140	13	targeted	target	VERB
aiua-11830	140	14	biopsy	biopsy	NOUN
aiua-11830	140	15	was	be	AUX
aiua-11830	140	16	performed	perform	VERB
aiua-11830	140	17	alone	alone	ADV
aiua-11830	140	18	,	,	PUNCT
aiua-11830	140	19	confirming	confirm	VERB
aiua-11830	140	20	the	the	DET
aiua-11830	140	21	importance	importance	NOUN
aiua-11830	140	22	of	of	ADP
aiua-11830	140	23	not	not	PART
aiua-11830	140	24	omitting	omit	VERB
aiua-11830	140	25	the	the	DET
aiua-11830	140	26	systematic	systematic	ADJ
aiua-11830	140	27	biopsy	biopsy	NOUN
aiua-11830	140	28	in	in	ADP
aiua-11830	140	29	this	this	DET
aiua-11830	140	30	setting	setting	NOUN
aiua-11830	140	31	.	.	PUNCT
aiua-11830	141	1	in	in	ADP
aiua-11830	141	2	our	our	PRON
aiua-11830	141	3	cohort	cohort	NOUN
aiua-11830	141	4	,	,	PUNCT
aiua-11830	141	5	the	the	DET
aiua-11830	141	6	value	value	NOUN
aiua-11830	141	7	of	of	ADP
aiua-11830	141	8	the	the	DET
aiua-11830	141	9	systematic	systematic	ADJ
aiua-11830	141	10	biopsy	biopsy	NOUN
aiua-11830	141	11	was	be	AUX
aiua-11830	141	12	demonstrated	demonstrate	VERB
aiua-11830	141	13	.	.	PUNCT
aiua-11830	142	1	no	no	DET
aiua-11830	142	2	case	case	NOUN
aiua-11830	142	3	of	of	ADP
aiua-11830	142	4	histological	histological	ADJ
aiua-11830	142	5	upgrading	upgrading	NOUN
aiua-11830	142	6	or	or	CCONJ
aiua-11830	142	7	only	only	ADV
aiua-11830	142	8	positive	positive	ADJ
aiua-11830	142	9	pathological	pathological	ADJ
aiua-11830	142	10	results	result	NOUN
aiua-11830	142	11	on	on	ADP
aiua-11830	142	12	target	target	NOUN
aiua-11830	142	13	biopsies	biopsy	NOUN
aiua-11830	142	14	were	be	AUX
aiua-11830	142	15	reported	report	VERB
aiua-11830	142	16	.	.	PUNCT
aiua-11830	143	1	in	in	ADP
aiua-11830	143	2	our	our	PRON
aiua-11830	143	3	opinion	opinion	NOUN
aiua-11830	143	4	,	,	PUNCT
aiua-11830	143	5	the	the	DET
aiua-11830	143	6	target	target	NOUN
aiua-11830	143	7	biopsy	biopsy	NOUN
aiua-11830	143	8	could	could	AUX
aiua-11830	143	9	be	be	AUX
aiua-11830	143	10	omitted	omit	VERB
aiua-11830	143	11	in	in	ADP
aiua-11830	143	12	pi	pi	NOUN
aiua-11830	143	13	-	-	PUNCT
aiua-11830	143	14	rads	rad	NOUN
aiua-11830	143	15	3	3	NUM
aiua-11830	143	16	lesions	lesion	NOUN
aiua-11830	143	17	,	,	PUNCT
aiua-11830	143	18	however	however	ADV
aiua-11830	143	19	the	the	DET
aiua-11830	143	20	systematic	systematic	ADJ
aiua-11830	143	21	biopsy	biopsy	NOUN
aiua-11830	143	22	should	should	AUX
aiua-11830	143	23	always	always	ADV
aiua-11830	143	24	be	be	AUX
aiua-11830	143	25	performed	perform	VERB
aiua-11830	143	26	if	if	SCONJ
aiua-11830	143	27	cspca	cspca	NOUN
aiua-11830	143	28	is	be	AUX
aiua-11830	143	29	suspected	suspect	VERB
aiua-11830	143	30	.	.	PUNCT
aiua-11830	144	1	the	the	DET
aiua-11830	144	2	importance	importance	NOUN
aiua-11830	144	3	of	of	ADP
aiua-11830	144	4	the	the	DET
aiua-11830	144	5	systematic	systematic	ADJ
aiua-11830	144	6	biopsies	biopsy	NOUN
aiua-11830	144	7	in	in	ADP
aiua-11830	144	8	cspca	cspca	PROPN
aiua-11830	144	9	detection	detection	NOUN
aiua-11830	144	10	in	in	ADP
aiua-11830	144	11	pi	pi	NOUN
aiua-11830	144	12	-	-	PUNCT
aiua-11830	144	13	rads	rad	NOUN
aiua-11830	144	14	3	3	NUM
aiua-11830	144	15	lesions	lesion	NOUN
aiua-11830	144	16	can	can	AUX
aiua-11830	144	17	be	be	AUX
aiua-11830	144	18	explained	explain	VERB
aiua-11830	144	19	due	due	ADP
aiua-11830	144	20	to	to	ADP
aiua-11830	144	21	mri	mri	NOUN
aiua-11830	144	22	interpretation	interpretation	NOUN
aiua-11830	144	23	and	and	CCONJ
aiua-11830	144	24	mistargeting	mistargete	VERB
aiua-11830	144	25	issues	issue	NOUN
aiua-11830	144	26	(	(	PUNCT
aiua-11830	144	27	i.e.	i.e.	X
aiua-11830	144	28	,	,	PUNCT
aiua-11830	144	29	the	the	DET
aiua-11830	144	30	lesion	lesion	NOUN
aiua-11830	144	31	has	have	AUX
aiua-11830	144	32	been	be	AUX
aiua-11830	144	33	correctly	correctly	ADV
aiua-11830	144	34	identified	identify	VERB
aiua-11830	144	35	by	by	ADP
aiua-11830	144	36	mpmri	mpmri	PROPN
aiua-11830	144	37	but	but	CCONJ
aiua-11830	144	38	missed	miss	VERB
aiua-11830	144	39	by	by	ADP
aiua-11830	144	40	mpmri	mpmri	PROPN
aiua-11830	144	41	-	-	PUNCT
aiua-11830	144	42	targeted	target	VERB
aiua-11830	144	43	biopsy	biopsy	NOUN
aiua-11830	144	44	and	and	CCONJ
aiua-11830	144	45	detected	detect	VERB
aiua-11830	144	46	by	by	ADP
aiua-11830	144	47	systematic	systematic	ADJ
aiua-11830	144	48	sampling	sampling	NOUN
aiua-11830	144	49	)	)	PUNCT
aiua-11830	144	50	,	,	PUNCT
aiua-11830	144	51	especially	especially	ADV
aiua-11830	144	52	in	in	ADP
aiua-11830	144	53	non	non	ADJ
aiua-11830	144	54	-	-	ADJ
aiua-11830	144	55	peripheral	peripheral	ADJ
aiua-11830	144	56	zones	zone	NOUN
aiua-11830	144	57	and	and	CCONJ
aiua-11830	144	58	smaller	small	ADJ
aiua-11830	144	59	lesions	lesion	NOUN
aiua-11830	144	60	.	.	PUNCT
aiua-11830	145	1	some	some	DET
aiua-11830	145	2	authors	author	NOUN
aiua-11830	145	3	advocate	advocate	VERB
aiua-11830	145	4	a	a	DET
aiua-11830	145	5	saturation	saturation	NOUN
aiua-11830	145	6	targeted	target	VERB
aiua-11830	145	7	approach	approach	NOUN
aiua-11830	145	8	or	or	CCONJ
aiua-11830	145	9	increasing	increase	VERB
aiua-11830	145	10	the	the	DET
aiua-11830	145	11	number	number	NOUN
aiua-11830	145	12	of	of	ADP
aiua-11830	145	13	cores	core	NOUN
aiua-11830	145	14	taken	take	VERB
aiua-11830	145	15	by	by	ADP
aiua-11830	145	16	target	target	NOUN
aiua-11830	145	17	to	to	PART
aiua-11830	145	18	raise	raise	VERB
aiua-11830	145	19	the	the	DET
aiua-11830	145	20	cspca	cspca	NOUN
aiua-11830	145	21	detection	detection	NOUN
aiua-11830	145	22	(	(	PUNCT
aiua-11830	145	23	15	15	NUM
aiua-11830	145	24	,	,	PUNCT
aiua-11830	145	25	16	16	NUM
aiua-11830	145	26	)	)	PUNCT
aiua-11830	145	27	.	.	PUNCT
aiua-11830	146	1	we	we	PRON
aiua-11830	146	2	believe	believe	VERB
aiua-11830	146	3	that	that	SCONJ
aiua-11830	146	4	in	in	ADP
aiua-11830	146	5	reference	reference	NOUN
aiua-11830	146	6	centers	center	NOUN
aiua-11830	146	7	with	with	ADP
aiua-11830	146	8	large	large	ADJ
aiua-11830	146	9	number	number	NOUN
aiua-11830	146	10	of	of	ADP
aiua-11830	146	11	patients	patient	NOUN
aiua-11830	146	12	,	,	PUNCT
aiua-11830	146	13	experienced	experienced	ADJ
aiua-11830	146	14	teams	team	NOUN
aiua-11830	146	15	with	with	ADP
aiua-11830	146	16	dedicated	dedicated	ADJ
aiua-11830	146	17	radiologists	radiologist	NOUN
aiua-11830	146	18	and	and	CCONJ
aiua-11830	146	19	urologists	urologist	NOUN
aiua-11830	146	20	,	,	PUNCT
aiua-11830	146	21	well	well	ADV
aiua-11830	146	22	-	-	PUNCT
aiua-11830	146	23	defined	define	VERB
aiua-11830	146	24	protocols	protocol	NOUN
aiua-11830	146	25	and	and	CCONJ
aiua-11830	146	26	newer	new	ADJ
aiua-11830	146	27	technologies	technology	NOUN
aiua-11830	146	28	or	or	CCONJ
aiua-11830	146	29	softwares	software	NOUN
aiua-11830	146	30	,	,	PUNCT
aiua-11830	146	31	the	the	DET
aiua-11830	146	32	target	target	NOUN
aiua-11830	146	33	biopsy	biopsy	NOUN
aiua-11830	146	34	may	may	AUX
aiua-11830	146	35	be	be	AUX
aiua-11830	146	36	crucial	crucial	ADJ
aiua-11830	146	37	in	in	ADP
aiua-11830	146	38	pi	pi	NOUN
aiua-11830	146	39	-	-	PUNCT
aiua-11830	146	40	rads	rad	NOUN
aiua-11830	146	41	3	3	NUM
aiua-11830	146	42	lesions	lesion	NOUN
aiua-11830	146	43	.	.	PUNCT
aiua-11830	147	1	however	however	ADV
aiua-11830	147	2	,	,	PUNCT
aiua-11830	147	3	in	in	ADP
aiua-11830	147	4	tertiary	tertiary	ADJ
aiua-11830	147	5	centers	center	NOUN
aiua-11830	147	6	like	like	ADP
aiua-11830	147	7	ours	our	NOUN
aiua-11830	147	8	,	,	PUNCT
aiua-11830	147	9	there	there	PRON
aiua-11830	147	10	are	be	VERB
aiua-11830	147	11	some	some	DET
aiua-11830	147	12	disadvantages	disadvantage	NOUN
aiua-11830	147	13	smaller	small	ADJ
aiua-11830	147	14	number	number	NOUN
aiua-11830	147	15	of	of	ADP
aiua-11830	147	16	patients	patient	NOUN
aiua-11830	147	17	,	,	PUNCT
aiua-11830	147	18	interpretation	interpretation	NOUN
aiua-11830	147	19	of	of	ADP
aiua-11830	147	20	mpmri	mpmri	PROPN
aiua-11830	147	21	by	by	ADP
aiua-11830	147	22	different	different	ADJ
aiua-11830	147	23	radiologists	radiologist	NOUN
aiua-11830	147	24	and	and	CCONJ
aiua-11830	147	25	different	different	ADJ
aiua-11830	147	26	urologists	urologist	NOUN
aiua-11830	147	27	with	with	ADP
aiua-11830	147	28	different	different	ADJ
aiua-11830	147	29	levels	level	NOUN
aiua-11830	147	30	of	of	ADP
aiua-11830	147	31	experience	experience	NOUN
aiua-11830	147	32	.	.	PUNCT
aiua-11830	148	1	our	our	PRON
aiua-11830	148	2	targeted	targeted	ADJ
aiua-11830	148	3	biopsies	biopsy	NOUN
aiua-11830	148	4	were	be	AUX
aiua-11830	148	5	obtained	obtain	VERB
aiua-11830	148	6	by	by	ADP
aiua-11830	148	7	cognitive	cognitive	ADJ
aiua-11830	148	8	guidance	guidance	NOUN
aiua-11830	148	9	.	.	PUNCT
aiua-11830	149	1	the	the	DET
aiua-11830	149	2	current	current	ADJ
aiua-11830	149	3	literature	literature	NOUN
aiua-11830	149	4	does	do	AUX
aiua-11830	149	5	not	not	PART
aiua-11830	149	6	show	show	VERB
aiua-11830	149	7	superiority	superiority	NOUN
aiua-11830	149	8	or	or	CCONJ
aiua-11830	149	9	inferiority	inferiority	NOUN
aiua-11830	149	10	of	of	ADP
aiua-11830	149	11	the	the	DET
aiua-11830	149	12	cognitive	cognitive	ADJ
aiua-11830	149	13	technique	technique	NOUN
aiua-11830	149	14	compared	compare	VERB
aiua-11830	149	15	with	with	ADP
aiua-11830	149	16	us	we	PRON
aiua-11830	149	17	/	/	SYM
aiua-11830	149	18	mr	mr	PROPN
aiua-11830	149	19	fusion	fusion	NOUN
aiua-11830	149	20	software	software	NOUN
aiua-11830	149	21	or	or	CCONJ
aiua-11830	149	22	direct	direct	ADJ
aiua-11830	149	23	in	in	ADP
aiua-11830	149	24	-	-	PUNCT
aiua-11830	149	25	bore	bore	NOUN
aiua-11830	149	26	guidance	guidance	NOUN
aiua-11830	149	27	(	(	PUNCT
aiua-11830	149	28	17	17	NUM
aiua-11830	149	29	)	)	PUNCT
aiua-11830	149	30	.	.	PUNCT
aiua-11830	150	1	regarding	regard	VERB
aiua-11830	150	2	the	the	DET
aiua-11830	150	3	pathology	pathology	NOUN
aiua-11830	150	4	analyses	analyse	VERB
aiua-11830	150	5	,	,	PUNCT
aiua-11830	150	6	the	the	DET
aiua-11830	150	7	most	most	ADV
aiua-11830	150	8	common	common	ADJ
aiua-11830	150	9	result	result	NOUN
aiua-11830	150	10	was	be	AUX
aiua-11830	150	11	benign	benign	ADJ
aiua-11830	150	12	histology	histology	NOUN
aiua-11830	150	13	in	in	ADP
aiua-11830	150	14	both	both	DET
aiua-11830	150	15	groups	group	NOUN
aiua-11830	150	16	.	.	PUNCT
aiua-11830	151	1	the	the	DET
aiua-11830	151	2	cspca	cspca	PROPN
aiua-11830	151	3	detection	detection	NOUN
aiua-11830	151	4	in	in	ADP
aiua-11830	151	5	patients	patient	NOUN
aiua-11830	151	6	with	with	ADP
aiua-11830	151	7	previous	previous	ADJ
aiua-11830	151	8	negative	negative	ADJ
aiua-11830	151	9	biopsy	biopsy	NOUN
aiua-11830	151	10	was	be	AUX
aiua-11830	151	11	lower	low	ADJ
aiua-11830	151	12	comparative	comparative	ADJ
aiua-11830	151	13	to	to	ADP
aiua-11830	151	14	naive	naive	ADJ
aiua-11830	151	15	or	or	CCONJ
aiua-11830	151	16	active	active	ADJ
aiua-11830	151	17	surveillance	surveillance	NOUN
aiua-11830	151	18	patients	patient	NOUN
aiua-11830	151	19	.	.	PUNCT
aiua-11830	152	1	the	the	DET
aiua-11830	152	2	difference	difference	NOUN
aiua-11830	152	3	of	of	ADP
aiua-11830	152	4	cspca	cspca	NOUN
aiua-11830	152	5	rates	rate	NOUN
aiua-11830	152	6	among	among	ADP
aiua-11830	152	7	the	the	DET
aiua-11830	152	8	three	three	NUM
aiua-11830	152	9	groups	group	NOUN
aiua-11830	152	10	was	be	AUX
aiua-11830	152	11	not	not	PART
aiua-11830	152	12	statistically	statistically	ADV
aiua-11830	152	13	significant	significant	ADJ
aiua-11830	152	14	(	(	PUNCT
aiua-11830	152	15	p	p	X
aiua-11830	152	16	=	=	NOUN
aiua-11830	152	17	0.32	0.32	NUM
aiua-11830	152	18	)	)	PUNCT
aiua-11830	152	19	.	.	PUNCT
aiua-11830	153	1	given	give	VERB
aiua-11830	153	2	the	the	DET
aiua-11830	153	3	high	high	ADJ
aiua-11830	153	4	variability	variability	NOUN
aiua-11830	153	5	of	of	ADP
aiua-11830	153	6	the	the	DET
aiua-11830	153	7	published	publish	VERB
aiua-11830	153	8	studies	study	NOUN
aiua-11830	153	9	,	,	PUNCT
aiua-11830	153	10	it	it	PRON
aiua-11830	153	11	is	be	AUX
aiua-11830	153	12	difficult	difficult	ADJ
aiua-11830	153	13	to	to	PART
aiua-11830	153	14	decide	decide	VERB
aiua-11830	153	15	to	to	PART
aiua-11830	153	16	perform	perform	VERB
aiua-11830	153	17	prostate	prostate	NOUN
aiua-11830	153	18	biopsy	biopsy	NOUN
aiua-11830	153	19	in	in	ADP
aiua-11830	153	20	case	case	NOUN
aiua-11830	153	21	of	of	ADP
aiua-11830	153	22	pi	pi	NOUN
aiua-11830	153	23	-	-	PUNCT
aiua-11830	153	24	rads	rad	NOUN
aiua-11830	153	25	3	3	NUM
aiua-11830	153	26	lesions	lesion	NOUN
aiua-11830	153	27	independently	independently	ADV
aiua-11830	153	28	of	of	ADP
aiua-11830	153	29	clinical	clinical	ADJ
aiua-11830	153	30	scenario	scenario	NOUN
aiua-11830	153	31	(	(	PUNCT
aiua-11830	153	32	naive	naive	ADJ
aiua-11830	153	33	patient	patient	NOUN
aiua-11830	153	34	,	,	PUNCT
aiua-11830	153	35	or	or	CCONJ
aiua-11830	153	36	with	with	ADP
aiua-11830	153	37	previous	previous	ADJ
aiua-11830	153	38	negative	negative	ADJ
aiua-11830	153	39	biopsy	biopsy	NOUN
aiua-11830	153	40	,	,	PUNCT
aiua-11830	153	41	or	or	CCONJ
aiua-11830	153	42	active	active	ADJ
aiua-11830	153	43	surveillance	surveillance	NOUN
aiua-11830	153	44	)	)	PUNCT
aiua-11830	153	45	(	(	PUNCT
aiua-11830	153	46	11	11	NUM
aiua-11830	153	47	)	)	PUNCT
aiua-11830	153	48	.	.	PUNCT
aiua-11830	154	1	many	many	ADJ
aiua-11830	154	2	studies	study	NOUN
aiua-11830	154	3	tried	try	VERB
aiua-11830	154	4	to	to	PART
aiua-11830	154	5	identify	identify	VERB
aiua-11830	154	6	clinical	clinical	ADJ
aiua-11830	154	7	and	and	CCONJ
aiua-11830	154	8	imagiological	imagiological	ADJ
aiua-11830	154	9	findings	finding	NOUN
aiua-11830	154	10	that	that	PRON
aiua-11830	154	11	can	can	AUX
aiua-11830	154	12	help	help	VERB
aiua-11830	154	13	to	to	PART
aiua-11830	154	14	identify	identify	VERB
aiua-11830	154	15	which	which	PRON
aiua-11830	154	16	patients	patient	NOUN
aiua-11830	154	17	can	can	AUX
aiua-11830	154	18	be	be	AUX
aiua-11830	154	19	selected	select	VERB
aiua-11830	154	20	for	for	ADP
aiua-11830	154	21	surveillance	surveillance	NOUN
aiua-11830	154	22	.	.	PUNCT
aiua-11830	155	1	psad	psad	ADJ
aiua-11830	155	2	is	be	AUX
aiua-11830	155	3	the	the	DET
aiua-11830	155	4	most	most	ADV
aiua-11830	155	5	frequently	frequently	ADV
aiua-11830	155	6	investigated	investigate	VERB
aiua-11830	155	7	clinical	clinical	ADJ
aiua-11830	155	8	predictor	predictor	NOUN
aiua-11830	155	9	.	.	PUNCT
aiua-11830	156	1	recently	recently	ADV
aiua-11830	156	2	,	,	PUNCT
aiua-11830	156	3	a	a	DET
aiua-11830	156	4	risk	risk	NOUN
aiua-11830	156	5	-	-	PUNCT
aiua-11830	156	6	adapted	adapt	VERB
aiua-11830	156	7	biopsy	biopsy	NOUN
aiua-11830	156	8	decision	decision	NOUN
aiua-11830	156	9	was	be	AUX
aiua-11830	156	10	proposed	propose	VERB
aiua-11830	156	11	,	,	PUNCT
aiua-11830	156	12	based	base	VERB
aiua-11830	156	13	on	on	ADP
aiua-11830	156	14	psad	psad	ADJ
aiua-11830	156	15	and	and	CCONJ
aiua-11830	156	16	mpmri	mpmri	PROPN
aiua-11830	156	17	report	report	NOUN
aiua-11830	156	18	.	.	PUNCT
aiua-11830	157	1	concerning	concern	VERB
aiua-11830	157	2	the	the	DET
aiua-11830	157	3	pi	pi	NOUN
aiua-11830	157	4	-	-	PUNCT
aiua-11830	157	5	rads	rad	NOUN
aiua-11830	157	6	3	3	NUM
aiua-11830	157	7	lesions	lesion	NOUN
aiua-11830	157	8	,	,	PUNCT
aiua-11830	157	9	patients	patient	NOUN
aiua-11830	157	10	with	with	ADP
aiua-11830	157	11	high	high	ADJ
aiua-11830	157	12	-	-	PUNCT
aiua-11830	157	13	risk	risk	NOUN
aiua-11830	157	14	psad	psad	NOUN
aiua-11830	157	15	(	(	PUNCT
aiua-11830	157	16	>	>	X
aiua-11830	157	17	0.20	0.20	NUM
aiua-11830	157	18	ng	ng	PROPN
aiua-11830	157	19	/	/	SYM
aiua-11830	157	20	ml	ml	NOUN
aiua-11830	157	21	/	/	SYM
aiua-11830	157	22	ml	ml	NOUN
aiua-11830	157	23	)	)	PUNCT
aiua-11830	157	24	should	should	AUX
aiua-11830	157	25	be	be	AUX
aiua-11830	157	26	offered	offer	VERB
aiua-11830	157	27	targeted	target	VERB
aiua-11830	157	28	and	and	CCONJ
aiua-11830	157	29	systematic	systematic	ADJ
aiua-11830	157	30	biopsies	biopsy	NOUN
aiua-11830	157	31	as	as	SCONJ
aiua-11830	157	32	they	they	PRON
aiua-11830	157	33	have	have	VERB
aiua-11830	157	34	a	a	DET
aiua-11830	157	35	higher	high	ADJ
aiua-11830	157	36	risk	risk	NOUN
aiua-11830	157	37	for	for	ADP
aiua-11830	157	38	significant	significant	ADJ
aiua-11830	157	39	disease	disease	NOUN
aiua-11830	157	40	(	(	PUNCT
aiua-11830	157	41	29	29	NUM
aiua-11830	157	42	%	%	NOUN
aiua-11830	157	43	)	)	PUNCT
aiua-11830	157	44	.	.	PUNCT
aiua-11830	158	1	on	on	ADP
aiua-11830	158	2	the	the	DET
aiua-11830	158	3	other	other	ADJ
aiua-11830	158	4	hand	hand	NOUN
aiua-11830	158	5	,	,	PUNCT
aiua-11830	158	6	patients	patient	NOUN
aiua-11830	158	7	with	with	ADP
aiua-11830	158	8	low	low	ADJ
aiua-11830	158	9	risk	risk	NOUN
aiua-11830	158	10	psad	psad	NOUN
aiua-11830	158	11	(	(	PUNCT
aiua-11830	158	12	<	<	X
aiua-11830	158	13	0.10	0.10	NUM
aiua-11830	158	14	ng	ng	PROPN
aiua-11830	158	15	/	/	SYM
aiua-11830	158	16	ml	ml	NOUN
aiua-11830	158	17	/	/	SYM
aiua-11830	158	18	ml	ml	VERB
aiua-11830	158	19	)	)	PUNCT
aiua-11830	158	20	have	have	VERB
aiua-11830	158	21	a	a	DET
aiua-11830	158	22	low	low	ADJ
aiua-11830	158	23	risk	risk	NOUN
aiua-11830	158	24	of	of	ADP
aiua-11830	158	25	significant	significant	ADJ
aiua-11830	158	26	disease	disease	NOUN
aiua-11830	158	27	(	(	PUNCT
aiua-11830	158	28	4	4	NUM
aiua-11830	158	29	%	%	NOUN
aiua-11830	158	30	)	)	PUNCT
aiua-11830	158	31	and	and	CCONJ
aiua-11830	158	32	biopsies	biopsy	NOUN
aiua-11830	158	33	could	could	AUX
aiua-11830	158	34	be	be	AUX
aiua-11830	158	35	avoided	avoid	VERB
aiua-11830	158	36	(	(	PUNCT
aiua-11830	158	37	10	10	NUM
aiua-11830	158	38	)	)	PUNCT
aiua-11830	158	39	.	.	PUNCT
aiua-11830	159	1	in	in	ADP
aiua-11830	159	2	our	our	PRON
aiua-11830	159	3	study	study	NOUN
aiua-11830	159	4	,	,	PUNCT
aiua-11830	159	5	the	the	DET
aiua-11830	159	6	median	median	ADJ
aiua-11830	159	7	psad	psad	NOUN
aiua-11830	159	8	was	be	AUX
aiua-11830	159	9	similar	similar	ADJ
aiua-11830	159	10	in	in	ADP
aiua-11830	159	11	cspca	cspca	ADJ
aiua-11830	159	12	positive	positive	ADJ
aiua-11830	159	13	patients	patient	NOUN
aiua-11830	159	14	and	and	CCONJ
aiua-11830	159	15	the	the	DET
aiua-11830	159	16	general	general	ADJ
aiua-11830	159	17	pi	pi	NOUN
aiua-11830	159	18	-	-	PUNCT
aiua-11830	159	19	rads	rad	NOUN
aiua-11830	159	20	3	3	NUM
aiua-11830	159	21	lesions	lesion	NOUN
aiua-11830	159	22	cases	case	NOUN
aiua-11830	159	23	.	.	PUNCT
aiua-11830	160	1	a	a	DET
aiua-11830	160	2	higher	high	ADJ
aiua-11830	160	3	median	median	NOUN
aiua-11830	160	4	psad	psad	NOUN
aiua-11830	160	5	significantly	significantly	ADV
aiua-11830	160	6	predisposed	predispose	VERB
aiua-11830	160	7	for	for	ADP
aiua-11830	160	8	cspca	cspca	NOUN
aiua-11830	160	9	on	on	ADP
aiua-11830	160	10	univariate	univariate	ADJ
aiua-11830	160	11	analyses	analysis	NOUN
aiua-11830	160	12	(	(	PUNCT
aiua-11830	160	13	p	p	X
aiua-11830	160	14	=	=	NOUN
aiua-11830	160	15	0.05	0.05	NUM
aiua-11830	160	16	)	)	PUNCT
aiua-11830	160	17	but	but	CCONJ
aiua-11830	160	18	not	not	PART
aiua-11830	160	19	significant	significant	ADJ
aiua-11830	160	20	in	in	ADP
aiua-11830	160	21	the	the	DET
aiua-11830	160	22	multivariate	multivariate	NOUN
aiua-11830	160	23	analysis	analysis	NOUN
aiua-11830	160	24	(	(	PUNCT
aiua-11830	160	25	p	p	X
aiua-11830	160	26	=	=	NOUN
aiua-11830	160	27	0.76	0.76	NUM
aiua-11830	160	28	)	)	PUNCT
aiua-11830	160	29	.	.	PUNCT
aiua-11830	161	1	in	in	ADP
aiua-11830	161	2	our	our	PRON
aiua-11830	161	3	population	population	NOUN
aiua-11830	161	4	,	,	PUNCT
aiua-11830	161	5	using	use	VERB
aiua-11830	161	6	0.10	0.10	NUM
aiua-11830	161	7	ng	ng	NOUN
aiua-11830	161	8	/	/	SYM
aiua-11830	161	9	ml	ml	NOUN
aiua-11830	161	10	/	/	SYM
aiua-11830	161	11	ml	ml	NOUN
aiua-11830	161	12	as	as	ADP
aiua-11830	161	13	a	a	DET
aiua-11830	161	14	cut	cut	NOUN
aiua-11830	161	15	-	-	PUNCT
aiua-11830	161	16	off	off	NOUN
aiua-11830	161	17	to	to	PART
aiua-11830	161	18	perform	perform	VERB
aiua-11830	161	19	biopsy	biopsy	NOUN
aiua-11830	161	20	,	,	PUNCT
aiua-11830	161	21	41	41	NUM
aiua-11830	161	22	patients	patient	NOUN
aiua-11830	161	23	would	would	AUX
aiua-11830	161	24	have	have	AUX
aiua-11830	161	25	avoided	avoid	VERB
aiua-11830	161	26	biopsy	biopsy	NOUN
aiua-11830	161	27	(	(	PUNCT
aiua-11830	161	28	31.5	31.5	NUM
aiua-11830	161	29	%	%	NOUN
aiua-11830	161	30	)	)	PUNCT
aiua-11830	161	31	,	,	PUNCT
aiua-11830	161	32	but	but	CCONJ
aiua-11830	161	33	5	5	NUM
aiua-11830	161	34	cases	case	NOUN
aiua-11830	161	35	of	of	ADP
aiua-11830	161	36	cspca	cspca	NOUN
aiua-11830	161	37	would	would	AUX
aiua-11830	161	38	not	not	PART
aiua-11830	161	39	have	have	AUX
aiua-11830	161	40	been	be	AUX
aiua-11830	161	41	detected	detect	VERB
aiua-11830	161	42	(	(	PUNCT
aiua-11830	161	43	3.4	3.4	NUM
aiua-11830	161	44	%	%	NOUN
aiua-11830	161	45	)	)	PUNCT
aiua-11830	161	46	.	.	PUNCT
aiua-11830	162	1	venderink	venderink	VERB
aiua-11830	162	2	et	et	PROPN
aiua-11830	162	3	al	al	PROPN
aiua-11830	162	4	.	.	PROPN
aiua-11830	162	5	demonstrated	demonstrate	VERB
aiua-11830	162	6	that	that	SCONJ
aiua-11830	162	7	biopsying	biopsye	VERB
aiua-11830	162	8	only	only	ADV
aiua-11830	162	9	pi	pi	NOUN
aiua-11830	162	10	-	-	PUNCT
aiua-11830	162	11	rads	rad	NOUN
aiua-11830	162	12	3	3	NUM
aiua-11830	162	13	cases	case	NOUN
aiua-11830	162	14	with	with	ADP
aiua-11830	162	15	a	a	DET
aiua-11830	162	16	psad	psad	NOUN
aiua-11830	162	17	of	of	ADP
aiua-11830	162	18	≥	≥	NOUN
aiua-11830	162	19	0.15	0.15	NUM
aiua-11830	162	20	ng	ng	PROPN
aiua-11830	162	21	/	/	SYM
aiua-11830	162	22	ml	ml	NOUN
aiua-11830	162	23	/	/	SYM
aiua-11830	162	24	ml	ml	NOUN
aiua-11830	162	25	resulted	result	VERB
aiua-11830	162	26	in	in	ADP
aiua-11830	162	27	42	42	NUM
aiua-11830	162	28	%	%	NOUN
aiua-11830	162	29	of	of	ADP
aiua-11830	162	30	cases	case	NOUN
aiua-11830	162	31	who	who	PRON
aiua-11830	162	32	would	would	AUX
aiua-11830	162	33	avoid	avoid	VERB
aiua-11830	162	34	biopsy	biopsy	NOUN
aiua-11830	162	35	,	,	PUNCT
aiua-11830	162	36	thus	thus	ADV
aiua-11830	162	37	missing	miss	VERB
aiua-11830	162	38	6	6	NUM
aiua-11830	162	39	%	%	NOUN
aiua-11830	162	40	archivio	archivio	NOUN
aiua-11830	162	41	italiano	italiano	NOUN
aiua-11830	162	42	di	di	X
aiua-11830	162	43	urologia	urologia	PROPN
aiua-11830	162	44	e	e	PROPN
aiua-11830	162	45	andrologia	andrologia	NOUN
aiua-11830	162	46	2023	2023	NUM
aiua-11830	162	47	;	;	PUNCT
aiua-11830	162	48	95(4):11830	95(4):11830	NUM
aiua-11830	162	49	5	5	NUM
aiua-11830	162	50	mri	mri	NOUN
aiua-11830	162	51	pi	pi	NOUN
aiua-11830	162	52	-	-	PUNCT
aiua-11830	162	53	rads	rad	NOUN
aiua-11830	162	54	3	3	NUM
aiua-11830	162	55	lesions	lesion	NOUN
aiua-11830	162	56	of	of	ADP
aiua-11830	162	57	cspca	cspca	NOUN
aiua-11830	162	58	cases	case	NOUN
aiua-11830	162	59	.	.	PUNCT
aiua-11830	163	1	lowering	lower	VERB
aiua-11830	163	2	the	the	DET
aiua-11830	163	3	cut	cut	VERB
aiua-11830	163	4	-	-	PUNCT
aiua-11830	163	5	off	off	ADP
aiua-11830	163	6	value	value	NOUN
aiua-11830	163	7	to	to	ADP
aiua-11830	163	8	0.12	0.12	NUM
aiua-11830	163	9	ng	ng	PROPN
aiua-11830	163	10	/	/	SYM
aiua-11830	163	11	ml	ml	NOUN
aiua-11830	163	12	/	/	SYM
aiua-11830	163	13	ml	ml	NOUN
aiua-11830	163	14	resulted	result	VERB
aiua-11830	163	15	in	in	ADP
aiua-11830	163	16	26	26	NUM
aiua-11830	163	17	%	%	NOUN
aiua-11830	163	18	of	of	ADP
aiua-11830	163	19	cases	case	NOUN
aiua-11830	163	20	that	that	PRON
aiua-11830	163	21	would	would	AUX
aiua-11830	163	22	have	have	AUX
aiua-11830	163	23	avoided	avoid	VERB
aiua-11830	163	24	biopsy	biopsy	NOUN
aiua-11830	163	25	without	without	ADP
aiua-11830	163	26	missing	miss	VERB
aiua-11830	163	27	any	any	DET
aiua-11830	163	28	cspca	cspca	NOUN
aiua-11830	163	29	(	(	PUNCT
aiua-11830	163	30	18	18	NUM
aiua-11830	163	31	)	)	PUNCT
aiua-11830	163	32	.	.	PUNCT
aiua-11830	164	1	an	an	DET
aiua-11830	164	2	abnormal	abnormal	ADJ
aiua-11830	164	3	dre	dre	NOUN
aiua-11830	164	4	(	(	PUNCT
aiua-11830	164	5	p	p	NOUN
aiua-11830	164	6	=	=	NOUN
aiua-11830	164	7	0.02	0.02	NUM
aiua-11830	164	8	)	)	PUNCT
aiua-11830	164	9	and	and	CCONJ
aiua-11830	164	10	a	a	DET
aiua-11830	164	11	peripheral	peripheral	ADJ
aiua-11830	164	12	target	target	NOUN
aiua-11830	164	13	lesion	lesion	NOUN
aiua-11830	164	14	(	(	PUNCT
aiua-11830	164	15	p	p	NOUN
aiua-11830	164	16	=	=	NOUN
aiua-11830	164	17	0.01	0.01	NUM
aiua-11830	164	18	)	)	PUNCT
aiua-11830	164	19	significantly	significantly	ADV
aiua-11830	164	20	predisposed	predispose	VERB
aiua-11830	164	21	for	for	ADP
aiua-11830	164	22	cspca	cspca	NOUN
aiua-11830	164	23	in	in	ADP
aiua-11830	164	24	multivariate	multivariate	NOUN
aiua-11830	164	25	logistic	logistic	ADJ
aiua-11830	164	26	regression	regression	NOUN
aiua-11830	164	27	.	.	PUNCT
aiua-11830	165	1	the	the	DET
aiua-11830	165	2	frequency	frequency	NOUN
aiua-11830	165	3	of	of	ADP
aiua-11830	165	4	abnormal	abnormal	ADJ
aiua-11830	165	5	dre	dre	NOUN
aiua-11830	165	6	was	be	AUX
aiua-11830	165	7	higher	high	ADJ
aiua-11830	165	8	in	in	ADP
aiua-11830	165	9	the	the	DET
aiua-11830	165	10	cspca	cspca	NOUN
aiua-11830	165	11	patients	patient	NOUN
aiua-11830	165	12	group	group	NOUN
aiua-11830	165	13	comparatively	comparatively	ADV
aiua-11830	165	14	to	to	ADP
aiua-11830	165	15	general	general	ADJ
aiua-11830	165	16	pi	pi	NOUN
aiua-11830	165	17	-	-	PUNCT
aiua-11830	165	18	rads	rad	NOUN
aiua-11830	165	19	3	3	NUM
aiua-11830	165	20	cases	case	NOUN
aiua-11830	165	21	(	(	PUNCT
aiua-11830	165	22	29.0	29.0	NUM
aiua-11830	165	23	%	%	NOUN
aiua-11830	165	24	vs	vs	ADP
aiua-11830	165	25	14.0	14.0	NUM
aiua-11830	165	26	%	%	NOUN
aiua-11830	165	27	,	,	PUNCT
aiua-11830	165	28	respectively	respectively	ADV
aiua-11830	165	29	)	)	PUNCT
aiua-11830	165	30	.	.	PUNCT
aiua-11830	166	1	sheridan	sheridan	PROPN
aiua-11830	166	2	et	et	PROPN
aiua-11830	166	3	al	al	PROPN
aiua-11830	166	4	.	.	PROPN
aiua-11830	166	5	calculated	calculate	VERB
aiua-11830	166	6	risks	risk	NOUN
aiua-11830	166	7	factors	factor	NOUN
aiua-11830	166	8	of	of	ADP
aiua-11830	166	9	cspca	cspca	NOUN
aiua-11830	166	10	in	in	ADP
aiua-11830	166	11	pi	pi	NOUN
aiua-11830	166	12	-	-	PUNCT
aiua-11830	166	13	rads	rad	NOUN
aiua-11830	166	14	3	3	NUM
aiua-11830	166	15	lesions	lesion	NOUN
aiua-11830	166	16	in	in	ADP
aiua-11830	166	17	their	their	PRON
aiua-11830	166	18	multivariate	multivariate	NOUN
aiua-11830	166	19	analyses	analysis	NOUN
aiua-11830	166	20	and	and	CCONJ
aiua-11830	166	21	demonstrated	demonstrate	VERB
aiua-11830	166	22	that	that	SCONJ
aiua-11830	166	23	an	an	DET
aiua-11830	166	24	abnormal	abnormal	ADJ
aiua-11830	166	25	dre	dre	NOUN
aiua-11830	166	26	was	be	AUX
aiua-11830	166	27	a	a	DET
aiua-11830	166	28	significant	significant	ADJ
aiua-11830	166	29	predictor	predictor	NOUN
aiua-11830	166	30	of	of	ADP
aiua-11830	166	31	cspca	cspca	PROPN
aiua-11830	166	32	(	(	PUNCT
aiua-11830	166	33	or.3.92	or.3.92	NOUN
aiua-11830	166	34	,	,	PUNCT
aiua-11830	166	35	p	p	X
aiua-11830	166	36	=	=	NOUN
aiua-11830	166	37	0.03	0.03	NUM
aiua-11830	166	38	)	)	PUNCT
aiua-11830	166	39	,	,	PUNCT
aiua-11830	166	40	as	as	SCONJ
aiua-11830	166	41	was	be	AUX
aiua-11830	166	42	advanced	advanced	ADJ
aiua-11830	166	43	age	age	NOUN
aiua-11830	166	44	(	(	PUNCT
aiua-11830	166	45	≥	≥	NOUN
aiua-11830	166	46	70	70	NUM
aiua-11830	166	47	years	year	NOUN
aiua-11830	166	48	)	)	PUNCT
aiua-11830	166	49	and	and	CCONJ
aiua-11830	166	50	smaller	small	ADJ
aiua-11830	166	51	prostates	prostate	NOUN
aiua-11830	166	52	(	(	PUNCT
aiua-11830	166	53	≤	≤	NOUN
aiua-11830	166	54	36cc	36cc	NOUN
aiua-11830	166	55	)	)	PUNCT
aiua-11830	166	56	(	(	PUNCT
aiua-11830	166	57	19	19	NUM
aiua-11830	166	58	)	)	PUNCT
aiua-11830	166	59	.	.	PUNCT
aiua-11830	167	1	radtle	radtle	VERB
aiua-11830	167	2	et	et	PROPN
aiua-11830	167	3	al	al	PROPN
aiua-11830	167	4	.	.	PROPN
aiua-11830	167	5	showed	show	VERB
aiua-11830	167	6	that	that	SCONJ
aiua-11830	167	7	a	a	DET
aiua-11830	167	8	higher	high	ADJ
aiua-11830	167	9	psa	psa	NOUN
aiua-11830	167	10	level	level	NOUN
aiua-11830	167	11	(	(	PUNCT
aiua-11830	167	12	or	or	CCONJ
aiua-11830	167	13	,	,	PUNCT
aiua-11830	167	14	2.08	2.08	NUM
aiua-11830	167	15	)	)	PUNCT
aiua-11830	167	16	,	,	PUNCT
aiua-11830	167	17	a	a	DET
aiua-11830	167	18	smaller	small	ADJ
aiua-11830	167	19	gland	gland	NOUN
aiua-11830	167	20	size	size	NOUN
aiua-11830	167	21	(	(	PUNCT
aiua-11830	167	22	or	or	CCONJ
aiua-11830	167	23	,	,	PUNCT
aiua-11830	167	24	0.81	0.81	NUM
aiua-11830	167	25	)	)	PUNCT
aiua-11830	167	26	,	,	PUNCT
aiua-11830	167	27	abnormal	abnormal	ADJ
aiua-11830	167	28	dre	dre	PROPN
aiua-11830	167	29	findings	findings	PROPN
aiua-11830	167	30	(	(	PUNCT
aiua-11830	167	31	ct2	ct2	NOUN
aiua-11830	167	32	or	or	CCONJ
aiua-11830	167	33	more	more	ADJ
aiua-11830	167	34	lesion	lesion	NOUN
aiua-11830	167	35	,	,	PUNCT
aiua-11830	167	36	or	or	CCONJ
aiua-11830	167	37	,	,	PUNCT
aiua-11830	167	38	4.09	4.09	NUM
aiua-11830	167	39	)	)	PUNCT
aiua-11830	167	40	and	and	CCONJ
aiua-11830	167	41	advanced	advanced	ADJ
aiua-11830	167	42	age	age	NOUN
aiua-11830	167	43	(	(	PUNCT
aiua-11830	167	44	or	or	CCONJ
aiua-11830	167	45	,	,	PUNCT
aiua-11830	167	46	1.09	1.09	NUM
aiua-11830	167	47	)	)	PUNCT
aiua-11830	167	48	were	be	AUX
aiua-11830	167	49	independently	independently	ADV
aiua-11830	167	50	associated	associate	VERB
aiua-11830	167	51	with	with	ADP
aiua-11830	167	52	cspca	cspca	NOUN
aiua-11830	167	53	in	in	ADP
aiua-11830	167	54	pirads	pirad	NOUN
aiua-11830	167	55	3	3	NUM
aiua-11830	167	56	lesions	lesion	NOUN
aiua-11830	167	57	.	.	PUNCT
aiua-11830	168	1	(	(	PUNCT
aiua-11830	168	2	20	20	X
aiua-11830	168	3	)	)	PUNCT
aiua-11830	168	4	abnormal	abnormal	ADJ
aiua-11830	168	5	dre	dre	NOUN
aiua-11830	168	6	is	be	AUX
aiua-11830	168	7	a	a	DET
aiua-11830	168	8	strong	strong	ADJ
aiua-11830	168	9	predictor	predictor	NOUN
aiua-11830	168	10	of	of	ADP
aiua-11830	168	11	advanced	advanced	ADJ
aiua-11830	168	12	pca	pca	NOUN
aiua-11830	168	13	that	that	PRON
aiua-11830	168	14	is	be	AUX
aiua-11830	168	15	associated	associate	VERB
aiua-11830	168	16	with	with	ADP
aiua-11830	168	17	an	an	DET
aiua-11830	168	18	increasing	increase	VERB
aiua-11830	168	19	risk	risk	NOUN
aiua-11830	168	20	of	of	ADP
aiua-11830	168	21	higher	high	ADJ
aiua-11830	168	22	isup	isup	NOUN
aiua-11830	168	23	and	and	CCONJ
aiua-11830	168	24	,	,	PUNCT
aiua-11830	168	25	despite	despite	SCONJ
aiua-11830	168	26	being	be	AUX
aiua-11830	168	27	a	a	DET
aiua-11830	168	28	subjective	subjective	ADJ
aiua-11830	168	29	test	test	NOUN
aiua-11830	168	30	,	,	PUNCT
aiua-11830	168	31	is	be	AUX
aiua-11830	168	32	an	an	DET
aiua-11830	168	33	important	important	ADJ
aiua-11830	168	34	tool	tool	NOUN
aiua-11830	168	35	in	in	ADP
aiua-11830	168	36	our	our	PRON
aiua-11830	168	37	population	population	NOUN
aiua-11830	168	38	to	to	PART
aiua-11830	168	39	decide	decide	VERB
aiua-11830	168	40	who	who	PRON
aiua-11830	168	41	should	should	AUX
aiua-11830	168	42	underwent	underwent	VERB
aiua-11830	168	43	biopsy	biopsy	NOUN
aiua-11830	168	44	.	.	PUNCT
aiua-11830	169	1	most	most	ADJ
aiua-11830	169	2	of	of	ADP
aiua-11830	169	3	the	the	DET
aiua-11830	169	4	pi	pi	NOUN
aiua-11830	169	5	-	-	PUNCT
aiua-11830	169	6	rads	rad	NOUN
aiua-11830	169	7	3	3	NUM
aiua-11830	169	8	lesions	lesion	NOUN
aiua-11830	169	9	in	in	ADP
aiua-11830	169	10	our	our	PRON
aiua-11830	169	11	cohort	cohort	NOUN
aiua-11830	169	12	were	be	AUX
aiua-11830	169	13	located	locate	VERB
aiua-11830	169	14	in	in	ADP
aiua-11830	169	15	the	the	DET
aiua-11830	169	16	peripheral	peripheral	ADJ
aiua-11830	169	17	zone	zone	NOUN
aiua-11830	169	18	,	,	PUNCT
aiua-11830	169	19	independently	independently	ADV
aiua-11830	169	20	of	of	ADP
aiua-11830	169	21	cspca	cspca	NOUN
aiua-11830	169	22	results	result	NOUN
aiua-11830	169	23	.	.	PUNCT
aiua-11830	170	1	liddell	liddell	PROPN
aiua-11830	170	2	et	et	PROPN
aiua-11830	170	3	al	al	PROPN
aiua-11830	170	4	.	.	PROPN
aiua-11830	170	5	showed	show	VERB
aiua-11830	170	6	that	that	SCONJ
aiua-11830	170	7	pi	pi	NOUN
aiua-11830	170	8	-	-	PUNCT
aiua-11830	170	9	rads	rad	VERB
aiua-11830	170	10	3	3	NUM
aiua-11830	170	11	lesions	lesion	NOUN
aiua-11830	170	12	within	within	ADP
aiua-11830	170	13	the	the	DET
aiua-11830	170	14	pz	pz	NOUN
aiua-11830	170	15	were	be	AUX
aiua-11830	170	16	more	more	ADV
aiua-11830	170	17	likely	likely	ADJ
aiua-11830	170	18	to	to	PART
aiua-11830	170	19	be	be	AUX
aiua-11830	170	20	associated	associate	VERB
aiua-11830	170	21	with	with	ADP
aiua-11830	170	22	malignant	malignant	ADJ
aiua-11830	170	23	disease	disease	NOUN
aiua-11830	170	24	compared	compare	VERB
aiua-11830	170	25	with	with	ADP
aiua-11830	170	26	lesions	lesion	NOUN
aiua-11830	170	27	identified	identify	VERB
aiua-11830	170	28	within	within	ADP
aiua-11830	170	29	tz	tz	PROPN
aiua-11830	170	30	(	(	PUNCT
aiua-11830	170	31	10.8	10.8	NUM
aiua-11830	170	32	%	%	NOUN
aiua-11830	170	33	vs.	vs.	ADP
aiua-11830	170	34	3.8	3.8	NUM
aiua-11830	170	35	%	%	NOUN
aiua-11830	170	36	)	)	PUNCT
aiua-11830	170	37	(	(	PUNCT
aiua-11830	170	38	21	21	NUM
aiua-11830	170	39	)	)	PUNCT
aiua-11830	170	40	.	.	PUNCT
aiua-11830	171	1	yang	yang	PROPN
aiua-11830	171	2	et	et	PROPN
aiua-11830	171	3	al	al	PROPN
aiua-11830	171	4	.	.	PROPN
aiua-11830	171	5	demonstrated	demonstrate	VERB
aiua-11830	171	6	in	in	ADP
aiua-11830	171	7	his	his	PRON
aiua-11830	171	8	study	study	NOUN
aiua-11830	171	9	that	that	SCONJ
aiua-11830	171	10	pirads	pirad	VERB
aiua-11830	171	11	3	3	NUM
aiua-11830	171	12	lesions	lesion	NOUN
aiua-11830	171	13	were	be	AUX
aiua-11830	171	14	most	most	ADV
aiua-11830	171	15	frequent	frequent	ADJ
aiua-11830	171	16	in	in	ADP
aiua-11830	171	17	tz	tz	PROPN
aiua-11830	171	18	than	than	ADP
aiua-11830	171	19	pz	pz	PROPN
aiua-11830	171	20	(	(	PUNCT
aiua-11830	171	21	n	n	NOUN
aiua-11830	171	22	=	=	SYM
aiua-11830	171	23	67	67	NUM
aiua-11830	171	24	and	and	CCONJ
aiua-11830	171	25	n	n	CCONJ
aiua-11830	171	26	=	=	SYM
aiua-11830	171	27	54	54	NUM
aiua-11830	171	28	,	,	PUNCT
aiua-11830	171	29	respectively	respectively	ADV
aiua-11830	171	30	)	)	PUNCT
aiua-11830	171	31	,	,	PUNCT
aiua-11830	171	32	however	however	ADV
aiua-11830	171	33	the	the	DET
aiua-11830	171	34	cspca	cspca	NOUN
aiua-11830	171	35	rate	rate	NOUN
aiua-11830	171	36	was	be	AUX
aiua-11830	171	37	superior	superior	ADJ
aiua-11830	171	38	in	in	ADP
aiua-11830	171	39	pz	pz	PROPN
aiua-11830	171	40	(	(	PUNCT
aiua-11830	171	41	18.5	18.5	NUM
aiua-11830	171	42	%	%	NOUN
aiua-11830	171	43	vs.	vs.	ADP
aiua-11830	171	44	6.0	6.0	NUM
aiua-11830	171	45	%	%	NOUN
aiua-11830	171	46	,	,	PUNCT
aiua-11830	171	47	respectively	respectively	ADV
aiua-11830	171	48	)	)	PUNCT
aiua-11830	171	49	(	(	PUNCT
aiua-11830	171	50	22	22	NUM
aiua-11830	171	51	)	)	PUNCT
aiua-11830	171	52	.	.	PUNCT
aiua-11830	172	1	galosi	galosi	NOUN
aiua-11830	172	2	et	et	PROPN
aiua-11830	172	3	al	al	PROPN
aiua-11830	172	4	.	.	PROPN
aiua-11830	173	1	defended	defend	VERB
aiua-11830	173	2	a	a	DET
aiua-11830	173	3	low	low	ADJ
aiua-11830	173	4	risk	risk	NOUN
aiua-11830	173	5	of	of	ADP
aiua-11830	173	6	cancer	cancer	NOUN
aiua-11830	173	7	in	in	ADP
aiua-11830	173	8	pi	pi	NOUN
aiua-11830	173	9	-	-	PUNCT
aiua-11830	173	10	rads	rad	NOUN
aiua-11830	173	11	3	3	NUM
aiua-11830	173	12	lesions	lesion	NOUN
aiua-11830	173	13	located	locate	VERB
aiua-11830	173	14	in	in	ADP
aiua-11830	173	15	tz	tz	NOUN
aiua-11830	173	16	;	;	PUNCT
aiua-11830	173	17	they	they	PRON
aiua-11830	173	18	concluded	conclude	VERB
aiua-11830	173	19	that	that	SCONJ
aiua-11830	173	20	biopsy	biopsy	NOUN
aiua-11830	173	21	could	could	AUX
aiua-11830	173	22	be	be	AUX
aiua-11830	173	23	omitted	omit	VERB
aiua-11830	173	24	in	in	ADP
aiua-11830	173	25	same	same	ADJ
aiua-11830	173	26	patients	patient	NOUN
aiua-11830	173	27	considering	consider	VERB
aiua-11830	173	28	a	a	DET
aiua-11830	173	29	nomogram	nomogram	NOUN
aiua-11830	173	30	with	with	ADP
aiua-11830	173	31	pca	pca	PROPN
aiua-11830	173	32	risk	risk	NOUN
aiua-11830	173	33	,	,	PUNCT
aiua-11830	173	34	psad	psad	ADJ
aiua-11830	173	35	,	,	PUNCT
aiua-11830	173	36	and	and	CCONJ
aiua-11830	173	37	lesion	lesion	NOUN
aiua-11830	173	38	location	location	NOUN
aiua-11830	173	39	(	(	PUNCT
aiua-11830	173	40	23	23	NUM
aiua-11830	173	41	)	)	PUNCT
aiua-11830	173	42	.	.	PUNCT
aiua-11830	174	1	a	a	DET
aiua-11830	174	2	systematic	systematic	ADJ
aiua-11830	174	3	review	review	NOUN
aiua-11830	174	4	and	and	CCONJ
aiua-11830	174	5	meta	meta	NOUN
aiua-11830	174	6	-	-	PUNCT
aiua-11830	174	7	analyses	analysis	NOUN
aiua-11830	174	8	of	of	ADP
aiua-11830	174	9	a	a	DET
aiua-11830	174	10	total	total	NOUN
aiua-11830	174	11	of	of	ADP
aiua-11830	174	12	17	17	NUM
aiua-11830	174	13	articles	article	NOUN
aiua-11830	174	14	showed	show	VERB
aiua-11830	174	15	no	no	DET
aiua-11830	174	16	systematic	systematic	ADJ
aiua-11830	174	17	difference	difference	NOUN
aiua-11830	174	18	of	of	ADP
aiua-11830	174	19	cancer	cancer	NOUN
aiua-11830	174	20	detection	detection	NOUN
aiua-11830	174	21	rate	rate	NOUN
aiua-11830	174	22	between	between	ADP
aiua-11830	174	23	pz	pz	NOUN
aiua-11830	174	24	lesions	lesion	NOUN
aiua-11830	174	25	and	and	CCONJ
aiua-11830	174	26	tz	tz	NOUN
aiua-11830	174	27	lesions	lesion	NOUN
aiua-11830	174	28	in	in	ADP
aiua-11830	174	29	different	different	ADJ
aiua-11830	174	30	pi	pi	NOUN
aiua-11830	174	31	-	-	PUNCT
aiua-11830	174	32	rads	rad	NOUN
aiua-11830	174	33	classifications	classification	NOUN
aiua-11830	174	34	(	(	PUNCT
aiua-11830	174	35	24	24	NUM
aiua-11830	174	36	)	)	PUNCT
aiua-11830	174	37	.	.	PUNCT
aiua-11830	175	1	schoots	schoot	NOUN
aiua-11830	175	2	et	et	PROPN
aiua-11830	175	3	al	al	PROPN
aiua-11830	175	4	.	.	PROPN
aiua-11830	175	5	explain	explain	VERB
aiua-11830	175	6	that	that	SCONJ
aiua-11830	175	7	mpmri	mpmri	PROPN
aiua-11830	175	8	interpretation	interpretation	NOUN
aiua-11830	175	9	of	of	ADP
aiua-11830	175	10	tz	tz	PROPN
aiua-11830	175	11	is	be	AUX
aiua-11830	175	12	more	more	ADV
aiua-11830	175	13	challenging	challenging	ADJ
aiua-11830	175	14	comparative	comparative	ADJ
aiua-11830	175	15	to	to	ADP
aiua-11830	175	16	pz	pz	NOUN
aiua-11830	175	17	because	because	SCONJ
aiua-11830	175	18	the	the	DET
aiua-11830	175	19	tz	tz	NOUN
aiua-11830	175	20	shows	show	VERB
aiua-11830	175	21	heterogeneous	heterogeneous	ADJ
aiua-11830	175	22	signal	signal	NOUN
aiua-11830	175	23	intensities	intensity	NOUN
aiua-11830	175	24	due	due	ADP
aiua-11830	175	25	to	to	ADP
aiua-11830	175	26	presence	presence	NOUN
aiua-11830	175	27	of	of	ADP
aiua-11830	175	28	nodules	nodule	NOUN
aiua-11830	175	29	of	of	ADP
aiua-11830	175	30	benign	benign	ADJ
aiua-11830	175	31	prostatic	prostatic	ADJ
aiua-11830	175	32	hyperplasia	hyperplasia	NOUN
aiua-11830	175	33	while	while	SCONJ
aiua-11830	175	34	a	a	DET
aiua-11830	175	35	normal	normal	ADJ
aiua-11830	175	36	pz	pz	NOUN
aiua-11830	175	37	is	be	AUX
aiua-11830	175	38	brightly	brightly	ADV
aiua-11830	175	39	hyperintense	hyperintense	NOUN
aiua-11830	175	40	on	on	ADP
aiua-11830	175	41	t2	t2	NOUN
aiua-11830	175	42	images	image	NOUN
aiua-11830	175	43	and	and	CCONJ
aiua-11830	175	44	hypointense	hypointense	NOUN
aiua-11830	175	45	abnormalities	abnormality	NOUN
aiua-11830	175	46	can	can	AUX
aiua-11830	175	47	be	be	AUX
aiua-11830	175	48	easily	easily	ADV
aiua-11830	175	49	identified	identify	VERB
aiua-11830	175	50	.	.	PUNCT
aiua-11830	176	1	in	in	ADP
aiua-11830	176	2	case	case	NOUN
aiua-11830	176	3	of	of	ADP
aiua-11830	176	4	pi	pi	NOUN
aiua-11830	176	5	-	-	PUNCT
aiua-11830	176	6	rads	rad	NOUN
aiua-11830	176	7	3	3	NUM
aiua-11830	176	8	lesions	lesion	NOUN
aiua-11830	176	9	,	,	PUNCT
aiua-11830	176	10	the	the	DET
aiua-11830	176	11	overlapping	overlapping	NOUN
aiua-11830	176	12	with	with	ADP
aiua-11830	176	13	benign	benign	ADJ
aiua-11830	176	14	situations	situation	NOUN
aiua-11830	176	15	often	often	ADV
aiua-11830	176	16	interpreted	interpret	VERB
aiua-11830	176	17	as	as	ADP
aiua-11830	176	18	false	false	ADJ
aiua-11830	176	19	-	-	PUNCT
aiua-11830	176	20	positive	positive	ADJ
aiua-11830	176	21	mpmri	mpmri	NOUN
aiua-11830	176	22	findings	finding	NOUN
aiua-11830	176	23	(	(	PUNCT
aiua-11830	176	24	benign	benign	ADJ
aiua-11830	176	25	prostate	prostate	NOUN
aiua-11830	176	26	hyperplasia	hyperplasia	NOUN
aiua-11830	176	27	,	,	PUNCT
aiua-11830	176	28	inflammation	inflammation	NOUN
aiua-11830	176	29	or	or	CCONJ
aiua-11830	176	30	fibrosis	fibrosis	NOUN
aiua-11830	176	31	)	)	PUNCT
aiua-11830	176	32	are	be	AUX
aiua-11830	176	33	more	more	ADV
aiua-11830	176	34	common	common	ADJ
aiua-11830	176	35	(	(	PUNCT
aiua-11830	176	36	25	25	NUM
aiua-11830	176	37	)	)	PUNCT
aiua-11830	176	38	.	.	PUNCT
aiua-11830	177	1	this	this	PRON
aiua-11830	177	2	can	can	AUX
aiua-11830	177	3	explain	explain	VERB
aiua-11830	177	4	the	the	DET
aiua-11830	177	5	higher	high	ADJ
aiua-11830	177	6	frequency	frequency	NOUN
aiua-11830	177	7	of	of	ADP
aiua-11830	177	8	pi	pi	NOUN
aiua-11830	177	9	-	-	PUNCT
aiua-11830	177	10	rads	rad	NOUN
aiua-11830	177	11	3	3	NUM
aiua-11830	177	12	lesions	lesion	NOUN
aiua-11830	177	13	on	on	ADP
aiua-11830	177	14	tz	tz	NOUN
aiua-11830	177	15	,	,	PUNCT
aiua-11830	177	16	however	however	ADV
aiua-11830	177	17	,	,	PUNCT
aiua-11830	177	18	it	it	PRON
aiua-11830	177	19	was	be	AUX
aiua-11830	177	20	not	not	PART
aiua-11830	177	21	observed	observe	VERB
aiua-11830	177	22	in	in	ADP
aiua-11830	177	23	our	our	PRON
aiua-11830	177	24	cohort	cohort	NOUN
aiua-11830	177	25	.	.	PUNCT
aiua-11830	178	1	our	our	PRON
aiua-11830	178	2	study	study	NOUN
aiua-11830	178	3	has	have	VERB
aiua-11830	178	4	several	several	ADJ
aiua-11830	178	5	limitations	limitation	NOUN
aiua-11830	178	6	.	.	PUNCT
aiua-11830	179	1	it	it	PRON
aiua-11830	179	2	is	be	AUX
aiua-11830	179	3	a	a	DET
aiua-11830	179	4	retrospective	retrospective	ADJ
aiua-11830	179	5	study	study	NOUN
aiua-11830	179	6	,	,	PUNCT
aiua-11830	179	7	from	from	ADP
aiua-11830	179	8	a	a	DET
aiua-11830	179	9	single	single	ADJ
aiua-11830	179	10	institution	institution	NOUN
aiua-11830	179	11	and	and	CCONJ
aiua-11830	179	12	with	with	ADP
aiua-11830	179	13	limited	limited	ADJ
aiua-11830	179	14	pi	pi	NOUN
aiua-11830	179	15	-	-	PUNCT
aiua-11830	179	16	rads	rad	NOUN
aiua-11830	179	17	3	3	NUM
aiua-11830	179	18	lesions	lesion	NOUN
aiua-11830	179	19	enrolled	enrol	VERB
aiua-11830	179	20	which	which	PRON
aiua-11830	179	21	may	may	AUX
aiua-11830	179	22	have	have	AUX
aiua-11830	179	23	resulted	result	VERB
aiua-11830	179	24	in	in	ADP
aiua-11830	179	25	possible	possible	ADJ
aiua-11830	179	26	risk	risk	NOUN
aiua-11830	179	27	of	of	ADP
aiua-11830	179	28	selection	selection	NOUN
aiua-11830	179	29	bias	bias	NOUN
aiua-11830	179	30	.	.	PUNCT
aiua-11830	180	1	it	it	PRON
aiua-11830	180	2	included	include	VERB
aiua-11830	180	3	patients	patient	NOUN
aiua-11830	180	4	from	from	ADP
aiua-11830	180	5	2017	2017	NUM
aiua-11830	180	6	to	to	ADP
aiua-11830	180	7	2022	2022	NUM
aiua-11830	180	8	and	and	CCONJ
aiua-11830	180	9	some	some	DET
aiua-11830	180	10	lesions	lesion	NOUN
aiua-11830	180	11	were	be	AUX
aiua-11830	180	12	classified	classify	VERB
aiua-11830	180	13	as	as	ADP
aiua-11830	180	14	intermediate	intermediate	ADJ
aiua-11830	180	15	probability	probability	NOUN
aiua-11830	180	16	using	use	VERB
aiua-11830	180	17	criteria	criterion	NOUN
aiua-11830	180	18	from	from	ADP
aiua-11830	180	19	version	version	NOUN
aiua-11830	180	20	2	2	NUM
aiua-11830	180	21	and	and	CCONJ
aiua-11830	180	22	others	other	NOUN
aiua-11830	180	23	with	with	ADP
aiua-11830	180	24	version	version	NOUN
aiua-11830	180	25	2.1	2.1	NUM
aiua-11830	180	26	.	.	PUNCT
aiua-11830	181	1	therefore	therefore	ADV
aiua-11830	181	2	,	,	PUNCT
aiua-11830	181	3	the	the	DET
aiua-11830	181	4	possibility	possibility	NOUN
aiua-11830	181	5	of	of	ADP
aiua-11830	181	6	a	a	DET
aiua-11830	181	7	bias	bias	NOUN
aiua-11830	181	8	of	of	ADP
aiua-11830	181	9	interpretation	interpretation	NOUN
aiua-11830	181	10	is	be	AUX
aiua-11830	181	11	higher	high	ADJ
aiua-11830	181	12	given	give	VERB
aiua-11830	181	13	that	that	SCONJ
aiua-11830	181	14	the	the	DET
aiua-11830	181	15	mpmri	mpmri	PROPN
aiua-11830	181	16	reports	report	NOUN
aiua-11830	181	17	are	be	AUX
aiua-11830	181	18	reviewed	review	VERB
aiua-11830	181	19	by	by	ADP
aiua-11830	181	20	multiple	multiple	ADJ
aiua-11830	181	21	readers	reader	NOUN
aiua-11830	181	22	,	,	PUNCT
aiua-11830	181	23	with	with	ADP
aiua-11830	181	24	an	an	DET
aiua-11830	181	25	interobserver	interobserver	ADJ
aiua-11830	181	26	variability	variability	NOUN
aiua-11830	181	27	of	of	ADP
aiua-11830	181	28	identification	identification	NOUN
aiua-11830	181	29	and	and	CCONJ
aiua-11830	181	30	classification	classification	NOUN
aiua-11830	181	31	of	of	ADP
aiua-11830	181	32	the	the	DET
aiua-11830	181	33	lesions	lesion	NOUN
aiua-11830	181	34	.	.	PUNCT
aiua-11830	182	1	biopsies	biopsy	NOUN
aiua-11830	182	2	were	be	AUX
aiua-11830	182	3	also	also	ADV
aiua-11830	182	4	performed	perform	VERB
aiua-11830	182	5	by	by	ADP
aiua-11830	182	6	different	different	ADJ
aiua-11830	182	7	urologists	urologist	NOUN
aiua-11830	182	8	with	with	ADP
aiua-11830	182	9	different	different	ADJ
aiua-11830	182	10	experience	experience	NOUN
aiua-11830	182	11	and	and	CCONJ
aiua-11830	182	12	biopsy	biopsy	NOUN
aiua-11830	182	13	specimens	specimen	NOUN
aiua-11830	182	14	were	be	AUX
aiua-11830	182	15	evaluated	evaluate	VERB
aiua-11830	182	16	by	by	ADP
aiua-11830	182	17	multiple	multiple	ADJ
aiua-11830	182	18	pathologists	pathologist	NOUN
aiua-11830	182	19	.	.	PUNCT
aiua-11830	183	1	it	it	PRON
aiua-11830	183	2	was	be	AUX
aiua-11830	183	3	not	not	PART
aiua-11830	183	4	possible	possible	ADJ
aiua-11830	183	5	to	to	PART
aiua-11830	183	6	compare	compare	VERB
aiua-11830	183	7	the	the	DET
aiua-11830	183	8	results	result	NOUN
aiua-11830	183	9	with	with	ADP
aiua-11830	183	10	other	other	ADJ
aiua-11830	183	11	approaches	approach	NOUN
aiua-11830	183	12	,	,	PUNCT
aiua-11830	183	13	namely	namely	ADV
aiua-11830	183	14	transperineal	transperineal	NOUN
aiua-11830	183	15	biopsy	biopsy	NOUN
aiua-11830	183	16	or	or	CCONJ
aiua-11830	183	17	fusion	fusion	NOUN
aiua-11830	183	18	guided	guide	VERB
aiua-11830	183	19	software	software	NOUN
aiua-11830	183	20	,	,	PUNCT
aiua-11830	183	21	to	to	PART
aiua-11830	183	22	analyse	analyse	VERB
aiua-11830	183	23	differences	difference	NOUN
aiua-11830	183	24	in	in	ADP
aiua-11830	183	25	cspca	cspca	PROPN
aiua-11830	183	26	detection	detection	NOUN
aiua-11830	183	27	.	.	PUNCT
aiua-11830	184	1	our	our	PRON
aiua-11830	184	2	definition	definition	NOUN
aiua-11830	184	3	of	of	ADP
aiua-11830	184	4	cspca	cspca	NOUN
aiua-11830	184	5	considered	consider	VERB
aiua-11830	184	6	only	only	ADV
aiua-11830	184	7	the	the	DET
aiua-11830	184	8	gleason	gleason	PROPN
aiua-11830	184	9	/	/	SYM
aiua-11830	184	10	isup	isup	ADJ
aiua-11830	184	11	score	score	NOUN
aiua-11830	184	12	without	without	ADP
aiua-11830	184	13	any	any	DET
aiua-11830	184	14	interpretation	interpretation	NOUN
aiua-11830	184	15	on	on	ADP
aiua-11830	184	16	basis	basis	NOUN
aiua-11830	184	17	in	in	ADP
aiua-11830	184	18	lesion	lesion	NOUN
aiua-11830	184	19	volume	volume	NOUN
aiua-11830	184	20	.	.	PUNCT
aiua-11830	185	1	larger	large	ADJ
aiua-11830	185	2	studies	study	NOUN
aiua-11830	185	3	,	,	PUNCT
aiua-11830	185	4	prospective	prospective	ADJ
aiua-11830	185	5	and	and	CCONJ
aiua-11830	185	6	randomized	randomize	VERB
aiua-11830	185	7	,	,	PUNCT
aiua-11830	185	8	are	be	AUX
aiua-11830	185	9	required	require	VERB
aiua-11830	185	10	to	to	PART
aiua-11830	185	11	evaluate	evaluate	VERB
aiua-11830	185	12	the	the	DET
aiua-11830	185	13	reproducibility	reproducibility	NOUN
aiua-11830	185	14	of	of	ADP
aiua-11830	185	15	our	our	PRON
aiua-11830	185	16	results	result	NOUN
aiua-11830	185	17	.	.	PUNCT
aiua-11830	186	1	conclusions	conclusion	NOUN
aiua-11830	186	2	we	we	PRON
aiua-11830	186	3	have	have	AUX
aiua-11830	186	4	demonstrated	demonstrate	VERB
aiua-11830	186	5	in	in	ADP
aiua-11830	186	6	our	our	PRON
aiua-11830	186	7	cohort	cohort	NOUN
aiua-11830	186	8	that	that	SCONJ
aiua-11830	186	9	prostate	prostate	NOUN
aiua-11830	186	10	lesions	lesion	NOUN
aiua-11830	186	11	characterized	characterize	VERB
aiua-11830	186	12	as	as	ADP
aiua-11830	186	13	pi	pi	NOUN
aiua-11830	186	14	-	-	PUNCT
aiua-11830	186	15	rads	rad	NOUN
aiua-11830	186	16	3	3	NUM
aiua-11830	186	17	lesions	lesion	NOUN
aiua-11830	186	18	,	,	PUNCT
aiua-11830	186	19	according	accord	VERB
aiua-11830	186	20	to	to	ADP
aiua-11830	186	21	the	the	DET
aiua-11830	186	22	current	current	ADJ
aiua-11830	186	23	prevalent	prevalent	ADJ
aiua-11830	186	24	scoring	scoring	NOUN
aiua-11830	186	25	systems	system	NOUN
aiua-11830	186	26	,	,	PUNCT
aiua-11830	186	27	were	be	AUX
aiua-11830	186	28	associated	associate	VERB
aiua-11830	186	29	with	with	ADP
aiua-11830	186	30	a	a	DET
aiua-11830	186	31	low	low	ADJ
aiua-11830	186	32	likelihood	likelihood	NOUN
aiua-11830	186	33	of	of	ADP
aiua-11830	186	34	the	the	DET
aiua-11830	186	35	cspca	cspca	PROPN
aiua-11830	186	36	detection	detection	NOUN
aiua-11830	186	37	.	.	PUNCT
aiua-11830	187	1	a	a	DET
aiua-11830	187	2	systematic	systematic	ADJ
aiua-11830	187	3	biopsy	biopsy	NOUN
aiua-11830	187	4	associated	associate	VERB
aiua-11830	187	5	or	or	CCONJ
aiua-11830	187	6	not	not	PART
aiua-11830	187	7	with	with	ADP
aiua-11830	187	8	a	a	DET
aiua-11830	187	9	target	target	NOUN
aiua-11830	187	10	biopsy	biopsy	NOUN
aiua-11830	187	11	is	be	AUX
aiua-11830	187	12	essential	essential	ADJ
aiua-11830	187	13	in	in	ADP
aiua-11830	187	14	pirads	pirad	NOUN
aiua-11830	187	15	3	3	NUM
aiua-11830	187	16	lesions	lesion	NOUN
aiua-11830	187	17	,	,	PUNCT
aiua-11830	187	18	and	and	CCONJ
aiua-11830	187	19	targeted	target	VERB
aiua-11830	187	20	biopsy	biopsy	NOUN
aiua-11830	187	21	did	do	AUX
aiua-11830	187	22	not	not	PART
aiua-11830	187	23	demonstrate	demonstrate	VERB
aiua-11830	187	24	to	to	PART
aiua-11830	187	25	be	be	AUX
aiua-11830	187	26	superior	superior	ADJ
aiua-11830	187	27	in	in	ADP
aiua-11830	187	28	the	the	DET
aiua-11830	187	29	detection	detection	NOUN
aiua-11830	187	30	of	of	ADP
aiua-11830	187	31	cspca	cspca	NOUN
aiua-11830	187	32	.	.	PUNCT
aiua-11830	188	1	the	the	DET
aiua-11830	188	2	presence	presence	NOUN
aiua-11830	188	3	of	of	ADP
aiua-11830	188	4	abnormal	abnormal	ADJ
aiua-11830	188	5	dre	dre	NOUN
aiua-11830	188	6	and	and	CCONJ
aiua-11830	188	7	lesions	lesion	NOUN
aiua-11830	188	8	localized	localize	VERB
aiua-11830	188	9	in	in	ADP
aiua-11830	188	10	pz	pz	NOUN
aiua-11830	188	11	potentially	potentially	ADV
aiua-11830	188	12	predict	predict	VERB
aiua-11830	188	13	the	the	DET
aiua-11830	188	14	presence	presence	NOUN
aiua-11830	188	15	of	of	ADP
aiua-11830	188	16	cspca	cspca	NOUN
aiua-11830	188	17	in	in	ADP
aiua-11830	188	18	biopsied	biopsied	ADJ
aiua-11830	188	19	pi	pi	NOUN
aiua-11830	188	20	-	-	PUNCT
aiua-11830	188	21	rads	rad	NOUN
aiua-11830	188	22	3	3	NUM
aiua-11830	188	23	lesions	lesion	NOUN
aiua-11830	188	24	.	.	PUNCT
aiua-11830	189	1	references	reference	NOUN
aiua-11830	189	2	1	1	NUM
aiua-11830	189	3	.	.	PUNCT
aiua-11830	189	4	ahmed	ahmed	PROPN
aiua-11830	189	5	hu	hu	PROPN
aiua-11830	189	6	,	,	PUNCT
aiua-11830	189	7	el	el	PROPN
aiua-11830	189	8	-	-	PUNCT
aiua-11830	189	9	shater	shater	NOUN
aiua-11830	189	10	bosaily	bosaily	ADV
aiua-11830	189	11	a	a	DET
aiua-11830	189	12	,	,	PUNCT
aiua-11830	189	13	brown	brown	ADJ
aiua-11830	189	14	lc	lc	PROPN
aiua-11830	189	15	,	,	PUNCT
aiua-11830	189	16	et	et	PROPN
aiua-11830	189	17	al	al	PROPN
aiua-11830	189	18	.	.	PUNCT
aiua-11830	190	1	diagnostic	diagnostic	ADJ
aiua-11830	190	2	accuracy	accuracy	NOUN
aiua-11830	190	3	of	of	ADP
aiua-11830	190	4	multi	multi	ADJ
aiua-11830	190	5	-	-	ADJ
aiua-11830	190	6	parametric	parametric	ADJ
aiua-11830	190	7	mri	mri	NOUN
aiua-11830	190	8	and	and	CCONJ
aiua-11830	190	9	trus	trus	NOUN
aiua-11830	190	10	biopsy	biopsy	NOUN
aiua-11830	190	11	in	in	ADP
aiua-11830	190	12	prostate	prostate	NOUN
aiua-11830	190	13	cancer	cancer	NOUN
aiua-11830	190	14	(	(	PUNCT
aiua-11830	190	15	promis	promis	PROPN
aiua-11830	190	16	):	):	PUNCT
aiua-11830	190	17	a	a	DET
aiua-11830	190	18	paired	pair	VERB
aiua-11830	190	19	validating	validate	VERB
aiua-11830	190	20	confirmatory	confirmatory	ADJ
aiua-11830	190	21	study	study	NOUN
aiua-11830	190	22	.	.	PUNCT
aiua-11830	191	1	the	the	DET
aiua-11830	191	2	lancet	lancet	NOUN
aiua-11830	191	3	.	.	PUNCT
aiua-11830	192	1	2017	2017	NUM
aiua-11830	192	2	;	;	PUNCT
aiua-11830	192	3	389:815	389:815	NOUN
aiua-11830	192	4	-	-	SYM
aiua-11830	192	5	22	22	NUM
aiua-11830	192	6	.	.	PUNCT
aiua-11830	193	1	2	2	X
aiua-11830	193	2	.	.	X
aiua-11830	193	3	rouvière	rouvière	PROPN
aiua-11830	193	4	o	o	PROPN
aiua-11830	193	5	,	,	PUNCT
aiua-11830	193	6	puech	puech	NOUN
aiua-11830	193	7	p	p	NOUN
aiua-11830	193	8	,	,	PUNCT
aiua-11830	193	9	renard	renard	NOUN
aiua-11830	193	10	-	-	PUNCT
aiua-11830	193	11	penna	penna	NOUN
aiua-11830	193	12	r	r	NOUN
aiua-11830	193	13	,	,	PUNCT
aiua-11830	193	14	et	et	PROPN
aiua-11830	193	15	al	al	PROPN
aiua-11830	193	16	.	.	PUNCT
aiua-11830	193	17	use	use	NOUN
aiua-11830	193	18	of	of	ADP
aiua-11830	193	19	prostate	prostate	NOUN
aiua-11830	193	20	systematic	systematic	ADJ
aiua-11830	193	21	and	and	CCONJ
aiua-11830	193	22	targeted	target	VERB
aiua-11830	193	23	biopsy	biopsy	NOUN
aiua-11830	193	24	on	on	ADP
aiua-11830	193	25	the	the	DET
aiua-11830	193	26	basis	basis	NOUN
aiua-11830	193	27	of	of	ADP
aiua-11830	193	28	multiparametric	multiparametric	ADJ
aiua-11830	193	29	mri	mri	NOUN
aiua-11830	193	30	in	in	ADP
aiua-11830	193	31	biopsy	biopsy	ADJ
aiua-11830	193	32	-	-	PUNCT
aiua-11830	193	33	naive	naive	ADJ
aiua-11830	193	34	patients	patient	NOUN
aiua-11830	193	35	(	(	PUNCT
aiua-11830	193	36	mri	mri	NOUN
aiua-11830	193	37	-	-	PUNCT
aiua-11830	193	38	first	first	ADV
aiua-11830	193	39	):	):	PUNCT
aiua-11830	193	40	a	a	DET
aiua-11830	193	41	prospective	prospective	ADJ
aiua-11830	193	42	,	,	PUNCT
aiua-11830	193	43	multicentre	multicentre	NOUN
aiua-11830	193	44	,	,	PUNCT
aiua-11830	193	45	paired	pair	VERB
aiua-11830	193	46	diagnostic	diagnostic	ADJ
aiua-11830	193	47	study	study	NOUN
aiua-11830	193	48	.	.	PUNCT
aiua-11830	194	1	lancet	lancet	PROPN
aiua-11830	194	2	oncol	oncol	PROPN
aiua-11830	194	3	.	.	PUNCT
aiua-11830	195	1	2019	2019	NUM
aiua-11830	195	2	;	;	PUNCT
aiua-11830	195	3	20:100	20:100	NUM
aiua-11830	195	4	-	-	SYM
aiua-11830	195	5	9	9	NUM
aiua-11830	195	6	.	.	NOUN
aiua-11830	196	1	3	3	X
aiua-11830	196	2	.	.	X
aiua-11830	196	3	van	van	PROPN
aiua-11830	196	4	der	der	PROPN
aiua-11830	196	5	leest	lee	ADJ
aiua-11830	196	6	m	m	PROPN
aiua-11830	196	7	,	,	PUNCT
aiua-11830	196	8	cornel	cornel	PROPN
aiua-11830	196	9	e	e	NOUN
aiua-11830	196	10	,	,	PUNCT
aiua-11830	196	11	israël	israël	NOUN
aiua-11830	196	12	b	b	PROPN
aiua-11830	196	13	,	,	PUNCT
aiua-11830	196	14	et	et	PROPN
aiua-11830	196	15	al	al	PROPN
aiua-11830	196	16	.	.	PROPN
aiua-11830	196	17	head	head	PROPN
aiua-11830	196	18	-	-	PUNCT
aiua-11830	196	19	to	to	ADP
aiua-11830	196	20	-	-	PUNCT
aiua-11830	196	21	head	head	NOUN
aiua-11830	196	22	comparison	comparison	NOUN
aiua-11830	196	23	of	of	ADP
aiua-11830	196	24	transrectal	transrectal	ADJ
aiua-11830	196	25	ultrasound	ultrasound	NOUN
aiua-11830	196	26	-	-	PUNCT
aiua-11830	196	27	guided	guide	VERB
aiua-11830	196	28	prostate	prostate	NOUN
aiua-11830	196	29	biopsy	biopsy	NOUN
aiua-11830	196	30	versus	versus	ADP
aiua-11830	196	31	multiparametric	multiparametric	ADJ
aiua-11830	196	32	prostate	prostate	NOUN
aiua-11830	196	33	resonance	resonance	NOUN
aiua-11830	196	34	imaging	imaging	NOUN
aiua-11830	196	35	with	with	ADP
aiua-11830	196	36	subsequent	subsequent	ADJ
aiua-11830	196	37	magnetic	magnetic	ADJ
aiua-11830	196	38	resonance	resonance	NOUN
aiua-11830	196	39	-	-	PUNCT
aiua-11830	196	40	guided	guide	VERB
aiua-11830	196	41	biopsy	biopsy	NOUN
aiua-11830	196	42	in	in	ADP
aiua-11830	196	43	biopsy	biopsy	NOUN
aiua-11830	196	44	-	-	PUNCT
aiua-11830	196	45	naïve	naïve	ADJ
aiua-11830	196	46	men	man	NOUN
aiua-11830	196	47	with	with	ADP
aiua-11830	196	48	elevated	elevated	ADJ
aiua-11830	196	49	prostate	prostate	NOUN
aiua-11830	196	50	-	-	PUNCT
aiua-11830	196	51	specific	specific	ADJ
aiua-11830	196	52	antigen	antigen	NOUN
aiua-11830	196	53	:	:	PUNCT
aiua-11830	196	54	a	a	DET
aiua-11830	196	55	large	large	ADJ
aiua-11830	196	56	prospective	prospective	ADJ
aiua-11830	196	57	multicenter	multicenter	ADJ
aiua-11830	196	58	clinical	clinical	ADJ
aiua-11830	196	59	study	study	NOUN
aiua-11830	196	60	.	.	PUNCT
aiua-11830	197	1	eur	eur	PROPN
aiua-11830	197	2	urol	urol	PROPN
aiua-11830	197	3	.	.	PROPN
aiua-11830	198	1	2019	2019	NUM
aiua-11830	198	2	;	;	PUNCT
aiua-11830	198	3	75:570	75:570	NUM
aiua-11830	198	4	-	-	SYM
aiua-11830	198	5	8	8	NUM
aiua-11830	198	6	.	.	NOUN
aiua-11830	198	7	4	4	NUM
aiua-11830	198	8	.	.	X
aiua-11830	198	9	drost	drost	PROPN
aiua-11830	198	10	fjh	fjh	PROPN
aiua-11830	198	11	,	,	PUNCT
aiua-11830	198	12	osses	osse	VERB
aiua-11830	198	13	df	df	PROPN
aiua-11830	198	14	,	,	PUNCT
aiua-11830	198	15	nieboer	nieboer	PROPN
aiua-11830	198	16	d	d	NOUN
aiua-11830	198	17	,	,	PUNCT
aiua-11830	198	18	et	et	PROPN
aiua-11830	198	19	al	al	PROPN
aiua-11830	198	20	.	.	PUNCT
aiua-11830	198	21	prostate	prostate	NOUN
aiua-11830	198	22	mri	mri	NOUN
aiua-11830	198	23	,	,	PUNCT
aiua-11830	198	24	with	with	ADP
aiua-11830	198	25	or	or	CCONJ
aiua-11830	198	26	without	without	ADP
aiua-11830	198	27	mri	mri	NOUN
aiua-11830	198	28	-	-	PUNCT
aiua-11830	198	29	targeted	target	VERB
aiua-11830	198	30	biopsy	biopsy	NOUN
aiua-11830	198	31	,	,	PUNCT
aiua-11830	198	32	and	and	CCONJ
aiua-11830	198	33	systematic	systematic	ADJ
aiua-11830	198	34	biopsy	biopsy	NOUN
aiua-11830	198	35	for	for	ADP
aiua-11830	198	36	detecting	detect	VERB
aiua-11830	198	37	prostate	prostate	NOUN
aiua-11830	198	38	cancer	cancer	NOUN
aiua-11830	198	39	.	.	PUNCT
aiua-11830	199	1	cochrane	cochrane	PROPN
aiua-11830	199	2	database	database	PROPN
aiua-11830	199	3	syst	syst	PROPN
aiua-11830	199	4	rev	rev	PROPN
aiua-11830	199	5	.	.	PROPN
aiua-11830	199	6	2019	2019	NUM
aiua-11830	199	7	;	;	PUNCT
aiua-11830	199	8	4	4	NUM
aiua-11830	199	9	:	:	PUNCT
aiua-11830	199	10	cd012663	cd012663	ADJ
aiua-11830	199	11	.	.	PUNCT
aiua-11830	200	1	5	5	X
aiua-11830	200	2	.	.	X
aiua-11830	200	3	barentsz	barentsz	PROPN
aiua-11830	200	4	jo	jo	PROPN
aiua-11830	200	5	,	,	PUNCT
aiua-11830	200	6	richenberg	richenberg	PROPN
aiua-11830	200	7	j	j	PROPN
aiua-11830	200	8	,	,	PUNCT
aiua-11830	200	9	clements	clements	PROPN
aiua-11830	200	10	r	r	PROPN
aiua-11830	200	11	,	,	PUNCT
aiua-11830	200	12	et	et	PROPN
aiua-11830	200	13	al	al	PROPN
aiua-11830	200	14	.	.	PROPN
aiua-11830	200	15	esur	esur	PROPN
aiua-11830	200	16	prostate	prostate	NOUN
aiua-11830	200	17	mr	mr	PROPN
aiua-11830	200	18	guidelines	guideline	NOUN
aiua-11830	200	19	2012	2012	NUM
aiua-11830	200	20	.	.	PUNCT
aiua-11830	201	1	eur	eur	NOUN
aiua-11830	201	2	radiol	radiol	NOUN
aiua-11830	201	3	.	.	PUNCT
aiua-11830	202	1	2012	2012	NUM
aiua-11830	202	2	;	;	PUNCT
aiua-11830	202	3	22:746	22:746	NUM
aiua-11830	202	4	-	-	SYM
aiua-11830	202	5	57	57	NUM
aiua-11830	202	6	.	.	NOUN
aiua-11830	203	1	6	6	NUM
aiua-11830	203	2	.	.	X
aiua-11830	203	3	turkbey	turkbey	PROPN
aiua-11830	203	4	b	b	PROPN
aiua-11830	203	5	,	,	PUNCT
aiua-11830	203	6	rosenkrantz	rosenkrantz	PROPN
aiua-11830	203	7	ab	ab	PROPN
aiua-11830	203	8	,	,	PUNCT
aiua-11830	203	9	haider	haider	PROPN
aiua-11830	203	10	ma	ma	PROPN
aiua-11830	203	11	,	,	PUNCT
aiua-11830	203	12	et	et	PROPN
aiua-11830	203	13	al	al	PROPN
aiua-11830	203	14	.	.	PROPN
aiua-11830	204	1	prostate	prostate	NOUN
aiua-11830	204	2	imaging	imaging	NOUN
aiua-11830	204	3	reporting	reporting	NOUN
aiua-11830	204	4	and	and	CCONJ
aiua-11830	204	5	data	datum	NOUN
aiua-11830	204	6	system	system	NOUN
aiua-11830	204	7	version	version	NOUN
aiua-11830	204	8	2.1	2.1	NUM
aiua-11830	204	9	:	:	SYM
aiua-11830	204	10	2019	2019	NUM
aiua-11830	204	11	update	update	NOUN
aiua-11830	204	12	of	of	ADP
aiua-11830	204	13	prostate	prostate	NOUN
aiua-11830	204	14	imaging	imaging	NOUN
aiua-11830	204	15	reporting	reporting	NOUN
aiua-11830	204	16	and	and	CCONJ
aiua-11830	204	17	data	datum	NOUN
aiua-11830	204	18	system	system	NOUN
aiua-11830	204	19	version	version	NOUN
aiua-11830	204	20	2	2	NUM
aiua-11830	204	21	.	.	PUNCT
aiua-11830	204	22	eur	eur	PROPN
aiua-11830	204	23	urol	urol	PROPN
aiua-11830	204	24	.	.	PUNCT
aiua-11830	204	25	2019	2019	NUM
aiua-11830	204	26	;	;	PUNCT
aiua-11830	204	27	76:340	76:340	NUM
aiua-11830	204	28	-	-	SYM
aiua-11830	204	29	51	51	NUM
aiua-11830	204	30	.	.	PUNCT
aiua-11830	205	1	7	7	X
aiua-11830	205	2	.	.	X
aiua-11830	205	3	eau	eau	PROPN
aiua-11830	205	4	guidelines	guideline	NOUN
aiua-11830	205	5	.	.	PUNCT
aiua-11830	206	1	edn	edn	NOUN
aiua-11830	206	2	.	.	PUNCT
aiua-11830	207	1	presented	present	VERB
aiua-11830	207	2	at	at	ADP
aiua-11830	207	3	the	the	DET
aiua-11830	207	4	eau	eau	PROPN
aiua-11830	207	5	annual	annual	PROPN
aiua-11830	207	6	congress	congress	PROPN
aiua-11830	207	7	milan	milan	PROPN
aiua-11830	207	8	2023	2023	NUM
aiua-11830	207	9	.	.	PUNCT
aiua-11830	208	1	isbn	isbn	ADJ
aiua-11830	208	2	978	978	NUM
aiua-11830	208	3	-	-	SYM
aiua-11830	208	4	94	94	NUM
aiua-11830	208	5	-	-	PUNCT
aiua-11830	208	6	92671	92671	NUM
aiua-11830	208	7	-	-	PUNCT
aiua-11830	208	8	19	19	NUM
aiua-11830	208	9	-	-	PUNCT
aiua-11830	208	10	6	6	NUM
aiua-11830	208	11	.	.	NOUN
aiua-11830	208	12	8	8	NUM
aiua-11830	208	13	.	.	PUNCT
aiua-11830	208	14	weinreb	weinreb	PROPN
aiua-11830	208	15	jc	jc	PROPN
aiua-11830	208	16	,	,	PUNCT
aiua-11830	208	17	barentsz	barentsz	VERB
aiua-11830	208	18	jo	jo	PROPN
aiua-11830	208	19	,	,	PUNCT
aiua-11830	208	20	choyke	choyke	PROPN
aiua-11830	208	21	pl	pl	PROPN
aiua-11830	208	22	,	,	PUNCT
aiua-11830	208	23	et	et	PROPN
aiua-11830	208	24	al	al	PROPN
aiua-11830	208	25	.	.	PROPN
aiua-11830	209	1	pi	pi	NOUN
aiua-11830	209	2	-	-	PUNCT
aiua-11830	209	3	rads	rad	NOUN
aiua-11830	209	4	prostate	prostate	NOUN
aiua-11830	209	5	imaging	imaging	NOUN
aiua-11830	209	6	reporting	reporting	NOUN
aiua-11830	209	7	and	and	CCONJ
aiua-11830	209	8	data	datum	NOUN
aiua-11830	209	9	system	system	NOUN
aiua-11830	209	10	:	:	PUNCT
aiua-11830	209	11	2015	2015	NUM
aiua-11830	209	12	,	,	PUNCT
aiua-11830	209	13	version	version	NOUN
aiua-11830	209	14	2	2	NUM
aiua-11830	209	15	.	.	PUNCT
aiua-11830	209	16	eur	eur	PROPN
aiua-11830	209	17	urol	urol	PROPN
aiua-11830	209	18	.	.	PUNCT
aiua-11830	209	19	2016	2016	NUM
aiua-11830	209	20	;	;	PUNCT
aiua-11830	209	21	69:16	69:16	NUM
aiua-11830	209	22	-	-	SYM
aiua-11830	209	23	40	40	NUM
aiua-11830	209	24	.	.	PUNCT
aiua-11830	210	1	9	9	NUM
aiua-11830	210	2	.	.	X
aiua-11830	211	1	oerther	oerther	PROPN
aiua-11830	211	2	b	b	PROPN
aiua-11830	211	3	,	,	PUNCT
aiua-11830	211	4	engel	engel	PROPN
aiua-11830	211	5	h	h	PROPN
aiua-11830	211	6	,	,	PUNCT
aiua-11830	211	7	bamberg	bamberg	PROPN
aiua-11830	211	8	f	f	PROPN
aiua-11830	211	9	,	,	PUNCT
aiua-11830	211	10	sigle	sigle	VERB
aiua-11830	211	11	a	a	PRON
aiua-11830	211	12	,	,	PUNCT
aiua-11830	211	13	gratzke	gratzke	NOUN
aiua-11830	211	14	c	c	PROPN
aiua-11830	211	15	,	,	PUNCT
aiua-11830	211	16	benndorf	benndorf	PROPN
aiua-11830	211	17	m.	m.	NOUN
aiua-11830	211	18	cancer	cancer	NOUN
aiua-11830	211	19	detection	detection	NOUN
aiua-11830	211	20	rates	rate	NOUN
aiua-11830	211	21	of	of	ADP
aiua-11830	211	22	the	the	DET
aiua-11830	211	23	pi	pi	NOUN
aiua-11830	211	24	-	-	PUNCT
aiua-11830	211	25	radsv2.1	radsv2.1	NOUN
aiua-11830	211	26	assessment	assessment	NOUN
aiua-11830	211	27	categories	category	NOUN
aiua-11830	211	28	:	:	PUNCT
aiua-11830	211	29	systematic	systematic	ADJ
aiua-11830	211	30	review	review	NOUN
aiua-11830	211	31	and	and	CCONJ
aiua-11830	211	32	meta	meta	NOUN
aiua-11830	211	33	-	-	PUNCT
aiua-11830	211	34	analysis	analysis	NOUN
aiua-11830	211	35	on	on	ADP
aiua-11830	211	36	lesion	lesion	NOUN
aiua-11830	211	37	level	level	NOUN
aiua-11830	211	38	and	and	CCONJ
aiua-11830	211	39	patient	patient	ADJ
aiua-11830	211	40	level	level	NOUN
aiua-11830	211	41	.	.	PUNCT
aiua-11830	212	1	prostate	prostate	NOUN
aiua-11830	212	2	cancer	cancer	NOUN
aiua-11830	212	3	prostatic	prostatic	ADJ
aiua-11830	212	4	dis	dis	PROPN
aiua-11830	212	5	.	.	PUNCT
aiua-11830	213	1	2022	2022	NUM
aiua-11830	213	2	;	;	PUNCT
aiua-11830	213	3	25:256	25:256	NUM
aiua-11830	213	4	-	-	SYM
aiua-11830	213	5	63	63	NUM
aiua-11830	213	6	.	.	PUNCT
aiua-11830	214	1	10	10	NUM
aiua-11830	214	2	.	.	PUNCT
aiua-11830	214	3	schoots	schoot	VERB
aiua-11830	214	4	ig	ig	PROPN
aiua-11830	214	5	,	,	PUNCT
aiua-11830	214	6	padhani	padhani	PROPN
aiua-11830	214	7	ar	ar	PROPN
aiua-11830	214	8	.	.	PROPN
aiua-11830	214	9	risk	risk	NOUN
aiua-11830	214	10	-	-	PUNCT
aiua-11830	214	11	adapted	adapt	VERB
aiua-11830	214	12	biopsy	biopsy	NOUN
aiua-11830	214	13	decision	decision	NOUN
aiua-11830	214	14	based	base	VERB
aiua-11830	214	15	on	on	ADP
aiua-11830	214	16	prostate	prostate	NOUN
aiua-11830	214	17	magnetic	magnetic	ADJ
aiua-11830	214	18	resonance	resonance	NOUN
aiua-11830	214	19	imaging	imaging	NOUN
aiua-11830	214	20	and	and	CCONJ
aiua-11830	214	21	prostate	prostate	NOUN
aiua-11830	214	22	-	-	PUNCT
aiua-11830	214	23	specific	specific	ADJ
aiua-11830	214	24	antigen	antigen	ADJ
aiua-11830	214	25	density	density	NOUN
aiua-11830	214	26	for	for	ADP
aiua-11830	214	27	enhanced	enhanced	ADJ
aiua-11830	214	28	biopsy	biopsy	NOUN
aiua-11830	214	29	avoidance	avoidance	NOUN
aiua-11830	214	30	in	in	ADP
aiua-11830	214	31	first	first	ADJ
aiua-11830	214	32	prostate	prostate	NOUN
aiua-11830	214	33	cancer	cancer	NOUN
aiua-11830	214	34	diagnostic	diagnostic	ADJ
aiua-11830	214	35	evaluation	evaluation	NOUN
aiua-11830	214	36	.	.	PUNCT
aiua-11830	215	1	bju	bju	NOUN
aiua-11830	215	2	int	int	PROPN
aiua-11830	215	3	.	.	PUNCT
aiua-11830	216	1	2021	2021	NUM
aiua-11830	216	2	;	;	PUNCT
aiua-11830	216	3	127:175	127:175	NUM
aiua-11830	216	4	-	-	SYM
aiua-11830	216	5	8	8	NUM
aiua-11830	216	6	.	.	PUNCT
aiua-11830	217	1	11	11	NUM
aiua-11830	217	2	.	.	PUNCT
aiua-11830	218	1	maggi	maggi	PROPN
aiua-11830	218	2	m	m	PROPN
aiua-11830	218	3	,	,	PUNCT
aiua-11830	218	4	panebianco	panebianco	ADJ
aiua-11830	218	5	v	v	NOUN
aiua-11830	218	6	,	,	PUNCT
aiua-11830	218	7	mosca	mosca	PROPN
aiua-11830	218	8	a	a	PRON
aiua-11830	218	9	,	,	PUNCT
aiua-11830	218	10	et	et	PROPN
aiua-11830	218	11	al	al	PROPN
aiua-11830	218	12	.	.	PROPN
aiua-11830	219	1	prostate	prostate	NOUN
aiua-11830	219	2	imaging	image	VERB
aiua-11830	219	3	archivio	archivio	NOUN
aiua-11830	219	4	italiano	italiano	X
aiua-11830	219	5	di	di	X
aiua-11830	219	6	urologia	urologia	PROPN
aiua-11830	219	7	e	e	PROPN
aiua-11830	219	8	andrologia	andrologia	NOUN
aiua-11830	219	9	2023	2023	NUM
aiua-11830	219	10	;	;	PUNCT
aiua-11830	219	11	95(4):11830	95(4):11830	NUM
aiua-11830	219	12	d.	d.	PROPN
aiua-11830	219	13	araújo	araújo	PROPN
aiua-11830	219	14	,	,	PUNCT
aiua-11830	219	15	a.	a.	NOUN
aiua-11830	219	16	gromicho	gromicho	NOUN
aiua-11830	219	17	,	,	PUNCT
aiua-11830	219	18	j.	j.	PROPN
aiua-11830	219	19	dias	dias	PROPN
aiua-11830	219	20	,	,	PUNCT
aiua-11830	219	21	s.	s.	PROPN
aiua-11830	219	22	bastos	bastos	PROPN
aiua-11830	219	23	,	,	PUNCT
aiua-11830	219	24	r.	r.	PROPN
aiua-11830	219	25	miguel	miguel	PROPN
aiua-11830	219	26	maciel	maciel	PROPN
aiua-11830	219	27	,	,	PUNCT
aiua-11830	219	28	a.	a.	NOUN
aiua-11830	219	29	sabença	sabença	PROPN
aiua-11830	219	30	,	,	PUNCT
aiua-11830	219	31	l.	l.	PROPN
aiua-11830	219	32	xambre	xambre	PROPN
aiua-11830	219	33	6	6	NUM
aiua-11830	219	34	reporting	reporting	NOUN
aiua-11830	219	35	and	and	CCONJ
aiua-11830	219	36	data	datum	NOUN
aiua-11830	219	37	system	system	NOUN
aiua-11830	219	38	3	3	NUM
aiua-11830	219	39	category	category	NOUN
aiua-11830	219	40	cases	case	NOUN
aiua-11830	219	41	at	at	ADP
aiua-11830	219	42	multiparametric	multiparametric	ADJ
aiua-11830	219	43	magnetic	magnetic	ADJ
aiua-11830	219	44	resonance	resonance	NOUN
aiua-11830	219	45	for	for	ADP
aiua-11830	219	46	prostate	prostate	NOUN
aiua-11830	219	47	cancer	cancer	NOUN
aiua-11830	219	48	:	:	PUNCT
aiua-11830	219	49	a	a	DET
aiua-11830	219	50	systematic	systematic	ADJ
aiua-11830	219	51	review	review	NOUN
aiua-11830	219	52	and	and	CCONJ
aiua-11830	219	53	meta	meta	ADJ
aiua-11830	219	54	-	-	PUNCT
aiua-11830	219	55	analysis	analysis	NOUN
aiua-11830	219	56	.	.	PUNCT
aiua-11830	220	1	eur	eur	PROPN
aiua-11830	220	2	urol	urol	ADJ
aiua-11830	220	3	focus	focus	NOUN
aiua-11830	220	4	.	.	PUNCT
aiua-11830	221	1	2020	2020	NUM
aiua-11830	221	2	;	;	PUNCT
aiua-11830	221	3	6:463	6:463	NUM
aiua-11830	221	4	-	-	SYM
aiua-11830	221	5	78	78	NUM
aiua-11830	221	6	.	.	PUNCT
aiua-11830	222	1	12	12	NUM
aiua-11830	222	2	.	.	PUNCT
aiua-11830	223	1	maggi	maggi	PROPN
aiua-11830	223	2	m	m	PROPN
aiua-11830	223	3	,	,	PUNCT
aiua-11830	223	4	panebianco	panebianco	ADJ
aiua-11830	223	5	v	v	NOUN
aiua-11830	223	6	,	,	PUNCT
aiua-11830	223	7	mosca	mosca	PROPN
aiua-11830	223	8	a	a	PRON
aiua-11830	223	9	,	,	PUNCT
aiua-11830	223	10	et	et	PROPN
aiua-11830	223	11	al	al	PROPN
aiua-11830	223	12	.	.	PROPN
aiua-11830	223	13	prostate	prostate	NOUN
aiua-11830	223	14	imaging	imaging	NOUN
aiua-11830	223	15	reporting	reporting	NOUN
aiua-11830	223	16	and	and	CCONJ
aiua-11830	223	17	data	datum	NOUN
aiua-11830	223	18	system	system	NOUN
aiua-11830	223	19	3	3	NUM
aiua-11830	223	20	category	category	NOUN
aiua-11830	223	21	cases	case	NOUN
aiua-11830	223	22	at	at	ADP
aiua-11830	223	23	multiparametric	multiparametric	ADJ
aiua-11830	223	24	magnetic	magnetic	ADJ
aiua-11830	223	25	resonance	resonance	NOUN
aiua-11830	223	26	for	for	ADP
aiua-11830	223	27	prostate	prostate	NOUN
aiua-11830	223	28	cancer	cancer	NOUN
aiua-11830	223	29	:	:	PUNCT
aiua-11830	223	30	a	a	DET
aiua-11830	223	31	systematic	systematic	ADJ
aiua-11830	223	32	review	review	NOUN
aiua-11830	223	33	and	and	CCONJ
aiua-11830	223	34	meta	meta	ADJ
aiua-11830	223	35	-	-	PUNCT
aiua-11830	223	36	analysis	analysis	NOUN
aiua-11830	223	37	.	.	PUNCT
aiua-11830	224	1	eur	eur	PROPN
aiua-11830	224	2	urol	urol	ADJ
aiua-11830	224	3	focus	focus	NOUN
aiua-11830	224	4	.	.	PUNCT
aiua-11830	225	1	2020	2020	NUM
aiua-11830	225	2	;	;	PUNCT
aiua-11830	225	3	6:463	6:463	NUM
aiua-11830	225	4	-	-	SYM
aiua-11830	225	5	78	78	NUM
aiua-11830	225	6	.	.	PUNCT
aiua-11830	226	1	13	13	NUM
aiua-11830	226	2	.	.	PUNCT
aiua-11830	227	1	ullrich	ullrich	PROPN
aiua-11830	227	2	t	t	PROPN
aiua-11830	227	3	,	,	PUNCT
aiua-11830	227	4	quentin	quentin	PROPN
aiua-11830	227	5	m	m	PROPN
aiua-11830	227	6	,	,	PUNCT
aiua-11830	227	7	arsov	arsov	PROPN
aiua-11830	227	8	c	c	PROPN
aiua-11830	227	9	,	,	PUNCT
aiua-11830	227	10	et	et	PROPN
aiua-11830	227	11	al	al	PROPN
aiua-11830	227	12	.	.	PUNCT
aiua-11830	228	1	risk	risk	NOUN
aiua-11830	228	2	stratification	stratification	NOUN
aiua-11830	228	3	of	of	ADP
aiua-11830	228	4	equivocal	equivocal	ADJ
aiua-11830	228	5	lesions	lesion	NOUN
aiua-11830	228	6	on	on	ADP
aiua-11830	228	7	multiparametric	multiparametric	ADJ
aiua-11830	228	8	magnetic	magnetic	ADJ
aiua-11830	228	9	resonance	resonance	NOUN
aiua-11830	228	10	imaging	imaging	NOUN
aiua-11830	228	11	of	of	ADP
aiua-11830	228	12	the	the	DET
aiua-11830	228	13	prostate	prostate	NOUN
aiua-11830	228	14	.	.	PUNCT
aiua-11830	229	1	j	j	PROPN
aiua-11830	229	2	urol	urol	PROPN
aiua-11830	229	3	.	.	PROPN
aiua-11830	229	4	2018	2018	NUM
aiua-11830	229	5	;	;	PUNCT
aiua-11830	229	6	199:691	199:691	NUM
aiua-11830	229	7	-	-	SYM
aiua-11830	229	8	8	8	NUM
aiua-11830	229	9	.	.	PUNCT
aiua-11830	229	10	14	14	NUM
aiua-11830	229	11	.	.	PUNCT
aiua-11830	230	1	park	park	PROPN
aiua-11830	230	2	kj	kj	PROPN
aiua-11830	230	3	,	,	PUNCT
aiua-11830	230	4	choi	choi	PROPN
aiua-11830	230	5	sh	sh	PROPN
aiua-11830	230	6	,	,	PUNCT
aiua-11830	230	7	lee	lee	PROPN
aiua-11830	230	8	js	js	PROPN
aiua-11830	230	9	,	,	PUNCT
aiua-11830	230	10	et	et	PROPN
aiua-11830	230	11	al	al	PROPN
aiua-11830	230	12	.	.	PUNCT
aiua-11830	230	13	risk	risk	NOUN
aiua-11830	230	14	stratification	stratification	NOUN
aiua-11830	230	15	of	of	ADP
aiua-11830	230	16	prostate	prostate	NOUN
aiua-11830	230	17	cancer	cancer	NOUN
aiua-11830	230	18	according	accord	VERB
aiua-11830	230	19	to	to	ADP
aiua-11830	230	20	pi	pi	NOUN
aiua-11830	230	21	-	-	PUNCT
aiua-11830	230	22	rads	rad	NOUN
aiua-11830	230	23	®	®	NOUN
aiua-11830	230	24	version	version	NOUN
aiua-11830	230	25	2	2	NUM
aiua-11830	230	26	categories	category	NOUN
aiua-11830	230	27	:	:	PUNCT
aiua-11830	230	28	meta	meta	ADJ
aiua-11830	230	29	-	-	PUNCT
aiua-11830	230	30	analysis	analysis	NOUN
aiua-11830	230	31	for	for	ADP
aiua-11830	230	32	prospective	prospective	ADJ
aiua-11830	230	33	studies	study	NOUN
aiua-11830	230	34	.	.	PUNCT
aiua-11830	231	1	j	j	PROPN
aiua-11830	231	2	urol	urol	PROPN
aiua-11830	231	3	.	.	PUNCT
aiua-11830	232	1	2020	2020	NUM
aiua-11830	232	2	;	;	PUNCT
aiua-11830	232	3	204:1141	204:1141	NUM
aiua-11830	232	4	-	-	SYM
aiua-11830	232	5	9	9	NUM
aiua-11830	232	6	.	.	NOUN
aiua-11830	232	7	15	15	NUM
aiua-11830	232	8	.	.	PUNCT
aiua-11830	233	1	hansen	hansen	PROPN
aiua-11830	233	2	nl	nl	PROPN
aiua-11830	233	3	,	,	PUNCT
aiua-11830	233	4	barrett	barrett	PROPN
aiua-11830	233	5	t	t	PROPN
aiua-11830	233	6	,	,	PUNCT
aiua-11830	233	7	lloyd	lloyd	PROPN
aiua-11830	233	8	t	t	PROPN
aiua-11830	233	9	,	,	PUNCT
aiua-11830	233	10	et	et	PROPN
aiua-11830	233	11	al	al	PROPN
aiua-11830	233	12	.	.	PUNCT
aiua-11830	233	13	optimising	optimise	VERB
aiua-11830	233	14	the	the	DET
aiua-11830	233	15	number	number	NOUN
aiua-11830	233	16	of	of	ADP
aiua-11830	233	17	cores	core	NOUN
aiua-11830	233	18	for	for	ADP
aiua-11830	233	19	<	<	X
aiua-11830	233	20	scp	scp	PROPN
aiua-11830	233	21	>	>	PROPN
aiua-11830	233	22	magnetic	magnetic	PROPN
aiua-11830	233	23	resonance	resonance	NOUN
aiua-11830	233	24	imaging</scp	imaging</scp	PROPN
aiua-11830	233	25	>	>	X
aiua-11830	233	26	guided	guide	VERB
aiua-11830	233	27	targeted	target	VERB
aiua-11830	233	28	and	and	CCONJ
aiua-11830	233	29	systematic	systematic	ADJ
aiua-11830	233	30	transperineal	transperineal	NOUN
aiua-11830	233	31	prostate	prostate	NOUN
aiua-11830	233	32	biopsy	biopsy	NOUN
aiua-11830	233	33	.	.	PUNCT
aiua-11830	234	1	bju	bju	NOUN
aiua-11830	234	2	int	int	PROPN
aiua-11830	234	3	.	.	PUNCT
aiua-11830	235	1	2020	2020	NUM
aiua-11830	235	2	;	;	PUNCT
aiua-11830	235	3	125:260	125:260	NOUN
aiua-11830	235	4	-	-	SYM
aiua-11830	235	5	9	9	NUM
aiua-11830	235	6	.	.	NOUN
aiua-11830	235	7	16	16	NUM
aiua-11830	235	8	.	.	PUNCT
aiua-11830	235	9	cash	cash	NOUN
aiua-11830	235	10	h	h	NOUN
aiua-11830	235	11	,	,	PUNCT
aiua-11830	235	12	günzel	günzel	NOUN
aiua-11830	235	13	k	k	NOUN
aiua-11830	235	14	,	,	PUNCT
aiua-11830	235	15	maxeiner	maxeiner	AUX
aiua-11830	235	16	a	a	NOUN
aiua-11830	235	17	,	,	PUNCT
aiua-11830	235	18	et	et	PROPN
aiua-11830	235	19	al	al	PROPN
aiua-11830	235	20	.	.	PROPN
aiua-11830	235	21	prostate	prostate	NOUN
aiua-11830	235	22	cancer	cancer	NOUN
aiua-11830	235	23	detection	detection	NOUN
aiua-11830	235	24	on	on	ADP
aiua-11830	235	25	transrectal	transrectal	ADJ
aiua-11830	235	26	ultrasonography	ultrasonography	NOUN
aiua-11830	235	27	-	-	PUNCT
aiua-11830	235	28	guided	guide	VERB
aiua-11830	235	29	random	random	ADJ
aiua-11830	235	30	biopsy	biopsy	NOUN
aiua-11830	235	31	despite	despite	SCONJ
aiua-11830	235	32	negative	negative	ADJ
aiua-11830	235	33	real	real	ADJ
aiua-11830	235	34	-	-	PUNCT
aiua-11830	235	35	time	time	NOUN
aiua-11830	235	36	magnetic	magnetic	ADJ
aiua-11830	235	37	resonance	resonance	NOUN
aiua-11830	235	38	imaging	imaging	NOUN
aiua-11830	235	39	/	/	SYM
aiua-11830	235	40	ultrasonography	ultrasonography	NOUN
aiua-11830	235	41	fusionguided	fusionguide	VERB
aiua-11830	235	42	targeted	target	VERB
aiua-11830	235	43	biopsy	biopsy	NOUN
aiua-11830	235	44	:	:	PUNCT
aiua-11830	235	45	reasons	reason	NOUN
aiua-11830	235	46	for	for	ADP
aiua-11830	235	47	targeted	target	VERB
aiua-11830	235	48	biopsy	biopsy	NOUN
aiua-11830	235	49	failure	failure	NOUN
aiua-11830	235	50	.	.	PUNCT
aiua-11830	236	1	bju	bju	NOUN
aiua-11830	236	2	int	int	PROPN
aiua-11830	236	3	.	.	PUNCT
aiua-11830	237	1	2016	2016	NUM
aiua-11830	237	2	;	;	PUNCT
aiua-11830	237	3	118:35	118:35	NUM
aiua-11830	237	4	-	-	SYM
aiua-11830	237	5	43	43	NUM
aiua-11830	237	6	.	.	PUNCT
aiua-11830	238	1	17	17	NUM
aiua-11830	238	2	.	.	PUNCT
aiua-11830	239	1	wegelin	wegelin	PROPN
aiua-11830	239	2	o	o	PROPN
aiua-11830	239	3	,	,	PUNCT
aiua-11830	239	4	exterkate	exterkate	ADJ
aiua-11830	239	5	l	l	NOUN
aiua-11830	239	6	,	,	PUNCT
aiua-11830	239	7	van	van	PROPN
aiua-11830	239	8	der	der	NOUN
aiua-11830	239	9	leest	lee	ADJ
aiua-11830	239	10	m	m	PROPN
aiua-11830	239	11	,	,	PUNCT
aiua-11830	239	12	et	et	PROPN
aiua-11830	239	13	al	al	PROPN
aiua-11830	239	14	.	.	PUNCT
aiua-11830	240	1	the	the	DET
aiua-11830	240	2	future	future	ADJ
aiua-11830	240	3	trial	trial	NOUN
aiua-11830	240	4	:	:	PUNCT
aiua-11830	240	5	a	a	DET
aiua-11830	240	6	multicenter	multicenter	NOUN
aiua-11830	240	7	randomised	randomise	VERB
aiua-11830	240	8	controlled	control	VERB
aiua-11830	240	9	trial	trial	NOUN
aiua-11830	240	10	on	on	ADP
aiua-11830	240	11	target	target	NOUN
aiua-11830	240	12	biopsy	biopsy	NOUN
aiua-11830	240	13	techniques	technique	NOUN
aiua-11830	240	14	based	base	VERB
aiua-11830	240	15	on	on	ADP
aiua-11830	240	16	magnetic	magnetic	ADJ
aiua-11830	240	17	resonance	resonance	NOUN
aiua-11830	240	18	imaging	imaging	NOUN
aiua-11830	240	19	in	in	ADP
aiua-11830	240	20	the	the	DET
aiua-11830	240	21	diagnosis	diagnosis	NOUN
aiua-11830	240	22	of	of	ADP
aiua-11830	240	23	prostate	prostate	NOUN
aiua-11830	240	24	cancer	cancer	NOUN
aiua-11830	240	25	in	in	ADP
aiua-11830	240	26	patients	patient	NOUN
aiua-11830	240	27	with	with	ADP
aiua-11830	240	28	prior	prior	ADJ
aiua-11830	240	29	negative	negative	ADJ
aiua-11830	240	30	biopsies	biopsy	NOUN
aiua-11830	240	31	.	.	PUNCT
aiua-11830	241	1	eur	eur	PROPN
aiua-11830	241	2	urol	urol	PROPN
aiua-11830	241	3	.	.	PROPN
aiua-11830	242	1	2019	2019	NUM
aiua-11830	242	2	;	;	PUNCT
aiua-11830	242	3	75:582	75:582	NUM
aiua-11830	242	4	-	-	SYM
aiua-11830	242	5	90	90	NUM
aiua-11830	242	6	.	.	NOUN
aiua-11830	242	7	18	18	NUM
aiua-11830	242	8	.	.	X
aiua-11830	243	1	venderink	venderink	PROPN
aiua-11830	243	2	w	w	PROPN
aiua-11830	243	3	,	,	PUNCT
aiua-11830	243	4	van	van	PROPN
aiua-11830	243	5	luijtelaar	luijtelaar	PROPN
aiua-11830	243	6	a	a	PRON
aiua-11830	243	7	,	,	PUNCT
aiua-11830	243	8	bomers	bomers	PROPN
aiua-11830	243	9	jgr	jgr	PROPN
aiua-11830	243	10	,	,	PUNCT
aiua-11830	243	11	et	et	PROPN
aiua-11830	243	12	al	al	PROPN
aiua-11830	243	13	.	.	PROPN
aiua-11830	243	14	results	result	NOUN
aiua-11830	243	15	of	of	ADP
aiua-11830	243	16	targeted	target	VERB
aiua-11830	243	17	biopsy	biopsy	NOUN
aiua-11830	243	18	in	in	ADP
aiua-11830	243	19	men	man	NOUN
aiua-11830	243	20	with	with	ADP
aiua-11830	243	21	magnetic	magnetic	ADJ
aiua-11830	243	22	resonance	resonance	NOUN
aiua-11830	243	23	imaging	imaging	NOUN
aiua-11830	243	24	lesions	lesion	NOUN
aiua-11830	243	25	classified	classify	VERB
aiua-11830	243	26	equivocal	equivocal	ADJ
aiua-11830	243	27	,	,	PUNCT
aiua-11830	243	28	likely	likely	ADJ
aiua-11830	243	29	or	or	CCONJ
aiua-11830	243	30	highly	highly	ADV
aiua-11830	243	31	likely	likely	ADJ
aiua-11830	243	32	to	to	PART
aiua-11830	243	33	be	be	AUX
aiua-11830	243	34	clinically	clinically	ADV
aiua-11830	243	35	significant	significant	ADJ
aiua-11830	243	36	prostate	prostate	NOUN
aiua-11830	243	37	cancer	cancer	NOUN
aiua-11830	243	38	.	.	PUNCT
aiua-11830	244	1	eur	eur	PROPN
aiua-11830	244	2	urol	urol	PROPN
aiua-11830	244	3	.	.	PUNCT
aiua-11830	244	4	2018	2018	NUM
aiua-11830	244	5	;	;	PUNCT
aiua-11830	244	6	73:353	73:353	NUM
aiua-11830	244	7	-	-	SYM
aiua-11830	244	8	60	60	NUM
aiua-11830	244	9	.	.	PUNCT
aiua-11830	245	1	19	19	NUM
aiua-11830	245	2	.	.	PUNCT
aiua-11830	246	1	sheridan	sheridan	PROPN
aiua-11830	246	2	ad	ad	PROPN
aiua-11830	246	3	,	,	PUNCT
aiua-11830	246	4	nath	nath	NOUN
aiua-11830	246	5	sk	sk	PROPN
aiua-11830	246	6	,	,	PUNCT
aiua-11830	246	7	syed	syed	ADJ
aiua-11830	246	8	js	js	PROPN
aiua-11830	246	9	,	,	PUNCT
aiua-11830	246	10	et	et	PROPN
aiua-11830	246	11	al	al	PROPN
aiua-11830	246	12	.	.	PROPN
aiua-11830	246	13	risk	risk	NOUN
aiua-11830	246	14	of	of	ADP
aiua-11830	246	15	clinically	clinically	ADV
aiua-11830	246	16	significant	significant	ADJ
aiua-11830	246	17	prostate	prostate	NOUN
aiua-11830	246	18	cancer	cancer	NOUN
aiua-11830	246	19	associated	associate	VERB
aiua-11830	246	20	with	with	ADP
aiua-11830	246	21	prostate	prostate	NOUN
aiua-11830	246	22	imaging	imaging	NOUN
aiua-11830	246	23	reporting	reporting	NOUN
aiua-11830	246	24	and	and	CCONJ
aiua-11830	246	25	data	datum	NOUN
aiua-11830	246	26	system	system	NOUN
aiua-11830	246	27	category	category	NOUN
aiua-11830	246	28	3	3	NUM
aiua-11830	246	29	(	(	PUNCT
aiua-11830	246	30	equivocal	equivocal	ADJ
aiua-11830	246	31	)	)	PUNCT
aiua-11830	246	32	lesions	lesion	NOUN
aiua-11830	246	33	identified	identify	VERB
aiua-11830	246	34	on	on	ADP
aiua-11830	246	35	multiparametric	multiparametric	ADJ
aiua-11830	246	36	prostate	prostate	NOUN
aiua-11830	246	37	mri	mri	NOUN
aiua-11830	246	38	.	.	PUNCT
aiua-11830	247	1	ajr	ajr	PROPN
aiua-11830	247	2	am	be	AUX
aiua-11830	247	3	j	j	PROPN
aiua-11830	247	4	roentgenol	roentgenol	NOUN
aiua-11830	247	5	.	.	PUNCT
aiua-11830	248	1	2018	2018	NUM
aiua-11830	248	2	;	;	PUNCT
aiua-11830	249	1	210:347	210:347	NOUN
aiua-11830	249	2	-	-	SYM
aiua-11830	249	3	57	57	NUM
aiua-11830	249	4	.	.	NOUN
aiua-11830	249	5	20	20	NUM
aiua-11830	249	6	.	.	PUNCT
aiua-11830	250	1	radtke	radtke	PROPN
aiua-11830	250	2	jp	jp	PROPN
aiua-11830	250	3	,	,	PUNCT
aiua-11830	250	4	wiesenfarth	wiesenfarth	PROPN
aiua-11830	250	5	m	m	PROPN
aiua-11830	250	6	,	,	PUNCT
aiua-11830	250	7	kesch	kesch	PROPN
aiua-11830	250	8	c	c	NOUN
aiua-11830	250	9	,	,	PUNCT
aiua-11830	250	10	et	et	PROPN
aiua-11830	250	11	al	al	PROPN
aiua-11830	250	12	.	.	PROPN
aiua-11830	251	1	combined	combine	VERB
aiua-11830	251	2	clinical	clinical	ADJ
aiua-11830	251	3	parameters	parameter	NOUN
aiua-11830	251	4	and	and	CCONJ
aiua-11830	251	5	multiparametric	multiparametric	ADJ
aiua-11830	251	6	magnetic	magnetic	ADJ
aiua-11830	251	7	resonance	resonance	NOUN
aiua-11830	251	8	imaging	imaging	NOUN
aiua-11830	251	9	for	for	ADP
aiua-11830	251	10	advanced	advanced	ADJ
aiua-11830	251	11	risk	risk	NOUN
aiua-11830	251	12	modeling	modeling	NOUN
aiua-11830	251	13	of	of	ADP
aiua-11830	251	14	prostate	prostate	NOUN
aiua-11830	251	15	cancer	cancer	NOUN
aiua-11830	251	16	—	—	PUNCT
aiua-11830	251	17	patient	patient	NOUN
aiua-11830	251	18	-	-	PUNCT
aiua-11830	251	19	tailored	tailor	VERB
aiua-11830	251	20	risk	risk	NOUN
aiua-11830	251	21	stratification	stratification	NOUN
aiua-11830	251	22	can	can	AUX
aiua-11830	251	23	reduce	reduce	VERB
aiua-11830	251	24	unnecessary	unnecessary	ADJ
aiua-11830	251	25	biopsies	biopsy	NOUN
aiua-11830	251	26	.	.	PUNCT
aiua-11830	252	1	eur	eur	PROPN
aiua-11830	252	2	urol	urol	PROPN
aiua-11830	252	3	.	.	PROPN
aiua-11830	252	4	2017	2017	NUM
aiua-11830	252	5	;	;	PUNCT
aiua-11830	252	6	72:888	72:888	NUM
aiua-11830	252	7	-	-	SYM
aiua-11830	252	8	96	96	NUM
aiua-11830	252	9	.	.	PUNCT
aiua-11830	253	1	21	21	NUM
aiua-11830	253	2	.	.	PUNCT
aiua-11830	254	1	liddell	liddell	PROPN
aiua-11830	254	2	h	h	PROPN
aiua-11830	254	3	,	,	PUNCT
aiua-11830	254	4	jyoti	jyoti	PROPN
aiua-11830	254	5	r	r	PROPN
aiua-11830	254	6	,	,	PUNCT
aiua-11830	254	7	haxhimolla	haxhimolla	NOUN
aiua-11830	254	8	hz	hz	PROPN
aiua-11830	254	9	.	.	PROPN
aiua-11830	254	10	mp	mp	PROPN
aiua-11830	254	11	-	-	PUNCT
aiua-11830	254	12	mri	mri	NOUN
aiua-11830	254	13	prostate	prostate	NOUN
aiua-11830	254	14	characterised	characterise	VERB
aiua-11830	254	15	pirads	pirad	NOUN
aiua-11830	254	16	3	3	NUM
aiua-11830	254	17	lesions	lesion	NOUN
aiua-11830	254	18	are	be	AUX
aiua-11830	254	19	associated	associate	VERB
aiua-11830	254	20	with	with	ADP
aiua-11830	254	21	a	a	DET
aiua-11830	254	22	low	low	ADJ
aiua-11830	254	23	risk	risk	NOUN
aiua-11830	254	24	of	of	ADP
aiua-11830	254	25	clinically	clinically	ADV
aiua-11830	254	26	significant	significant	ADJ
aiua-11830	254	27	prostate	prostate	NOUN
aiua-11830	254	28	cancer	cancer	NOUN
aiua-11830	254	29	a	a	DET
aiua-11830	254	30	retrospective	retrospective	ADJ
aiua-11830	254	31	review	review	NOUN
aiua-11830	254	32	of	of	ADP
aiua-11830	254	33	92	92	NUM
aiua-11830	254	34	biopsied	biopsied	ADJ
aiua-11830	254	35	pirads	pirad	NOUN
aiua-11830	254	36	3	3	NUM
aiua-11830	254	37	lesions	lesion	NOUN
aiua-11830	254	38	.	.	PUNCT
aiua-11830	255	1	curr	curr	PROPN
aiua-11830	255	2	urol	urol	PROPN
aiua-11830	255	3	.	.	PROPN
aiua-11830	255	4	2015	2015	NUM
aiua-11830	255	5	;	;	PUNCT
aiua-11830	255	6	8:96	8:96	NUM
aiua-11830	255	7	-	-	SYM
aiua-11830	255	8	100	100	NUM
aiua-11830	255	9	.	.	PUNCT
aiua-11830	256	1	22	22	NUM
aiua-11830	256	2	.	.	PUNCT
aiua-11830	257	1	yang	yang	PROPN
aiua-11830	257	2	s	s	PROPN
aiua-11830	257	3	,	,	PUNCT
aiua-11830	257	4	zhao	zhao	PROPN
aiua-11830	257	5	w	w	PROPN
aiua-11830	257	6	,	,	PUNCT
aiua-11830	257	7	tan	tan	PROPN
aiua-11830	257	8	s	s	PART
aiua-11830	257	9	,	,	PUNCT
aiua-11830	257	10	et	et	PROPN
aiua-11830	257	11	al	al	PROPN
aiua-11830	257	12	.	.	PUNCT
aiua-11830	258	1	combining	combine	VERB
aiua-11830	258	2	clinical	clinical	ADJ
aiua-11830	258	3	and	and	CCONJ
aiua-11830	258	4	mri	mri	NOUN
aiua-11830	258	5	data	datum	NOUN
aiua-11830	258	6	to	to	PART
aiua-11830	258	7	manage	manage	VERB
aiua-11830	258	8	pi	pi	NOUN
aiua-11830	258	9	-	-	PUNCT
aiua-11830	258	10	rads	rad	NOUN
aiua-11830	258	11	3	3	NUM
aiua-11830	258	12	lesions	lesion	NOUN
aiua-11830	258	13	and	and	CCONJ
aiua-11830	258	14	reduce	reduce	VERB
aiua-11830	258	15	excessive	excessive	ADJ
aiua-11830	258	16	biopsy	biopsy	NOUN
aiua-11830	258	17	.	.	PUNCT
aiua-11830	259	1	transl	transl	PROPN
aiua-11830	259	2	androl	androl	PROPN
aiua-11830	259	3	urol	urol	PROPN
aiua-11830	259	4	.	.	PUNCT
aiua-11830	260	1	2020	2020	NUM
aiua-11830	260	2	;	;	PUNCT
aiua-11830	260	3	9:1252	9:1252	NUM
aiua-11830	260	4	-	-	SYM
aiua-11830	260	5	61	61	NUM
aiua-11830	260	6	.	.	PUNCT
aiua-11830	261	1	23	23	NUM
aiua-11830	261	2	.	.	PUNCT
aiua-11830	262	1	galosi	galosi	PROPN
aiua-11830	262	2	ab	ab	PROPN
aiua-11830	262	3	,	,	PUNCT
aiua-11830	262	4	palagonia	palagonia	NOUN
aiua-11830	262	5	e	e	NOUN
aiua-11830	262	6	,	,	PUNCT
aiua-11830	262	7	scarcella	scarcella	PROPN
aiua-11830	262	8	s	s	PART
aiua-11830	262	9	,	,	PUNCT
aiua-11830	262	10	et	et	PROPN
aiua-11830	262	11	al	al	PROPN
aiua-11830	262	12	.	.	PUNCT
aiua-11830	262	13	detection	detection	NOUN
aiua-11830	262	14	limits	limit	NOUN
aiua-11830	262	15	of	of	ADP
aiua-11830	262	16	significant	significant	ADJ
aiua-11830	262	17	prostate	prostate	NOUN
aiua-11830	262	18	cancer	cancer	NOUN
aiua-11830	262	19	using	use	VERB
aiua-11830	262	20	multiparametric	multiparametric	ADJ
aiua-11830	262	21	mr	mr	PROPN
aiua-11830	262	22	and	and	CCONJ
aiua-11830	262	23	digital	digital	ADJ
aiua-11830	262	24	rectal	rectal	ADJ
aiua-11830	262	25	examination	examination	NOUN
aiua-11830	262	26	in	in	ADP
aiua-11830	262	27	men	man	NOUN
aiua-11830	262	28	with	with	ADP
aiua-11830	262	29	low	low	ADJ
aiua-11830	262	30	serum	serum	NOUN
aiua-11830	262	31	psa	psa	NOUN
aiua-11830	262	32	:	:	PUNCT
aiua-11830	262	33	up	up	ADP
aiua-11830	262	34	-	-	PUNCT
aiua-11830	262	35	date	date	NOUN
aiua-11830	262	36	of	of	ADP
aiua-11830	262	37	the	the	DET
aiua-11830	262	38	italian	italian	ADJ
aiua-11830	262	39	society	society	NOUN
aiua-11830	262	40	of	of	ADP
aiua-11830	262	41	integrated	integrate	VERB
aiua-11830	262	42	diagnostic	diagnostic	NOUN
aiua-11830	262	43	in	in	ADP
aiua-11830	262	44	urology	urology	NOUN
aiua-11830	262	45	.	.	PUNCT
aiua-11830	263	1	arch	arch	ADJ
aiua-11830	263	2	ital	ital	PROPN
aiua-11830	263	3	urol	urol	PROPN
aiua-11830	263	4	androl	androl	PROPN
aiua-11830	263	5	.	.	PROPN
aiua-11830	263	6	2021	2021	NUM
aiua-11830	263	7	;	;	PUNCT
aiua-11830	263	8	93:92	93:92	NUM
aiua-11830	263	9	-	-	SYM
aiua-11830	263	10	100	100	NUM
aiua-11830	263	11	.	.	PUNCT
aiua-11830	264	1	24	24	NUM
aiua-11830	264	2	.	.	PUNCT
aiua-11830	265	1	oerther	oerther	PROPN
aiua-11830	265	2	b	b	PROPN
aiua-11830	265	3	,	,	PUNCT
aiua-11830	265	4	engel	engel	PROPN
aiua-11830	265	5	h	h	PROPN
aiua-11830	265	6	,	,	PUNCT
aiua-11830	265	7	bamberg	bamberg	PROPN
aiua-11830	265	8	f	f	PROPN
aiua-11830	265	9	,	,	PUNCT
aiua-11830	265	10	et	et	PROPN
aiua-11830	265	11	al	al	PROPN
aiua-11830	265	12	.	.	PUNCT
aiua-11830	266	1	cancer	cancer	NOUN
aiua-11830	266	2	detection	detection	NOUN
aiua-11830	266	3	rates	rate	NOUN
aiua-11830	266	4	of	of	ADP
aiua-11830	266	5	the	the	DET
aiua-11830	266	6	pi	pi	NOUN
aiua-11830	266	7	-	-	PUNCT
aiua-11830	266	8	radsv2.1	radsv2.1	NOUN
aiua-11830	266	9	assessment	assessment	NOUN
aiua-11830	266	10	categories	category	NOUN
aiua-11830	266	11	:	:	PUNCT
aiua-11830	266	12	systematic	systematic	ADJ
aiua-11830	266	13	review	review	NOUN
aiua-11830	266	14	and	and	CCONJ
aiua-11830	266	15	metaanalysis	metaanalysis	NOUN
aiua-11830	266	16	on	on	ADP
aiua-11830	266	17	lesion	lesion	NOUN
aiua-11830	266	18	level	level	NOUN
aiua-11830	266	19	and	and	CCONJ
aiua-11830	266	20	patient	patient	ADJ
aiua-11830	266	21	level	level	NOUN
aiua-11830	266	22	.	.	PUNCT
aiua-11830	267	1	prostate	prostate	NOUN
aiua-11830	267	2	cancer	cancer	NOUN
aiua-11830	267	3	prostatic	prostatic	ADJ
aiua-11830	267	4	dis	dis	PROPN
aiua-11830	267	5	.	.	PUNCT
aiua-11830	268	1	2022	2022	NUM
aiua-11830	268	2	;	;	PUNCT
aiua-11830	268	3	25:256	25:256	NUM
aiua-11830	268	4	-	-	SYM
aiua-11830	268	5	63	63	NUM
aiua-11830	268	6	.	.	PUNCT
aiua-11830	269	1	25	25	NUM
aiua-11830	269	2	.	.	PUNCT
aiua-11830	269	3	schoots	schoot	VERB
aiua-11830	269	4	ig	ig	PROPN
aiua-11830	269	5	.	.	PUNCT
aiua-11830	269	6	mri	mri	NOUN
aiua-11830	269	7	in	in	ADP
aiua-11830	269	8	early	early	ADJ
aiua-11830	269	9	prostate	prostate	NOUN
aiua-11830	269	10	cancer	cancer	NOUN
aiua-11830	269	11	detection	detection	NOUN
aiua-11830	269	12	:	:	PUNCT
aiua-11830	269	13	how	how	SCONJ
aiua-11830	269	14	to	to	PART
aiua-11830	269	15	manage	manage	VERB
aiua-11830	269	16	indeterminate	indeterminate	ADJ
aiua-11830	269	17	or	or	CCONJ
aiua-11830	269	18	equivocal	equivocal	ADJ
aiua-11830	269	19	pi	pi	NOUN
aiua-11830	269	20	-	-	PUNCT
aiua-11830	269	21	rads	rad	NOUN
aiua-11830	269	22	3	3	NUM
aiua-11830	269	23	lesions	lesion	NOUN
aiua-11830	269	24	?	?	PUNCT
aiua-11830	270	1	transl	transl	PROPN
aiua-11830	270	2	androl	androl	PROPN
aiua-11830	270	3	urol	urol	PROPN
aiua-11830	270	4	.	.	PROPN
aiua-11830	270	5	2018	2018	NUM
aiua-11830	270	6	;	;	PUNCT
aiua-11830	270	7	7:70	7:70	NUM
aiua-11830	270	8	-	-	SYM
aiua-11830	270	9	82	82	NUM
aiua-11830	270	10	.	.	PUNCT
aiua-11830	271	1	correspondence	correspondence	NOUN
aiua-11830	271	2	débora	débora	PROPN
aiua-11830	271	3	araújo	araújo	PROPN
aiua-11830	271	4	,	,	PUNCT
aiua-11830	271	5	md	md	PROPN
aiua-11830	271	6	deboracerqueiraaraujo@gmail.com	deboracerqueiraaraujo@gmail.com	PROPN
aiua-11830	272	1	jorge	jorge	PROPN
aiua-11830	272	2	dias	dias	PROPN
aiua-11830	272	3	,	,	PUNCT
aiua-11830	272	4	md	md	PROPN
aiua-11830	272	5	josh_dias@hotmail.com	josh_dias@hotmail.com	PROPN
aiua-11830	272	6	samuel	samuel	PROPN
aiua-11830	272	7	bastos	bastos	PROPN
aiua-11830	272	8	,	,	PUNCT
aiua-11830	272	9	md	md	PROPN
aiua-11830	272	10	samuel.sbastos@hotmail.com	samuel.sbastos@hotmail.com	PROPN
aiua-11830	272	11	rui	rui	PROPN
aiua-11830	272	12	miguel	miguel	PROPN
aiua-11830	272	13	maciel	maciel	PROPN
aiua-11830	272	14	,	,	PUNCT
aiua-11830	272	15	md	md	PROPN
aiua-11830	272	16	rui.painhas.maciel@chvng.min-saude.pt	rui.painhas.maciel@chvng.min-saude.pt	PROPN
aiua-11830	272	17	ana	ana	PROPN
aiua-11830	272	18	sabença	sabença	PROPN
aiua-11830	272	19	,	,	PUNCT
aiua-11830	272	20	md	md	PROPN
aiua-11830	272	21	anasofiassg@gmail.com	anasofiassg@gmail.com	X
aiua-11830	272	22	luís	luís	PROPN
aiua-11830	272	23	xambre	xambre	PROPN
aiua-11830	272	24	,	,	PUNCT
aiua-11830	272	25	md	md	PROPN
aiua-11830	272	26	xambreluis@gmail.com	xambreluis@gmail.com	PROPN
aiua-11830	272	27	urology	urology	PROPN
aiua-11830	272	28	department	department	PROPN
aiua-11830	272	29	,	,	PUNCT
aiua-11830	272	30	centro	centro	PROPN
aiua-11830	272	31	hospitalar	hospitalar	PROPN
aiua-11830	272	32	vila	vila	PROPN
aiua-11830	272	33	nova	nova	PROPN
aiua-11830	272	34	de	de	PROPN
aiua-11830	272	35	gaia	gaia	PROPN
aiua-11830	272	36	/	/	SYM
aiua-11830	272	37	espinho	espinho	PROPN
aiua-11830	272	38	epe	epe	PROPN
aiua-11830	272	39	,	,	PUNCT
aiua-11830	272	40	vila	vila	PROPN
aiua-11830	272	41	nova	nova	PROPN
aiua-11830	272	42	de	de	PROPN
aiua-11830	272	43	gaia	gaia	PROPN
aiua-11830	272	44	,	,	PUNCT
aiua-11830	272	45	portugal	portugal	PROPN
aiua-11830	272	46	alexandre	alexandre	PROPN
aiua-11830	272	47	gromicho	gromicho	NOUN
aiua-11830	272	48	,	,	PUNCT
aiua-11830	272	49	md	md	PROPN
aiua-11830	272	50	alexandrepgromicho@gmail.com	alexandrepgromicho@gmail.com	PROPN
aiua-11830	272	51	urology	urology	PROPN
aiua-11830	272	52	department	department	PROPN
aiua-11830	272	53	,	,	PUNCT
aiua-11830	272	54	centro	centro	PROPN
aiua-11830	272	55	hospitalar	hospitalar	PROPN
aiua-11830	272	56	do	do	VERB
aiua-11830	272	57	funchal	funchal	NOUN
aiua-11830	272	58	,	,	PUNCT
aiua-11830	272	59	madeira	madeira	PROPN
aiua-11830	272	60	,	,	PUNCT
aiua-11830	272	61	portugal	portugal	PROPN
aiua-11830	272	62	conflict	conflict	NOUN
aiua-11830	272	63	of	of	ADP
aiua-11830	272	64	interest	interest	NOUN
aiua-11830	272	65	:	:	PUNCT
aiua-11830	272	66	the	the	DET
aiua-11830	272	67	authors	author	NOUN
aiua-11830	272	68	declare	declare	VERB
aiua-11830	272	69	no	no	DET
aiua-11830	272	70	potential	potential	ADJ
aiua-11830	272	71	conflict	conflict	NOUN
aiua-11830	272	72	of	of	ADP
aiua-11830	272	73	interest	interest	NOUN
aiua-11830	272	74	.	.	PUNCT